
<html lang="en"     class="pb-page"  data-request-id="22d24ac1-6eb8-45c2-b5a7-6ae0f63c9a58"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2008.51.issue-24;website:website:acspubs;article:article:10.1021/jm801073z;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Further Studies with the 2-Amino-1,3-thiazol-4(5H)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model" /></meta><meta name="dc.Creator" content="Christopher  Fotsch" /></meta><meta name="dc.Creator" content="Michael D.  Bartberger" /></meta><meta name="dc.Creator" content="Eric A.  Bercot" /></meta><meta name="dc.Creator" content="Michelle  Chen" /></meta><meta name="dc.Creator" content="Rod  Cupples" /></meta><meta name="dc.Creator" content="Maury  Emery" /></meta><meta name="dc.Creator" content="Jenne  Fretland" /></meta><meta name="dc.Creator" content="Anil  Guram" /></meta><meta name="dc.Creator" content="Clarence  Hale" /></meta><meta name="dc.Creator" content="Nianhe  Han" /></meta><meta name="dc.Creator" content="Dean  Hickman" /></meta><meta name="dc.Creator" content="Randall W.  Hungate" /></meta><meta name="dc.Creator" content="Michael  Hayashi" /></meta><meta name="dc.Creator" content="Renee  Komorowski" /></meta><meta name="dc.Creator" content="Qingyian  Liu" /></meta><meta name="dc.Creator" content="Guy  Matsumoto" /></meta><meta name="dc.Creator" content="David J.  St. Jean, Jr." /></meta><meta name="dc.Creator" content="Stefania  Ursu" /></meta><meta name="dc.Creator" content="Murielle  Véniant" /></meta><meta name="dc.Creator" content="Guifen  Xu" /></meta><meta name="dc.Creator" content="Qiuping  Ye" /></meta><meta name="dc.Creator" content="Chester  Yuan" /></meta><meta name="dc.Creator" content="Jiandong  Zhang" /></meta><meta name="dc.Creator" content="Xiping  Zhang" /></meta><meta name="dc.Creator" content="Hua  Tu" /></meta><meta name="dc.Creator" content="Minghan  Wang" /></meta><meta name="dc.Description" content="A series of compounds containing the 2-amino-1,3-thiazol-4(5H)-one core were found to be potent inhibitors of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). One of our lead compound..." /></meta><meta name="Description" content="A series of compounds containing the 2-amino-1,3-thiazol-4(5H)-one core were found to be potent inhibitors of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). One of our lead compound..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 19, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm801073z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm801073z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm801073z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm801073z" /></link>
        
    
    

<title>Further Studies with the 2-Amino-1,3-thiazol-4(5H)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm801073z" /></meta><meta property="og:title" content="Further Studies with the 2-Amino-1,3-thiazol-4(5H)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0017.jpeg" /></meta><meta property="og:description" content=" A series of compounds containing the 2-amino-1,3-thiazol-4(5H)-one core were found to be potent inhibitors of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). One of our lead compounds from this series activated the human nuclear xenobiotic receptor, pregnane X receptor (PXR). To try and mitigate the PXR activity, we prepared analogues of our lead series that contained polar groups on the right-hand side of the thiazolone. Several analogues containing amides or alcohols appended to the C-5 position of the thiazolone showed a significant reduction in PXR activity. Through these structure−activity efforts, a compound containing a tert-alcohol group off the C-5 position, analogue (S)-33a, was found to have an 11β-HSD1 Ki = 35 nM and negligible PXR activity. Compound (S)-33a was advanced into a pharmacodynamic model in cynomolgus monkeys, where it inhibited adipose 11β-HSD1 activity after being orally administered." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm801073z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm801073z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm801073z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm801073z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm801073z&amp;href=/doi/10.1021/jm801073z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 7953-7967</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800831y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800964f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Further Studies with the 2-Amino-1,3-thiazol-4(5<i>H</i>)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Fotsch">Christopher Fotsch</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Bartberger">Michael D. Bartberger</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Bercot">Eric A. Bercot</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Chen">Michelle Chen</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rod++Cupples">Rod Cupples</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maury++Emery">Maury Emery</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenne++Fretland">Jenne Fretland</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anil++Guram">Anil Guram</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clarence++Hale">Clarence Hale</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nianhe++Han">Nianhe Han</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean++Hickman">Dean Hickman</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randall+W.++Hungate">Randall W. Hungate</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Hayashi">Michael Hayashi</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Renee++Komorowski">Renee Komorowski</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingyian++Liu">Qingyian Liu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Matsumoto">Guy Matsumoto</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++St.+Jean%2C++Jr.">David J. St. Jean, Jr.</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Ursu">Stefania Ursu</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murielle++V%C3%A9niant">Murielle Véniant</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guifen++Xu">Guifen Xu</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiuping++Ye">Qiuping Ye</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chester++Yuan">Chester Yuan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiandong++Zhang">Jiandong Zhang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiping++Zhang">Xiping Zhang</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Tu">Hua Tu</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minghan++Wang">Minghan Wang</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Tel: 805-447-7746. Fax: 805-480-1337. E-mail: <a href="/cdn-cgi/l/email-protection#3c5f5a53484f5f547c5d515b5952125f5351"><span class="__cf_email__" data-cfemail="7417121b0007171c34151913111a5a171b19">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Chemical Research and Development.</div><div class="corresp-fn" id="afn2">‡Department of Metabolic Disorders.</div><div class="corresp-fn" id="afn3">§Department of Pharmacokinetics and Drug Metabolism.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm801073z&amp;href=/doi/10.1021%2Fjm801073z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 7953–7967</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 19, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2008</li><li><span class="item_label"><b>Published</b> online</span>19 November 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 December 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm801073z" title="DOI URL">https://doi.org/10.1021/jm801073z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7953%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BFotsch%252C%2BMichael%2BD.%2BBartberger%252C%2BEric%2BA.%2BBercot%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D24%26contentID%3Djm801073z%26title%3DFurther%2BStudies%2Bwith%2Bthe%2B2-Amino-1%252C3-thiazol-4%25285H%2529-one%2BClass%2Bof%2B11%25CE%25B2-Hydroxysteroid%2BDehydrogenase%2BType%2B1%2BInhibitors%253A%2BReducing%2BPregnane%2BX%2BReceptor%2BActivity%2Band%2BExploring%2BActivity%2Bin%2Ba%2BMonkey%2BPharmacodynamic%2BModel%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7967%26publicationDate%3DDecember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm801073z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2634</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm801073z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Further Studies with the 2-Amino-1,3-thiazol-4(5H)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Fotsch&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Bartberger&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Bercot&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Rod&quot;,&quot;last_name&quot;:&quot;Cupples&quot;},{&quot;first_name&quot;:&quot;Maury&quot;,&quot;last_name&quot;:&quot;Emery&quot;},{&quot;first_name&quot;:&quot;Jenne&quot;,&quot;last_name&quot;:&quot;Fretland&quot;},{&quot;first_name&quot;:&quot;Anil&quot;,&quot;last_name&quot;:&quot;Guram&quot;},{&quot;first_name&quot;:&quot;Clarence&quot;,&quot;last_name&quot;:&quot;Hale&quot;},{&quot;first_name&quot;:&quot;Nianhe&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;Hickman&quot;},{&quot;first_name&quot;:&quot;Randall&quot;,&quot;last_name&quot;:&quot;W. Hungate&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Hayashi&quot;},{&quot;first_name&quot;:&quot;Renee&quot;,&quot;last_name&quot;:&quot;Komorowski&quot;},{&quot;first_name&quot;:&quot;Qingyian&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Matsumoto&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. St. Jean&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Ursu&quot;},{&quot;first_name&quot;:&quot;Murielle&quot;,&quot;last_name&quot;:&quot;Véniant&quot;},{&quot;first_name&quot;:&quot;Guifen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Qiuping&quot;,&quot;last_name&quot;:&quot;Ye&quot;},{&quot;first_name&quot;:&quot;Chester&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Jiandong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xiping&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Minghan&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;7953-7967&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm801073z&quot;},&quot;abstract&quot;:&quot;A series of compounds containing the 2-amino-1,3-thiazol-4(5H)-one core were found to be potent inhibitors of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). One of our lead compounds from this series activated the human nuclear xenobiotic receptor, pregnane X receptor (PXR). To try and mitigate the PXR activity, we prepared analogues of our lead series that contained polar groups on the right-hand side of the thiazolone. Several analogues containing amides or alcohols appended to the C-5 position of the thiazolone showed a significant reduction in PXR activity. Through these structure−activity efforts, a compound containing a tert-alcohol group off the C-5 position, analogue (S)-33a, was found to have an 11β-HSD1 Ki = 35 nM and negligible PXR activity. Compound (S)-33a was advanced into a pharmacodynamic model in cynomolgus monkeys, where it inhibited adipose 11β-HSD1 activity after being orally administered.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801073z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801073z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801073z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801073z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801073z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801073z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm801073z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801073z&amp;href=/doi/10.1021/jm801073z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm801073z" /></input><a href="/doi/pdf/10.1021/jm801073z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (441 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm801073z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm801073z%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DFotsch%26date%3D2008%26atitle%3DFurther%2BStudies%2Bwith%2Bthe%2B2-Amino-1%252C3-thiazol-4%25285H%2529-one%2BClass%2Bof%2B11%25CE%25B2-Hydroxysteroid%2BDehydrogenase%2BType%2B1%2BInhibitors%253A%2BReducing%2BPregnane%2BX%2BReceptor%2BActivity%2Band%2BExploring%2BActivity%2Bin%2Ba%2BMonkey%2BPharmacodynamic%2BModel%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D24%26spage%3D7953%26epage%3D7967%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of compounds containing the 2-amino-1,3-thiazol-4(5<i>H</i>)-one core were found to be potent inhibitors of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). One of our lead compounds from this series activated the human nuclear xenobiotic receptor, pregnane X receptor (PXR). To try and mitigate the PXR activity, we prepared analogues of our lead series that contained polar groups on the right-hand side of the thiazolone. Several analogues containing amides or alcohols appended to the C-5 position of the thiazolone showed a significant reduction in PXR activity. Through these structure−activity efforts, a compound containing a <i>tert</i>-alcohol group off the C-5 position, analogue (<i>S</i>)-<b>33a</b>, was found to have an 11β-HSD1 <i>K</i><sub>i</sub> = 35 nM and negligible PXR activity. Compound (<i>S</i>)-<b>33a</b> was advanced into a pharmacodynamic model in cynomolgus monkeys, where it inhibited adipose 11β-HSD1 activity after being orally administered.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An estimated 171 million people worldwide suffered from diabetes in the year 2000.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> By the year 2030, the number of people afflicted with diabetes could more than double.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The majority of these cases are defined as type II diabetes mellitus (T2DM), a condition characterized by an abnormally high fasting blood glucose (>126 mg/dL) and insulin resistance. Left untreated, T2DM can lead to debilitating sequelae such as retinopathy, neuropathy, coronary artery disease, and ischemic stroke. While many therapies are currently available for managing the symptoms associated with T2DM (e.g., insulin secretagogues, insulin sensitizers, and modulators of glucose uptake and production), improved therapies are being sought that target novel biological pathways involved in this disease. One target that has piqued the interest of many pharmaceutical companies is the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1<a class="ref internalNav" href="#fn1" aria-label="a">a</a>).<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2-5)</a></div><div class="NLM_p"><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: 11β-HSD1, 11β-hydroxysteroid dehydrogenase; CYP, cytochrome P450; PXR, pregnane X receptor; thiazolone, 1,3-thiazol-4(5<i>H</i>)-one; AUC, area under the curve; POC, percent of control.</p></div></div><div class="NLM_p">Expressed mainly in liver, adipose, and brain, 11β-HSD1 is an NADPH-dependent enzyme that primarily acts as a reductase to convert the inactive glucocorticoid cortisone (<b>1a</b>) to the active form, cortisol (<b>2a</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). In rodents, 11β-HSD1 converts dehydrocorticosterone (<b>1b</b>) to the active form, corticosterone (<b>2b</b>). The isozyme of 11β-HSD1, 11β-HSD2, is mainly expressed in the kidney and acts as a dehydrogenase to convert cortisol (<b>2a</b>) to cortisone (<b>1a</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). In adipose and liver, cortisol activates the glucocorticoid receptor (GR), which upregulates the expression of genes involved in energy homeostasis, that is, genes that regulate gluconeogenesis,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> adipogenesis, and lipolysis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Because 11β-HSD1 is the enzyme that controls the tissue levels of the GR ligand, cortisol, excessive activity of 11β-HSD1 is thought to play a role in the development of hyperglycemia, insulin resistance, and lipid disorders. Evidence supporting this hypothesis was obtained in mice that have genetically altered 11β-HSD1 expression. Mice that overexpress 11β-HSD1 in adipose tissue developed central obesity, insulin resistance, and dyslipidemia.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Conversely, mice deficient in 11β-HSD1 were resistant to diet-induced obesity and insulin resistance.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> In addition, orally available 11β-HSD1 inhibitors have been shown to improve glucose tolerance and insulin resistance in mouse models of type II diabetes <a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> (see Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a> for examples of 11β-HSD1 inhibitors<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a>). Although there is no concrete evidence that patients with diabetes exhibit increased circulating glucocorticoid levels, elevated adipose 11β-HSD1 activity has been correlated with obesity in humans, suggesting that there is increased tissue-specific GR activity in obesity.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> The weight of evidence suggests that inhibition of 11β-HSD1 is an attractive strategy to lower GR activity, which could be useful for treating type II diabetes.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Interconversion of Cortisone, <b>1a</b> (Dehydrocorticosterone, <b>1b</b>), to Cortisol, <b>2a</b> (Corticosterone, <b>2b</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Examples of 11β-HSD1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Chart a</span>Ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>.</p><p><span class="fn-label">Chart b</span>Ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</p><p><span class="fn-label">Chart c</span>Ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p><p><span class="fn-label">Chart d</span>Ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p><p class="last"><span class="fn-label">Chart e</span>Ref <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a>.</p></p></figure><div class="NLM_p last">We have previously described a class of 11β-HSD1 inhibitors containing the 1,3-thiazol-4(5<i>H</i>)-one core (referred to as thiazolone).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In our publications,<a onclick="showRef(event, 'ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref23">(21, 23)</a> compound <b>3</b> was shown to be a potent and selective inhibitor of 11β-HSD1, which inhibited adipose 11β-HSD1 activity in vivo and was efficacious in rodent models of diabetes.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> After further profiling in drug metabolism studies, compound <b>3</b> was found to activate the human pregnane X receptor (PXR), a nuclear receptor that upregulates genes involved in drug metabolism [e.g., cytochrome P450 (CYP) 3A4 and multidrug resistance proteins]. By activating PXR, the efficacy of a compound may be reduced since PXR upregulates proteins that may increase the clearance of a drug.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Our strategy to reduce the PXR activation of compound <b>3</b> was to replace the CF<sub>3</sub> group at the 5-position with polar groups to decrease the logP, a strategy that is known to lower PXR activity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Also, the X-ray data<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and a homology model<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> of PXR suggest that its binding site is very hydrophobic, so adding polar groups to our compounds might make binding to this site unfavorable. Because we knew from our previous work that the left-hand α-methyl benzylamine group of <b>3</b> was important for 11β-HSD1 activity and metabolic stability,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we kept this group in the analogues prepared in this paper. Herein, we describe the structure−activity relationship (SAR) of 2-aminobenzyl thiazolone analogues that contain amides, carboxylic acids, and alcohols appended to the 5-position, and we describe how some of these changes affected PXR activity.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds containing an aryl group at the 5-position of the thiazolone were prepared using the methods outlined in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Thiourea <b>5</b> was prepared in two steps from the commercially available amine <b>4</b> by first treating the amine with benzoyl isothiocyanate followed by basic hydrolysis. Thiourea <b>5</b> was treated with α-bromo carboxylates <b>7</b> to give thiazolones, which were then methylated at the 5-position of the thiazolone ring to give compounds <b>8</b> and <b>9</b>. The aryl bromide on compound <b>9</b> was converted to a carboxymethyl group through a palladium-mediated carbonylation reaction to provide intermediate <b>10</b>. This intermediate was converted to the carboxylic acid <b>11</b>, which was then converted to amide derivatives <b>12a</b>−<b>e</b> and <b>13</b>. Alternatively, the ester <b>10</b> was converted to alcohol <b>14</b>, which was then converted in a three-step process to amide <b>15</b>.</div><div class="NLM_p">The thiourea <b>5</b> was also treated with methyl 2-bromopropanoate to give 5-methyl thiazolone <b>16</b> as a key intermediate, which was used for the preparation of the final compounds shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Amide <b>18</b> was prepared from thiazolone <b>16</b> by first alkylating the 5-position with 4-(bromomethyl)benzonitrile and then hydrolyzing the nitrile with KOH. To introduce an aromatic ring directly onto the 5-position of the thiazolone, aryl bromide <b>19</b> was cross-coupled with intermediate <b>16</b> using LiHMDS, Pd<sub>2</sub>(dba)<sub>3</sub>, and BINAP. The nitrile was then hydrolyzed as before to provide amide compound <b>20</b>. The cross-coupling procedure used to prepare <b>20</b> was also used in the preparation of analogues <b>23</b>, <b>26</b>, and <b>29</b>. Amide analogue <b>30</b> was prepared from alcohol <b>29</b> through commonly used functional group interconversions.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Strategy To Address the Issue of PXR Activation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PXR activity with a 20 μM concentration of <b>3</b> (100% of control is equivalent to the activity achieved with 12.5 μM rifampin).</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0006.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Benzoyl isothiocyanate, CH<sub>2</sub>Cl<sub>2</sub>. (b) K<sub>2</sub>CO<sub>3</sub>, THF/methanol/H<sub>2</sub>O, 98% for two steps. (c) NBS, AIBN, CCl<sub>4</sub>, 80 °C (X = F, R = H, 86%; X = Br, R = Et, 96%). (d) X = F, NaOAc, ethanol, reflux, 48%; X = Br, NEt(<i>i</i>-Pr)<sub>2</sub>, ethanol, reflux, 71%. (e) LDA, CH<sub>3</sub>I, THF, −78 °C, (X = F, 68%, X = Br, 97%). (f) CO, PPh<sub>3</sub>, Pd(OAc)<sub>2</sub>, KOAc, methanol, DMF, 100 °C, 99%. (g) LiOH, H<sub>2</sub>O, THF, methanol, reflux, 62%. (h) LiAlH<sub>4</sub>, THF, 0 °C, 70%. (i) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 100%. (j) HNR<sub>1</sub>R<sub>2</sub>, THF, 0 °C, 8−79%. (k) Morpholine, HOBT, dicyclohexanecarbodiimide, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 91%. (l) SOCl<sub>2</sub>, dioxane, room temperature, 100%. (m) Bu<sub>4</sub>NCN, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 63%. (n) KOH, <i>t</i>-BuOH, 100 °C, 17%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0007.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Methyl 2-bromopropanoate, Et<sub>3</sub>N, ethanol, 100 °C, microwave, 88%. (b) Compound <b>16</b>, LDA, THF, −78 to 0 °C, 87%. (c) KOH, <i>t</i>-BuOH, 85−100 °C, 66−86%. (d) Compound <b>16</b>, LiHMDS, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, toluene, 95 °C, 26−37%. (e) <i>t</i>-BuOK, 18-crown-6, CH<sub>3</sub>I, THF, −78 °C to room temperature, 99%. (f) CH<sub>3</sub>MgBr, THF, 0 °C to room temperature, 74%. (g) TMSCl, NEt(<i>i</i>-Pr)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temperature, 84%. (h) K<sub>2</sub>CO<sub>3</sub>, methanol, room temperature, 93%. (i) Imidazole, iodine, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 82%. (j) Bu<sub>4</sub>NCN, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 65%.</p></p></figure><div class="NLM_p">Compounds containing tertiary alcohols off the 5-position of the thiazolone were prepared as outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The thioureas for these compounds were prepared from commercially available benzyl amines using the procedure described above. To prepare 5-methyl thiazolones <b>32</b>, thioureas <b>31</b> were heated with 2-bromoproprionic acid and NaOAc (Compound <b>16</b> was prepared by this alternate procedure in addition to being prepared by the method illustrated in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. See the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>). Tertiary alcohol derivatives <b>33</b> were prepared from thiazolone <b>32</b> using LDA and the appropriate ketone. Analogue <b>35</b> was prepared from 5-methyl thiazolone <b>16</b> by alkylating the 5-position with 2-methyloxirane to give intermediate <b>34</b>. Oxidation of <b>34</b> and subsequent addition of methyl Grignard afforded the desired tertiary alcohol <b>35</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0008.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-Bromopropanoic acid, NaOAc, ethanol, reflux, 88−100%. (b) LDA, THF, −78 °C. (c) R<sub>1</sub>R<sub>2</sub>C═O, THF, −78−0 °C, 17−100%. (d) Lithium bis(trimethylsilyl)amide, THF, 0 °C. (e) 2-Methyloxirane, LiClO<sub>4</sub>, THF, 0 °C to room temperature, 71%. (f) Dess−Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 83%. (g) CH<sub>3</sub>MgBr, THF, 0 °C, 61%.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibition of 11β-HSD1 and 11β-HSD2 enzymatic activity was measured using a scintillation proximity assay (SPA).<a onclick="showRef(event, 'ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref21 ref29">(21, 29)</a> Cell-based activity was measured by monitoring the conversion of cortisone to cortisol in Chinese hamster ovary (CHO) cells stably transfected with human 11β-HSD1.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Results are reported as the average of at least two independent experiments with at least two replicates at each concentration. The variance in the measurements is expressed as the standard error of the mean (SEM).</div><div class="NLM_p">During the expansion of the SAR for lead compound <b>3</b>, analogue <b>8</b>, containing a 4-fluoro phenyl group at the 5-position of the thiazolone, was found to have 11β-HSD1 activity similar to our lead compound <b>3</b> (both have <i>K</i><sub>i</sub> values = 22 nM, see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Rather than trying to substitute polar groups off the CF<sub>3</sub> group of <b>3</b>, we felt that the C-5 phenyl group on <b>8</b> was an easier platform to append polar groups. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes the analogues of <b>8</b> that we prepared that contained polar groups on the C-5 aromatic ring. The first attempt at incorporating a polar group led to carboxylate analogue <b>11</b>, which had a <i>K</i><sub>i</sub> = 3.5 μM. We were able to quickly improve the activity of this compound with ester and primary amide derivatives, <b>10</b> and <b>12a</b>, which were ≥80-fold more potent than carboxylate analogue <b>11</b>. Keeping the primary amide in place, and extending the aromatic ring by one methylene group, gave compound <b>18</b>, which was ∼40-fold less potent than the amide analogue <b>12a</b>. Because activity decreased with the addition of a methylene spacer, subsequent analogues in this series contained an aromatic ring directly attached to 5-position of the thiazolone ring. Tertiary and secondary amide analogues, <b>12b</b>−<b>12d</b> and <b>13</b>, were all less potent (<i>K</i><sub>i</sub> values = 76−330 nM) than the primary amide analogue <b>12a</b>, but the pyrrolidine amide analogue <b>12e</b> was slightly more potent than <b>12a</b>. Four other primary amide analogues were also prepared. Analogue <b>15</b>, containing a methylene spacer between the amide and the aryl ring, was ∼2-fold less potent than amide analogue <b>12a</b>. An analogue containing geminal methyl groups at the benzylic position (analog <b>23</b>) and an analogue with a two-carbon spacer (<b>30</b>) were also less potent than primary amide <b>12a</b>. However, the analogue containing a cyclopropyl ring at the benzylic position, compound <b>20</b>, was slightly more potent than the primary amide <b>12a</b> (cf. <i>K</i><sub>i</sub> = 30 vs 44 nM). Analogues containing alcohols were also tested in this series of compounds. As observed in the SAR of the primary amides, the alcohol containing geminal methyl groups at the benzylic position (compound <b>26</b>) and the alcohol with a two-carbon spacer (compound <b>29</b>) were less potent that analogue containing the primary alcohol (compound <b>14</b>, <i>K</i><sub>i</sub> = 46 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Thiazolones Substituted with Polar Aryl Rings</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0009.gif" alt="" id="gr9" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0010.gif" alt="" id="_i11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> was derived from a SPA using human 11β-HSD1 expressed in <i>E. coli</i> cells and <sup>3</sup>H-cortisone as the substrate.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> was determined from a whole cell assay using CHO cells overexpressing human 11β-HSD1.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">SEM for at least two independent determinations.</p></div><div class="footnote" id="tbl1-fn4"><sup>d</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p">The most potent compounds from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were then tested in the PXR reporter gene assay. Analogue <b>8</b> had PXR activity of ca. 65% of control when tested at both 2 and 20 μM. At a test concentration of 2 μM, however, analogues with polar groups off the right-hand phenyl ring, compounds <b>12a</b>,<b>e</b>, <b>20</b>, and <b>14</b>, showed little activation of PXR (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Raising the test concentration to 20 μM, pyrrolidine amide <b>12e</b> and cyclopropyl analogue <b>20</b> activated PXR at 35 and 97% of control, respectively. On the other hand, the primary amide <b>12a</b> and alcohol <b>14</b>, at a test concentration of 20 μM, activated PXR by only 9.3 and 25%, respectively, which was significantly lower than our lead compound <b>3</b> (PXR = 45% of control). While these results were encouraging, amide analogue <b>12a</b> was found to be an efflux substrate in CACO-2 cells (efflux ratio = 10). Therefore, we focused on expanding the SAR of derivatives containing alcohols to maintain low PXR activation.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Transactivation of PXR<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0011.gif" alt="" id="_i13" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0012.gif" alt="" id="gr11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">PXR luciferase reporter gene assay.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Data were expressed as a percent of control (POC) where 100% of control is equivalent to the activity achieved with 12.5 μM rifampin. Compounds were run in triplicate and have been reported with the SEM.</p></div></div></div><div class="NLM_p">In the next set of analogues, we added hydroxyl groups to aliphatic chains on the C-5 position (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). An analogue containing the 2-methyl-propan-2-ol side chain, compound <b>35</b>, was 6-fold less potent than the benzyl alcohol analogue <b>14</b> but had similar PXR activity. Shortening the side chain further gave tertiary alcohol <b>33a</b>, which was nearly as potent as benzyl alcohol analogue <b>14</b> in the biochemical assay, but showed a significant decrease in PXR transactivation [10% (not significant) of control at a test concentration of 20 μM]. Encouraged by the lower PXR activity, more analogues were prepared that contained the tertiary alcohol directly attached to the C-5 position of the thiazolone. The biochemical and cell-based potency of such analogues improved with tertiary alcohol analogues containing the cyclobutyl and cylcopentyl groups (analogues <b>33b</b> and <b>33c</b>). However, in both cases, PXR activity increased (26 and 61% of control). Therefore, we kept the dimethyl tertiary alcohol in place and tried to improve potency by modifying the left-hand side of the molecule. Analogues containing groups larger than a fluorine atom at the <i>para</i>-position, analogues <b>33d</b>−<b>f</b>, or the analogue without a substituent on the phenyl ring, analogue <b>33h</b>, were less potent than analogue <b>33a</b>. Moving the fluoro to the <i>meta</i>-position gave analogue <b>33i</b>, which was ∼3-fold less potent than <i>para</i>-fluoro analogue <b>33a</b>. The <i>ortho</i>-fluoro analogue <b>33j</b>, on the other hand, was 2-fold more potent than <b>33a</b>. Other analogues with electron-withdrawing groups at the <i>ortho</i>-position, for example, <b>33k</b> and <b>33l</b>, were also more potent than <i>para</i>-fluoro analogue <b>33a</b>. However, all three of these <i>ortho</i>-substituted analogues, <b>33j</b>−<b>l</b>, were also more potent in the PXR assay than the <i>para</i>-fluoro substituted analogue <b>33a</b>. From this last set of results, PXR transactivation seems to be affected by subtle changes made to the phenyl ring on <b>33</b>. For example, the slight change of moving the fluoro from the <i>para</i>-position to the <i>ortho</i>-position led to a statistically significant increase in PXR transactivation (cf. the PXR values for <b>33a</b> and <b>33j</b>). Even more surprising is the PXR activity of the unsubstituted analogue <b>33h</b>, which had a PXR activity nearly 7-fold higher than the <i>para</i>-fluoro analogue <b>33a</b>. Because the goal of this work was to mitigate PXR transactivation, we only measured PXR functional activity and not PXR binding. We cannot, therefore, exclude the possibility that <b>33a</b> may bind to PXR and not activate the receptor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Nevertheless, compound <b>33a</b> seemed to strike the right balance between 11β-HSD1 potency and low PXR activity, so we subjected compound <b>33a</b> to further in vitro and in vivo testing.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Thiazolones Substituted with Aliphatic Alcohols</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0013.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0014.gif" alt="" id="_i15" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> was derived from a SPA using human 11β-HSD1 expressed in <i>E. coli</i> cells and <sup>3</sup>H-cortisone as the substrate.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> was determined from a whole cell assay using CHO cells overexpressing human 11β-HSD1.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">SEM for at least two independent determinations.</p></div><div class="footnote" id="tbl3-fn4"><sup>d</sup><p class="last"><i>n</i> = 1.</p></div><div class="footnote" id="tbl3-fn5"><sup>e</sup><p class="last">PXR luciferase reporter gene assay.</p></div><div class="footnote" id="tbl3-fn6"><sup>f</sup><p class="last">Data were expressed as a POC where 100% of control is equivalent to the activity achieved with 12.5 μM rifampin. Compounds were run in triplicate and have been reported with the SEM.</p></div><div class="footnote" id="tbl3-fn7"><sup>g</sup><p class="last">Compounds <b>33a</b>−<b>c</b> and <b>33j</b>−<b>l</b> had IC<sub>50</sub> values > 10000 nM in the human 11β-HSD2 assay.</p></div></div></div><div class="NLM_p">Before running additional studies with compound <b>33a</b>, the two diastereomers were separated using supercritical fluid chromatography. The C-5 (<i>S</i>)-isomer,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> compound (<i>S</i>)-<b>33a</b>, had a <i>K</i><sub>i</sub> and cell IC<sub>50</sub> of ∼35 nM, while the corresponding (<i>R</i>)-isomer was 6−8-fold less potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound (<i>S</i>)-<b>33a</b> was cocrystallized with human 11β-HSD1 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and occupied the catalytic binding pocket of the enzyme. As we observed with a related thiazolone inhibitor,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> the OH of Tyr183 formed a hydrogen bond with the C-2 NH of (<i>S</i>)-<b>33a</b>, and the backbone NH of Ala172 formed a hydrogen bond with the carbonyl group of thiazolone (<i>S</i>)-<b>33a</b>. The Ser170 OH formed a hydrogen bond with the side chain oxygen of Tyr183, which was also observed in our previously reported structure.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The phenyl ring of (<i>S</i>)-<b>33a</b> formed an edge-to-face π-stacking interaction with Tyr183, which was likely enhanced by the presence of the <i>para</i>-fluoro substituent.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The fluorophenyl ring also formed hydrophobic contacts with the side chain of Leu126 and other nearby residues. The “rearward” methyl group at the chiral C-5 position of (<i>S</i>)-<b>33a</b> formed a van der Waals contact with the backbone nitrogen atom of Leu217. The proximity of the C-5 substituent to Leu217 may explain why (<i>R</i>)-<b>33a</b> is less potent than (<i>S</i>)-<b>33a</b> in the human 11β-HSD1 assay, since the bulkier tertiary alcohol group at the C-5 of (<i>R</i>)-<b>33a</b> would suffer a steric clash with Leu217. The tertiary alcohol group of (<i>S</i>)-<b>33a</b> formed a hydrophobic contact with the side chain of Tyr177, but the hydroxyl group did not appear to form a direct H-bond contact with the protein. Instead, the hydroxyl may have interacted with solvent molecules. From prior crystallographic studies, water molecules have been observed in the 11β-HSD1 active site.<a onclick="showRef(event, 'ref22 ref32'); return false;" href="javascript:void(0);" class="ref ref22 ref32">(22, 32)</a></div><div class="NLM_table-wrap" id="tbl4">Table 4<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0015.gif" alt="" id="_i16" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char="±">hu11β-HSD1 activity</th></tr><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle" char="±">SPA<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char="±">cell<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></th></tr><tr valign="top"><th align="center" valign="middle">#</th><th align="center" valign="middle" char="±"><i>K</i><sub>i</sub> ± SEM<a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a></th><th align="center" valign="middle" char="±">IC<sub>50</sub> ± SEM<a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left">(<i>R</i>)-<b>33a</b></td><td align="char" char="±">210 ± 38</td><td align="char" char="±">300 ± 80</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>33a</b></td><td align="char" char="±">35 ± 1</td><td align="char" char="±">34 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> was derived from a SPA using the human 11β-HSD1 expressed in <i>E. coli</i> cells and <sup>3</sup>H-cortisone as the substrate.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> was determined from a whole cell assay using CHO cells overexpressing the human 11β-HSD1.</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last">SEM for at least two independent determinations.</p></div></div></div><figure id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0002.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray structure of human 11β-HSD1−(<i>S</i>)-<b>33a</b> complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the PXR assay, the POCs at 20 μM of compound (<i>S</i>)-<b>33a</b> and its diastereomer (<i>R</i>)-<b>33a</b> were 6 and 11, respectively. The result for (<i>S</i>)-<b>33a</b> represented a greater than 7-fold improvement over the PXR value obtained for compound <b>3</b>. To determine how PXR activation correlated with induction of CYP3A4, we measured the mRNA expression and enzyme activity of CYP3A4 in cryopreserved human hepatocytes.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a> Using hepatocytes from two different donors, compound <b>3</b> at a test concentration of 20 μM showed an increase in both CYP3A4 mRNA and enzyme activity (67−110 and 56−64% of control, respectively). Compound (<i>S</i>)-<b>33a</b>, on the other hand, only showed a modest increase in CYP3A4 mRNA expression and enzyme activity (13−45 and 10−17% of control, respectively). The CYP3A4 activities for compounds <b>3</b> and (<i>S</i>)-<b>33a</b> are consistent with the results from the PXR reporter gene assay; that is, increased PXR transactivation led to higher levels of CYP3A4 mRNA expression and enzyme activity.</div><div class="NLM_p">Encouraged by the PXR results, we next assessed (<i>S</i>)-<b>33a</b> for nonhuman 11β-HSD1 activity and in vivo pharmacokinetics (PK) to determine which species might be most appropriate for in vivo assessment (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In mouse, rat, dog, and monkey, the in vivo pharmacokinetics showed that compound (<i>S</i>)-<b>33a</b> had moderate to low clearance and oral bioavailabilities between 56 and 100%. In the 11β-HSD1 biochemical and cell-based assays, (<i>S</i>)-<b>33a</b> was less potent in the rodent assays (<i>K</i><sub>i</sub> = 100 and 300 nM for mouse and rat, respectively) than in the nonrodent assays (<i>K</i><sub>i</sub> = 12 and 48 nM for dog and monkey, respectively). Because compound (<i>S</i>)-<b>33a</b> was less potent in the rat assay than in the monkey assay, we chose to run the in vivo pharmacodynamic assay in monkeys. In addition, performing such a study in monkeys would lay the groundwork for additional studies in diabetic models with nonhuman primates.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Human PXR Activity and CYP3A4 Activity in Cryopreserved Hepatocytes</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="char" valign="middle" char="±"> </th><th colspan="4" align="center" valign="middle" char="±">activity in cryopreserved human hepatocytes</th></tr><tr valign="top"><th align="center" valign="middle"> </th><th align="char" valign="middle" char="±"> </th><th colspan="2" align="center" valign="middle" char="±">CYP3A4 mRNA (% of control)<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a> ± SD</th><th colspan="2" align="center" valign="middle" char="±">CYP3A4 activity<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a> (% of control)<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a> ± SD</th></tr><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle" char="±">PXR activity (% of control) ± SEM<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char="±">donor DJV</th><th align="center" valign="middle" char="±">donor NPV</th><th align="center" valign="middle" char="±">donor DJV</th><th align="center" valign="middle" char="±">donor NPV</th></tr></thead><tbody><tr valign="top"><td align="left">rifampin</td><td align="char" char="±">100 ± 10</td><td align="char" char="±">100 ± 9</td><td align="char" char="±">100 ± 5</td><td align="char" char="±">100 ± 2</td><td align="char" char="±">100 ± 3</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="char" char="±">45 ± 5</td><td align="char" char="±">110 ± 10</td><td align="char" char="±">67 ± 4</td><td align="char" char="±">64 ± 10</td><td align="char" char="±">56 ± 5</td></tr><tr valign="top"><td align="left">(<i>S</i>)-<b>33a</b></td><td align="char" char="±">6 ± 2</td><td align="char" char="±">45 ± 4</td><td align="char" char="±">13 ± 1</td><td align="char" char="±">17 ± 1</td><td align="char" char="±">10 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">PXR luciferase reporter gene assay. Data are expressed as a POC where 100% of control is equivalent to the activity achieved with 12.5 μM rifampin. Compounds were run in triplicate and have been reported with the SEM.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Data are expressed as a POC where 100% of control is equivalent to the activity achieved with 20 μM rifampin. Compounds were run twice and have been reported with the SD.</p></div><div class="footnote" id="tbl5-fn3"><sup>c</sup><p class="last">Enzyme activity was determined by measuring the conversion of midazolam to 1′-hydroxy midazolam. For details, see the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Potency and Pharmacokinetics of Compound (<i>S</i>)-<b>33a</b> in Four Different Species</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char="±">11β-HSD1 activity</th><th colspan="5" align="center" valign="middle" char=".">in vivo pharmacokinetics<a class="ref internalNav" href="#tbl6-fn4" aria-label="d">d</a></th></tr><tr valign="top"><th align="center" valign="middle">species</th><th align="center" valign="middle" char="±">SPA<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a><i>K</i><sub>i</sub> ± SEM<a class="ref internalNav" href="#tbl6-fn3" aria-label="c">c</a></th><th align="center" valign="middle" char="±">cell<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a> IC<sub>50</sub> ± SEM<a class="ref internalNav" href="#tbl6-fn3" aria-label="c">c</a></th><th align="center" valign="middle" char=".">CL (L h<sup>−1</sup>kg<sup>−1</sup>)</th><th align="center" valign="middle" char="."><i>V</i><sub>ss</sub> (L kg<sup>−1</sup>)</th><th align="center" valign="middle" char="."><i>t</i><sub>1/2</sub> (i.v., h)</th><th align="center" valign="middle" char=".">AUC<sub>oral</sub><a class="ref internalNav" href="#tbl6-fn5" aria-label="e">e</a> (ng h mL<sup>−1</sup>)</th><th align="center" valign="middle" char="."><i>F</i><sub>oral</sub> (%)</th></tr></thead><tbody><tr valign="top"><td align="left">mouse</td><td align="char" char="±">100 ± 18</td><td align="char" char="±">140 ± 60</td><td align="char" char=".">1.6</td><td align="char" char=".">1.4</td><td align="char" char=".">3.3</td><td align="char" char=".">6500</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="left">rat</td><td align="char" char="±">300 ± 70</td><td align="char" char="±">340 ± 80</td><td align="char" char=".">0.31</td><td align="char" char=".">2.5</td><td align="char" char=".">5.6</td><td align="char" char=".">9200</td><td align="char" char=".">56</td></tr><tr valign="top"><td align="left">dog</td><td align="char" char="±">12 ± 2</td><td align="char" char="±">45 ± 22</td><td align="char" char=".">0.085</td><td align="char" char=".">0.88</td><td align="char" char=".">7.3</td><td align="char" char=".">54000</td><td align="char" char=".">91</td></tr><tr valign="top"><td align="left">monkey</td><td align="char" char="±">48 ± 13</td><td align="char" char="±">42 ± 6</td><td align="char" char=".">1.2</td><td align="char" char=".">1.9</td><td align="char" char=".">2.2</td><td align="char" char=".">5700</td><td align="char" char=".">65</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> was derived from a SPA using the species 11β-HSD1 expressed in <i>E. coli</i> cells and <sup>3</sup>H-cortisone as the substrate.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> was determined from a whole cell assay using CHO cells overexpressing the species 11β-HSD1.</p></div><div class="footnote" id="tbl6-fn3"><sup>c</sup><p class="last">SEM for at least two independent determinations.</p></div><div class="footnote" id="tbl6-fn4"><sup>d</sup><p class="last">Mouse dosed i.v., 2 mg kg<sup>−1</sup> in 10% dimethylacetamide, 23% water, 67% PEG 400; p.o. 10 mg kg<sup>−1</sup> in 0.1% Tween 80, 0.5% CMC, 99.4% water. Rat dosed i.v., 2 mg kg<sup>−1</sup> in DMSO; dosed p.o., 5 mg kg<sup>−1</sup> in 0.1% Tween 80, 0.5% CMC, 99.4% water. Dog dosed i.v., 2 mg kg<sup>−1</sup> in 10% dimethylacetamide, 23% water, 67% PEG 400; dosed p.o., 5 mg kg<sup>−1</sup> in 1% Tween 80, 47.5% OraPlus, 51.5% water. Monkey dosed i.v., 2 mg kg<sup>−1</sup> in 10% dimethylacetamide, 40% water, 50% PEG 400; dosed p.o., 10 mg kg<sup>−1</sup> in 10% dimethylacetamide, 40% water, 50% PEG 400.</p></div><div class="footnote" id="tbl6-fn5"><sup>e</sup><p class="last">AUC<sub>oral</sub> = oral area under the curve (AUC) for time 0−∞.</p></div></div></div><div class="NLM_p">To measure the pharmacodynamic effects of (<i>S</i>)-<b>33a</b> in cynomolgus monkeys, we measured the activity of 11β-HSD1 in a fat tissue explant 2 h after the compound was given orally to the animals. The enzyme activity was measured by incubating the mesenteric fat with <sup>3</sup>H-cortisone and monitoring for the conversion to <sup>3</sup>H-cortisol. At the same time, blood was collected from the animals so that the plasma concentrations of (<i>S</i>)-<b>33a</b> could be determined. Statistically significant inhibition of 11β-HSD1 activity was observed at 3 and 30 mg kg<sup>−1</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Plasma concentrations of (<i>S</i>)-<b>33a</b> at 3 and 30 mg kg<sup>−1</sup> were 4.9 and 26 μM, respectively. Running a linear regression analysis on the data from the plasma concentrations vs the percent enzyme inhibition gave a plasma IC<sub>50</sub> = 910 nM. Adjusting for plasma protein binding (monkey <i>f</i><sub>unbound</sub> = 10.8%), the unbound IC<sub>50</sub> was calculated as 98 nM, which was slightly greater than the monkey cell IC<sub>50</sub> (42 nM). These data indicate that, when given orally, compound (<i>S</i>)-<b>33a</b> is able to penetrate the fat and inhibit 11β-HSD1 in the target tissue at plasma concentrations that are near the cellular IC<sub>50</sub>, when corrected for fraction unbound.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0003.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of 11β-HSD1 activity with (<i>S</i>)-<b>33a</b> (dosed PO) in the mesenteric fat of cynomolgus monkeys. *<i>p</i> = 0.0048, **<i>p</i> = 0.0007, and <i>n</i> ≥ 4. Statistical analyses were carried out using a two-tailed Student’s t-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, while our strategy to lower PXR activity by adding polar groups worked for some analogues, in other cases, the functionality on other parts of the inhibitors also affected PXR activity. Reducing steric bulk on the right-hand side of the molecule often helped reduce PXR activity. In addition, the substituents on the left-hand aromatic ring also influenced the PXR activity. The right balance of low PXR activity, biochemical potency, and cell-based activity was achieved with a compound that had a 4-fluorophenyl group on the left-hand side of the molecule and a dimethyl tertiary alcohol group at the C-5 position (compound <b>33a</b>). The C-5 (<i>S</i>)-enantiomer of this compound had biochemical and cell-based hu11β-HSD1 activity of ∼35 nM. In cryopreserved human hepatocytes, the CYP3A4 mRNA and enzyme activity for (<i>S</i>)-<b>33a</b> was significantly lower than the lead compound <b>3</b>. The X-ray cocrystal structure of (<i>S</i>)-<b>33a</b> with human 11β-HSD1 indicated that the compound formed hydrogen bonds and hydrophobic interactions with the amino acid residues in the catalytic pocket of the enzyme. Compound (<i>S</i>)-<b>33a</b> also had good pharmacokinetics across four different species. In a monkey pharmacodynamic model, compound (<i>S</i>)-<b>33a</b> showed significant inhibition of 11β-HSD1 activity in the mesenteric fat of monkeys at both 3 and 30 mg kg<sup>−1</sup>. With these results, compound (<i>S</i>)-<b>33a</b> may be used to further understand the biological effects of inhibiting 11β-HSD1 in nonhuman primates.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General</h3><div class="NLM_p last">Unless otherwise noted, all materials were obtained from commercial sources and used without further purification. Preparative flash chromatography was carried out on Merck silica gel 60 (230−400 mesh) or prepacked silica gel cartridges (Biotage or Isco). <sup>1</sup>H NMR spectra were recorded on Bruker 400 MHz instrument. All spectra were recorded using the residual solvent proton resonance or tetramethylsilane (TMS) as an internal standard. Chemical shifts are reported in parts per million (ppm, δ units). For products containing a thiazolone, the <sup>1</sup>H NMR spectra were complex due to the presence of two diastereomers and the two tautomeric forms of the thiazolone. In many instances, the <sup>1</sup>H NMR spectra could be simplified by adding one drop of trifluoroacetic acid, which shifted the equilibrium of thiazolone tautomers to one form. In instances where the compound was a mixture of diastereomers, a pair of signals was observed for many of the protons in the spectra. The chemical shifts for the other diastereomer are reported parenthetically. Mass spectrometry (MS) was performed using an electrospray Agilent 1100 Series liquid chromatograph/mass selective detector (MSD) to give the molecular [M + H]<sup>+</sup> ion of the target molecules. The purity of final compounds was determined by either elemental analysis (performed by Atlantic Microlab, Inc., Norcross, GA) or by analytical reverse-phase high-performance liquid chromatography (HPLC) using two separate signals (215 and 254 nm) on two separate instruments (see the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a> for details).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-1-[1-(4-Fluorophenyl)ethyl]thiourea (<b>5</b>)</h3><div class="NLM_p last">A solution of (<i>S</i>)-1-(4-fluorophenyl)ethanamine (<b>4</b>) (5.0 g, 36 mmol) and benzoyl isothiocyanate (4.8 mL, 36 mmol) in CH<sub>2</sub>Cl<sub>2</sub> was stirred at ambient temperature in a round-bottomed flask overnight. The solvent was removed in vacuo, and the crude product was dissolved in THF/MeOH/H<sub>2</sub>O (30, 30, and 30 mL, respectively). K<sub>2</sub>CO<sub>3</sub> (20 g, 140 mmol) was added, and the mixture was stirred at ambient temperature in a round-bottomed flask. After 4 h, the solvent was removed under reduced pressure, and the crude reaction mixture was diluted with water (60 mL) and extracted with EtOAc (3 × 100 mL). The combined organic layers were washed with brine, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 0−5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound <b>5</b> (7 g, 98%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.33−7.20 (m, 2H), 7.10−7.05 (m, 2H), 6.48 (br s, 1H), 5.60 (br s, 2H), 4.56 (m, 1H), 1.52 (d, 3H, <i>J</i> = 4 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 199 (M + H).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Bromo-2-(4-fluorophenyl)acetic Acid (<b>7</b>, X = F)</h3><div class="NLM_p last">To a round-bottomed flask containing a solution of 2-(4-fluorophenyl)acetic acid (<b>6</b>, X = F) (2.0 g, 13 mmol) in CCl<sub>4</sub> (30 mL) were added <i>N</i>-bromosuccinimide (2.5 g, 14 mmol) and AIBN (0.32 g, 2.0 mmol). The mixture was gradually heated to reflux, and after 2.5 h, the heating was stopped and the mixture was stirred overnight at room temperature. The liquid was filtered and concentrated in vacuo. Purification by flash column chromatography (silica gel, 20−50% EtOAc in hexane) afforded the title compound as yellow oil (2.6 g, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.56 (dd, 2H, <i>J</i> = 4, 8 Hz), 7.08 (t, 2H, <i>J</i> = 8 Hz), 5.35 (s, 1H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 231, 233 (M + H).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-(4-Fluorophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]thiazol-4(5<i>H</i>)-one</h3><div class="NLM_p last">To a round-bottomed flask with (<i>S</i>)-1-[1-(4-fluorophenyl)ethyl]thiourea (<b>5</b>) (0.12 g, 0.62 mmol) and 2-bromo-2-(4-fluorophenyl)acetic acid (<b>7</b>, X = F) (0.16 g, 0.68 mmol) in ethanol (2 mL) was added sodium acetate (0.10 g, 1.2 mmol), and the mixture was heated to reflux overnight. A 10% solution of Na<sub>2</sub>CO<sub>3</sub> was then added to the reaction mixture, and the mixture was extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 0−5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a white solid (0.10 g, 48%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.42−7.48 (m, 2H), 7.32−7.36 (m, 1H), 7.18−7.22 (m, 1H), 6.96−7.09 (m, 4H), 5.20 (tautomer 5.12) (s, 1H), 4.63 (q, 1H, <i>J</i> = 8 Hz), 1.83 (tautomer 1.80) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 333 (M + H).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-(4-Fluorophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>8</b>)</h3><div class="NLM_p last">To a round-bottomed flask, cooled to −78 °C, containing a solution of 5-(4-fluorophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]thiazol-4(5<i>H</i>)-one (0.10 g, 0.30 mmol) in 2 mL of THF, was added LDA (0.90 mL of a 2.0 M solution in heptane/THF/ethylbenzene, 1.8 mmol). After 1 h, iodomethane (0.11 mL, 1.8 mmol) was added, and the reaction mixture was gradually warmed to −40 °C and quenched with 10 mL of saturated NH<sub>4</sub>Cl. The aqueous phase was extracted with ethyl acetate (3×), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification of the crude material by flash column chromatography (silica gel, 0−5% MeOH−CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a white solid (71 mg, 68%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + one drop of TFA, 400 MHz): δ 7.39−7.42 (m, 1H), 7.27−7.33 (m, 3H), 7.02−7.14 (m, 4H), 4.54−4.61 (m, 1H), 2.14 (2.04) (s, 3H), 1.77 (1.75) (d, 3H, <i>J</i> = 6 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 347 (M + H). Anal. (C<sub>18</sub>H<sub>16</sub>F<sub>2</sub>N<sub>2</sub>OS) C, H, N.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Ethyl 2-Bromo-2-(4-bromophenyl)acetate (<b>7</b>, X = Br)</h3><div class="NLM_p last">According to the procedure described for <b>7</b>, X = F, the title compound was prepared from ethyl 2-(4-bromophenyl)acetate (<b>6</b>, X = Br) (3.0 g, 12 mmol), <i>N</i>-bromosuccinimide (2.4 g, 14 mmol), and AIBN (0.20 g, 1.2 mmol). After purification by silica gel chromatography (7% EtOAc in hexane), the desired product was isolated as a colorless oil (3.8 g, 96%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.50 (d, 2H, <i>J</i> = 8 Hz), 7.43 (d, 2H, <i>J</i> = 8 Hz), 5.28 (s, 1H), 4.24 (m, 2H), 1.28 (m, 3H).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-(4-Bromophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]thiazol-4(5<i>H</i>)-one</h3><div class="NLM_p last">According to the procedure described for 5-(4-fluorophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]thiazol-4(5<i>H</i>)-one, the title compound was prepared from (<i>S</i>)-1-[1-(4-fluorophenyl)ethyl]thiourea (<b>5</b>) (1.0 g, 5.0 mmol), ethyl 2-bromo-2-(4-bromophenyl)acetate (<b>7</b>, X = Br) (2.0 g, 6.1 mmol), and di-<i>iso</i>-propylethylamine (1.05 mL, 6.05 mmol). After purification (silica gel chromatography: 34% EtOAc in hexane and then 40% EtOAc in hexane), the desired product was isolated as a white solid (1.4 g, 71%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.53−7.34 (m, 4H), 7.24−6.99 (m, 4H), 5.17 (5.09) (s, 1H), 4.62 (q, 1H, <i>J</i> = 8 Hz), 1.80 (1.77) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 393, 395 (M + H).</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-(4-Bromophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>9</b>)</h3><div class="NLM_p last">According to the procedure described for <b>8</b>, the title compound was prepared from 5-(4-bromophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]thiazol-4(5<i>H</i>)-one (1.3 g, 3.2 mmol), LDA (9.6 mL of a 2.0 M solution in heptane/THF/ethylbenzene, 19 mmol), and iodomethane (1.2 mL, 19 mmol). After purification (silica gel chromatography, 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, and then 3% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the product was isolated as a light yellow solid (1.27 g, 97%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.50−7.35 (m, 5H), 7.19 (d, 1H, <i>J</i> = 8 Hz), 7.10−6.96 (m, 3H), 4.57 (m, 1H), 2.06 (1.98) (s, 3H), 1.78 (1.76) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 407, 409 (M + H).</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoate (<b>10</b>)</h3><div class="NLM_p last">A round-bottomed flask with a mixture of 5-(4-bromophenyl)-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>9</b>) (0.79 g, 1.9 mmol), triphenylphosphine (0.15 g, 0.58 mmol), and palladium acetate (0.11 g, 0.48 mmol) in MeOH/DMF (3 mL/3 mL) was pressurized with CO(g), purged twice with CO(g), and then heated to 100 °C overnight at 40−50 psi of CO(g). The reaction mixture was cooled to room temperature, and the mixture was filtered through Celite. The Celite pad was washed with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was washed with water (3×). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 2−3.6% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a light yellow solid (0.74 g, 99%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 11.42 (br s, 1H), 7.94−8.04 (m, 2H), 7.39−7.67 (m, 4H), 6.63−7.01 (m, 2H), 4.56 (q, 1H, <i>J</i> = 8 Hz), 3.92 (s, 3H), 2.11 (2.02) (s, 3H), 1.82 (1.80) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 387 (M + H).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoic Acid (<b>11</b>)</h3><div class="NLM_p last">In a round-bottomed flask was added a mixture of methyl 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoate (<b>10</b>) (1.2 g, 3.1 mmol), THF (6 mL), MeOH (2 mL), H<sub>2</sub>O (2 mL), and lithium hydroxide hydrate (0.26 g, 6.2 mmol). The mixture was heated to reflux for 2 h, then neutralized with 1 N HCl, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (5×). The organic solution was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 3.6−10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a light brown solid (0.72 g, 62%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.85 (d, 1H, <i>J</i> = 8 Hz), 7.83−7.93 (m, 2H), 7.40−7.65 (m, 4H), 7.17−7.24 (m, 2H), 5.28 (qn, 1H, <i>J</i> = 8 Hz), 1.90 (1.95) (s, 3H), 1.50 (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 373 (M + H).</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzamide (<b>12a</b>)</h3><div class="NLM_p last">To a solution of 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoic acid (<b>11</b>) (0.25 g, 0.67 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) were added thionyl chloride (0.10 mL, 1.3 mmol) and two drops of DMF. After the reaction mixture was stirred overnight at room temperature, the mixture was concentrated in vacuo. The crude product was dissolved in THF (2.5 mL), and then, ammonium hydroxide (37% solution in H<sub>2</sub>O, 0.6 mL) was added to the solution at 0 °C. After 1 h, the mixture was diluted with water (5 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 4−10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) gave the product as a white solid (0.20 g, 79%). Analytical data for single diastereomer: <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.87 (br s, 1H), 7.82 (d, 2H, <i>J</i> = 8 Hz), 7.45 (d, 2H, <i>J</i> = 8 Hz), 7.30−7.33 (m, 2H), 7.08−7.12 (m, 2H), 6.51 (br s, 1H), 4.62 (q, 1H, <i>J</i> = 8 Hz), 2.19 (s, 3H), 1.78 (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 372 (M + H). Anal. (C<sub>19</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>2</sub>S·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-Cyclopropyl-4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzamide (<b>12b</b>)</h3><div class="NLM_p last">The title compound was prepared according to the procedure of example <b>12a</b> using 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoyl chloride (0.080 g, 0.20 mmol) and cyclopropylamine (0.20 mL, 2.9 mmol). After purification (preparative TLC, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the product was obtained as a white solid (6.7 mg, 8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.72−7.63 (m, 2H), 7.51−7.34 (m, 4H), 7.06−6.90 (m, 2H), 6.49 (6.63) (br s, 1H), 4.56 (q, 1H, <i>J</i> = 8 Hz), 2.88 (m, 1H), 2.09 (2.00) (s, 3H), 1.79 (1.77) (d, 3H, <i>J</i> = 8 Hz), 0.89−0.80 (m, 2H), 0.61 (m, 2H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 412 (M + H). HPLC purity at 215 and 254 nm: 98 and 100% in system C; 96 and 99% in system A.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-Cyclopentyl-4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzamide (<b>12c</b>)</h3><div class="NLM_p last">The title compound was prepared according to the procedure described for example <b>12a</b> using 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoyl chloride (0.10 g, 0.30 mmol) and cyclopentylamine (0.2 mL, 2.0 mmol). After purification (preparative TLC, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, and then 50% EtOAc in hexane), the product was isolated as a white solid (44 mg, 49%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.76 (7.69) (d, 2H, <i>J</i> = 8 Hz), 7.51 (7.39) (d, 2H, <i>J</i> = 8 Hz), 7.29−7.34 (m, 2H), 7.07−7.14 (m, 2H), 6.255 (6.21) (d, 1H, <i>J</i> = 8 Hz), 4.55−4.62 (m, 1H), 4.36−4.43 (m, 1H), 2.16 (2.05) (s, 3H), 2.08−2.13 (m, 2H), 1.75 (1.77) (d, 3H, <i>J</i> = 8 Hz), 1.46−1.73 (m, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 440 (M + H). Anal. (C<sub>24</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>2</sub>S·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}-<i>N</i>-methylbenzamide (<b>12d</b>)</h3><div class="NLM_p last">The title compound was prepared according to the procedure of example <b>12a</b> using 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoyl chloride (0.10 g, 0.26 mmol) and methylamine (1.0 mL of a 2 M solution in THF, 2.0 mmol). After purification (preparative TLC, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the product was obtained as a white solid (10 mg, 10%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.75−7.66 (m, 2H), 7.53−7.36 (m, 4H), 7.09−6.92 (m, 2H), 6.63 (6.18) (m, 1H), 4.56 (q, 1H, <i>J</i> = 8 Hz), 3.02−2.96 (m, 3H), 2.09 (2.05) (s, 3H), 1.79 (1.77) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 386 (M + H). HPLC purity at 215 and 254 nm: 97 and 100% in system C; 98 and 99% in system A.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-5-[4-(pyrrolidine-1-carbonyl)phenyl]thiazol-4(5<i>H</i>)-one (<b>12e</b>)</h3><div class="NLM_p last">The title compound was prepared according to the procedure of example <b>12a</b> using 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoyl chloride (0.10 g, 0.26 mmol) and pyrrolidine (0.063 mL, 0.77 mmol). After purification (preparative TLC, 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, and then 100% EtOAc), the product was obtained as a white solid (67 mg, 61%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + one drop of TFA, 400 MHz): δ 7.58−7.30 (m, 6H), 7.15−7.08 (m, 2H), 4.64−4.57 (m, 1H), 3.73−3.67 (m, 2H), 3.46−3.40 (m, 2H), 2.17 (2.07) (s, 3H), 2.06−1.92 (m, 4H), 1.76 (1.78) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 426 (M + H). Anal. (C<sub>23</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>S·0.4H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-5-[4-(morpholine-4-carbonyl)phenyl]thiazol-4(5<i>H</i>)-one (<b>13</b>)</h3><div class="NLM_p last">Into a round-bottomed flask was added 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoic acid (89 mg, 0.24 mmol), dicyclohexanecarbodiimide (74 mg, 0.36 mmol), 1-hydroxybenzotriazole (29 mg, 0.22 mmol), and morpholine (0.042 mL, 0.48 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL). After the mixture was stirred overnight at room temperature, the reaction mixture was diluted with 10% Na<sub>2</sub>CO<sub>3</sub> (15 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification (preparative TLC, 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the desired product was isolated as a white solid (97 mg, 91%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.53−7.30 (m, 6H), 7.15−7.08 (m, 2H), 4.64−4.57 (m, 1H), 3.87 (m, 4H), 3.69 (m, 2H), 3.46 (m, 2H), 2.18 (2.08) (s, 3H), 1.78 (1.76) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 442 (M + H). Anal. (C<sub>23</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>3</sub>S) C, H, N.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-[4-(hydroxymethyl)phenyl]-5-methylthiazol-4(5<i>H</i>)-one (<b>14</b>)</h3><div class="NLM_p last">Into a round-bottomed flask was added methyl 4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}benzoate (23 mg, 0.060 mmol) in THF (1 mL) and lithium aluminum hydride (1.0 M solution in THF, 0.089 mL, 0.089 mmol) at 0 °C. The reaction was quenched by adding sodium sulfate decahydrate. The solid was filtered and washed with CH<sub>2</sub>Cl<sub>2</sub> (3×). The filtrate was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification (preparative TLC 8% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the desired product was isolated as a white solid (15 mg, 70%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.47−7.31 (m, 6H), 7.00−6.91 (m, 2H), 4.67 (m, 2H), 4.55 (m, 1H), 2.09 (2.00) (s, 3H), 1.81 (1.79) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 359 (M + H). HPLC purity at 215 and 254 nm: 99 and 100% in system C; 98 and 96% in system A.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-[4-(Chloromethyl)phenyl]-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one</h3><div class="NLM_p last">Into a round-bottomed flask was added 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-[4-(hydroxymethyl)phenyl]-5-methylthiazol-4(5<i>H</i>)-one (0.17 g, 0.47 mmol) in 1,4-dioxane (5 mL) and thionyl chloride (0.14 mL, 1.9 mmol). After 45 min of stirring at room temperature, the reaction mixture was concentrated in vacuo. The white solid was used in the next step without purification. MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 377 (M + H).</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)acetonitrile (Intermediate B)</h3><div class="NLM_p last">Into a round-bottomed flask was added a solution of 5-[4-(chloromethyl)phenyl]-2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (0.18 g, 0.48 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3.5 mL) and tetrabutylammonium cyanide (0.26 g, 0.95 mmol). The reaction mixture was heated to reflux for 4 h, and then, the mixture was concentrated in vacuo. After purification by flash column chromatography (silica gel, 30−50% EtOAc in hexane), the desired product was isolated as a white solid (0.11 g, 63%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 11.33 (br s, 1H), 7.50−7.28 (m, 6H), 6.99−6.92 (m, 2H), 4.56 (m, 1H), 3.73 (m, 2H), 2.09 (2.00) (s, 3H), 1.82 (1.80) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 368 (M + H).</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)acetamide (<b>15</b>)</h3><div class="NLM_p last">Into a round-bottomed flask were added 2-(4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)acetonitrile (60 mg, 0.16 mmol), potassium hydroxide (0.12 g, 2.1 mmol), and <i>t</i>-BuOH (2 mL). The mixture was gradually heated to 100 °C, and after 2 h, the reaction mixture was cooled to room temperature and concentrated in vacuo. The residue was neutralized with 2 N HCl until the pH was 5−6, and then, the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification (preparative TLC, 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the title compound was isolated as a white solid (11 mg, 17%). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.42−7.23 (m, 6H), 7.12−7.07 (m, 2H), 5.34 (q, 1H, <i>J</i> = 8 Hz), 3.47−3.51 (m, 2H), 2.02−1.92 (m, 3H), 1.62−1.57 (m, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 386 (M + H). HPLC purity at 215 and 254 nm: 98 and 99% in system C; 99 and 100% in system A.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>)</h3><div class="NLM_p last">A mixture of (<i>S</i>)-1-[1-(4-fluorophenyl)ethyl]thiourea (<b>5</b>) (3.5 g, 18 mmol), methyl 2-bromopropanoate (2.2 mL, 19 mmol), and triethylamine (2.7 mL, 19 mmol) in ethanol (10 mL) was heated in a sealed vessel at 100 °C in a microwave reactor (Personal Chemistry). After 1 h, the reaction vessel was cooled to room temperature, and the solvent was removed in vacuo. The crude mixture was diluted with water (100 mL) and extracted with EtOAc (3 × 100 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 0−50% EtOAc in hexane) afforded the title compound <b>16</b> (4.0 g, 88%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.36−7.32 (m, 2H), 7.13−7.08 (m, 2 H), 4.57 (4.566) (q, 1H, <i>J</i> = 8 Hz), 4.21 (4.13) (q, 1H, <i>J</i> = 8 Hz), 1.76 (1.75) (d, 3H, <i>J</i> = 8 Hz), 1.72 (1.66) (d, 3H, <i>J</i> = 8 Hz)). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 253 (M + H).</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (Alternative Procedure)</h3><div class="NLM_p last">Into a round-bottomed flask equipped with stirring was added a mixture of (<i>S</i>)-1-[1-(4-fluorophenyl)ethyl]thiourea (<b>5</b>) (60 g, 30 mmol), 2-bromopropanoic acid (30 mL, 340 mmol), and sodium acetate (36 g, 440 mmol) in ethanol (220 mL), which was heated overnight at reflux. The reaction mixture was then cooled to room temperature, and then, water (500 mL) and saturated Na<sub>2</sub>CO<sub>3</sub> (50 mL) were added. The mixture was extracted with ethyl acetate (3 × 500 mL), and the combined organic layers were washed with saturated Na<sub>2</sub>CO<sub>3</sub>, water (3 × 400 mL), and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give 70 g of the desired product (91% yield).</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-({2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}methyl)benzonitrile</h3><div class="NLM_p last">Into a round-bottomed flask was added a solution of 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (0.30 g, 1.2 mmol) in THF (3 mL), and LDA (2.0 M solution in heptane/tetrahydrofuran/ethylbenzene, 2.4 mL, 4.8 mmol) was added at −78 °C. After 1 h, a solution of 4-(bromomethyl)benzonitrile (<b>17</b>) (0.70 g, 3.6 mmol) in THF (3 mL) was added at −78 °C. The mixture was gradually warmed to 0 °C, and then, saturated NH<sub>4</sub>Cl (4 mL) was added to quench the reaction. The mixture was extracted with EtOAc (3×), and the combined organic fractions were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification by flash column chromatography (silica gel, 17−50% EtOAc in hexane), the desired product was isolated as a white solid (0.38 g, 87%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.48−7.62 (m, 1H), 7.27−7.39 (m, 3H), 7.00−7.20 (m, 4H), 4.44 (m, 1H), 2.32−3.36 (m, 1H), 2.94−3.10 (m, 1H), 1.61−1.74 (m, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 368 (M + H).</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-({2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}methyl)benzamide (<b>18</b>)</h3><div class="NLM_p last">Into a round-bottomed flask was added 4-({2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}methyl)benzonitrile (70 mg, 0.19 mmol), potassium hydroxide (0.14 g, 2.5 mmol), and <i>t</i>-BuOH (2 mL). The mixture was gradually heated to 85 °C, and after 2 h, the reaction was concentrated in vacuo. A 2 N solution of HCl was added until the pH was 7−8. The mixture was then extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), and the organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification by flash column chromatography (silica gel, 0−10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the title compound was isolated as a white solid (54 mg, 74%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.83 (d, 1H, <i>J</i> = 8 Hz), 7.77 (7.71) (br s, 1H), 7.61 (d, 1H, <i>J</i> = 8 Hz), 7.33 (d, 1H, <i>J</i> = 8 Hz), 7.23−7.26 (m, 1H), 7.04−7.11 (m, 4H), 6.64 (6.57) (br s, 1H), 4.46 (q, 1H, <i>J</i> = 8 Hz), 3.01−3.45 (m, 2H), 1.82 (1.73) (s, 3H), 1.66 (1.63) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 386 (M + H). Anal. (C<sub>20</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>2</sub>S·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)cyclopropanecarbonitrile (Intermediate A)</h3><div class="NLM_p last">To a round-bottomed flask was added 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (0.20 g, 0.79 mmol), 1-(4-bromophenyl)cyclopropanecarbonitrile (<b>19</b>) (0.35 g, 1.6 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (51 mg, 0.055 mmol), BINAP (0.099 g, 0.16 mmol), and LiHMDS (0.33 g, 2.0 mmol) in toluene (8 mL). The mixture was heated to 95 °C and stirred overnight. Saturated NH<sub>4</sub>Cl (5 mL) was then added, and the mixture was extracted with EtOAc (30 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification (preparative TLC, 50% EtOAc in hexane), the desired product was isolated as a light yellow solid (0.12 g, 37%). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.44−7.26 (m, 6H), 7.10 (7.08) (d, 2H, <i>J</i> = 8 Hz), 5.33 (q, 1H, <i>J</i> = 8 Hz), 2.02−1.91 (m, 3H), 1.73−1.67 (m, 2H), 1.61−1.56 (m, 3H), 1.49−1.43 (m, 2H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 394 (M + H).</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)cyclopropanecarboxamide (<b>20</b>)</h3><div class="NLM_p last">The title compound was prepared according to the procedure of example <b>18</b> using 1-(4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)cyclopropanecarbonitrile (0.073 g, 0.19 mmol), KOH (0.13 g, 2.4 mmol), and <i>t</i>-BuOH (2 mL). After purification (preparative TLC, 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, then 50% EtOAc in hexane), the title compound was isolated as a white solid (50 mg, 66%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 10.91 (br s, 1H), 7.47−7.31 (m, 6H), 7.03−6.97 (m, 2H), 5.57 (5.32) (m, 2H), 4.57 (m, 1H), 2.10 (2.00) (s, 3H), 1.79 (1.77) (d, 3H, <i>J</i> = 8 Hz), 1.64−1.60 (m, 2H), 1.08−1.04 (m, 2H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 412 (M + H). HPLC purity at 215 and 254 nm: 97 and 99% in system C; 100 and 100% in system A.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-(4-Bromophenyl)-2-methylpropanenitrile (<b>22</b>)</h3><div class="NLM_p last">Into a round-bottomed flask was added 2-(4-bromophenyl)acetonitrile (<b>21</b>) (1.0 g, 5.1 mmol), 18-crown-6 (0.34 g, 1.3 mmol), iodomethane (0.70 mL, 11 mmol), and THF (50 mL). After the reaction flask was cooled to −78 °C, potassium <i>tert</i>-butoxide (1.3 g, 11 mmol) was added. The mixture was stirred at −78 °C for 2 h, then warmed to room temperature, and stirred overnight. Saturated NH<sub>4</sub>Cl was then added, and the reaction mixture was extracted with EtOAc (3×). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification by flash column chromatography (silica gel, 0−50% EtOAc in hexane), the desired product was isolated as an orange oil (1.1 g, 99%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.52 (d, 2H, <i>J</i> = 8 Hz), 7.35 (d, 2H, <i>J</i> = 8 Hz), 1.71 (s, 6H).</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)-2-methylpropanamide (<b>23</b>)</h3><div class="NLM_p last">This compound was prepared according to the procedure described for <b>20</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.46−7.29 (m, 6H), 7.15−7.09 (m, 2H), 4.62 (m, 1H), 2.17 (2.07) (s, 3H), 1.77 (1.75) (d, 3H, <i>J</i> = 8 Hz), 1.63 (1.60) (s, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 414 (M + H). Anal. (C<sub>22</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>S·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(4-Bromophenyl)propan-2-ol (<b>25</b>)</h3><div class="NLM_p last">To a round-bottomed flask containing a solution of methyl 4-bromobenzoate (<b>24</b>) (1.0 g, 4.7 mmol) in THF (30 mL) cooled to 0 °C was added methylmagnesium bromide (4.7 mL of a 3.0 M solution in diethyl ether, 14 mmol). After the addition, the reaction mixture was warmed to room temperature and stirred for 2 h. Saturated NH<sub>4</sub>Cl (10 mL) was added, and the reaction mixture was extracted with EtOAc (3×). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After purification by flash column chromatography (silica gel, 9−14% EtOAc in hexane), the title compound was isolated as a colorless oil (0.74 g, 74%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.45 (d, 2H, <i>J</i> = 8 Hz), 7.36 (d, 2H, <i>J</i> = 8 Hz), 1.56 (s, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 197, 199 [(M + H) − H<sub>2</sub>O].</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-[4-(2-hydroxypropan-2-yl)phenyl]-5-methylthiazol-4(5<i>H</i>)-one (<b>26</b>)</h3><div class="NLM_p last">Using the cross-coupling procedure used for the preparation of intermediate A, the title compound was prepared from 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (0.10 g, 0.40 mmol), 2-(4-bromophenyl)propan-2-ol (<b>25</b>) (0.17 g, 0.79 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.025 g, 0.028 mmol), (<i>S</i>)-BINAP (0.049 g, 0.079 mmol), and LiN(TMS)<sub>2</sub> (0.33 g, 2.0 mmol). After purification (preparative TLC, 50% EtOAc in hexane), the desired product was isolated as an off-white solid (45 mg, 30%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.53−7.28 (m, 6H), 7.14−7.08 (m, 2H), 4.60 (m, 1H), 2.16 (2.06) (s, 3H), 1.77 (1.75) (d, 3H, <i>J</i> = 8 Hz), 1.63 (1.59) (s, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 387 (M + H). Anal. (C<sub>21</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>2</sub>S·H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (4-Bromophenethoxy)trimethylsilane (<b>28</b>)</h3><div class="NLM_p last">To a round-bottomed flask with a solution of 2-(4-bromophenyl)ethanol (<b>27</b>) (3.0 g, 15 mmol) and diisopropylethylamine (3.9 mL, 22 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) cooled to 0 °C was added chlorotrimethylsilane (2.8 mL, 22 mmol). The mixture was warmed to room temperature and stirred overnight. K<sub>2</sub>CO<sub>3</sub> (1.1 g, 8.0 mmol) was then added, and the reaction mixture was stirred for an additional 3 h at room temperature. The solids were then filtered off, and the filtrate was concentrated in vacuo. After purification by flash column chromatography (silica gel, 15% EtOAc in hexane), the title compound was isolated as a colorless oil (3.4 g, 84%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.40 (d, 2H, <i>J</i> = 8 Hz), 7.08 (d, 2H, <i>J</i> = 8 Hz), 3.75 (t, 2H, <i>J</i> = 8 Hz), 2.77 (t, 2H, <i>J</i> = 8 Hz), 0.06 (s, 9H).</div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-5-{4-[2-(trimethylsilyloxy)ethyl]phenyl}thiazol-4(5<i>H</i>)-one</h3><div class="NLM_p last">Using the cross-coupling procedure used for the preparation of intermediate A, the title compound was prepared using 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (0.80 g, 3.2 mmol), (4-bromophenethoxy)trimethylsilane (<b>28</b>) (1.7 g, 6.3 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.20 g, 0.22 mmol), (<i>S</i>)-BINAP (0.40 g, 0.63 mmol), and LiN(TMS)<sub>2</sub> (1.6 g, 9.5 mmol). After purification (silica gel, 23% EtOAc in hexane, then 39% EtOAc in hexane), the title compound was isolated as a light yellow solid (0.43 g, 31%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.44−7.13 (m, 6H), 7.02−6.94 (m, 2H), 4.56 (m, 1H), 3.75 (m, 2H), 2.82 (m, 2H), 2.07 (1.98) (s, 3H), 1.79 (1.76) (d, 3H, <i>J</i> = 8 Hz), 0.08 (0.07) (s, 9H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 373 [(M + H) − Si(CH<sub>3</sub>)<sub>3</sub>].</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-{(<i>S</i>)-[1-(4-fluorophenyl)ethyl]amino}-5-[4-(2-hydroxyethyl)phenyl]-5-methyl-1,3-thiazol-4(5<i>H</i>)-one (<b>29</b>)</h3><div class="NLM_p last">Into a round-bottomed flask was added 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-5-{4-[2-(trimethylsilyloxy)ethyl]phenyl}thiazol-4(5<i>H</i>)-one (0.41 g, 0.92 mmol), K<sub>2</sub>CO<sub>3</sub> (0.64 g, 4.6 mmol), and MeOH (1.5 mL). After the mixture was stirred at room temperature for 1 h, the solids were filtered off, and the filtrate was concentrated in vacuo. Purification by flash column chromatography (silica gel, 0−6% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) gave the desired product as a white solid (0.32 g, 93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.42−7.17 (m, 6H), 7.04−6.96 (m, 2H), 4.57 (m, 1H), 3.85 (m, 2H), 2.86 (m, 2H), 2.09 (2.00) (s, 3H), 1.78 (1.75) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 373 (M + H). HPLC purity at 215 and 254 nm: 100 and 100% in systems C and A.</div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-[4-(2-iodoethyl)phenyl]-5-methylthiazol-4(5<i>H</i>)-one</h3><div class="NLM_p last">Into a round bottomed flask was added 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-[4-(2-hydroxyethyl)phenyl]-5-methylthiazol-4(5<i>H</i>)-one (<b>29</b>) (0.29 g, 0.79 mmol), triphenylphosphine (0.25 g, 0.94 mmol), imidazole (64 mg, 0.94 mmol), and iodine (0.22 g, 0.86 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL). After the mixture was stirred at room temperature for 2 h, the mixture was filtered, and the filtrate was concentrated in vacuo. Purification of the crude product by flash column chromatography (silica gel, 43% EtOAc in hexane) afforded the title compound as a white solid (0.31 g, 82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.43−7.26 (m, 4H), 7.20−6.95 (m, 4H), 4.57 (m, 1H), 3.32 (m, 2H), 3.17 (m, 2H), 2.09 (2.00) (s, 3H), 1.78 (1.76) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 483 (M + H).</div></div><div id="sec3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 3-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)propanenitrile</h3><div class="NLM_p last">Using the cyanide displacement reaction used in the synthesis intermediate B, the title compound was prepared from 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-[4-(2-iodoethyl)phenyl]-5-methylthiazol-4(5<i>H</i>)-one (0.31 g, 0.64 mmol) and tetrabutylammonium cyanide (0.86 g, 3.2 mmol). After purification (silica gel, 55% EtOAc in hexane), the desired product was isolated as a white solid (0.16 g, 65%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.45−7.40 (m, 2H), 7.31−7.17 (m, 4H), 7.02−6.95 (m, 2H), 4.57 (m, 1H), 2.94 (m, 2H), 2.61 (m, 2H), 2.08 (2.00) (s, 3H), 1.80 (1.77) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 382 (M + H).</div></div><div id="sec3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 3-(4-{2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)propanamide (<b>30</b>)</h3><div class="NLM_p last">According to the procedure of example <b>18</b>, the title compound was prepared from 3-(4-{2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl}phenyl)propanenitrile (70 mg, 0.18 mmol) and KOH (51 mg, 0.92 mmol). After purification (preparative TLC, 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the title compound was isolated as a white solid (63 mg, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.35−7.29 (m, 2H), 7.27−7.18 (m, 4H), 7.14−7.07 (m, 2H), 4.60 (m, 1H), 2.98 (m, 2H), 2.60 (m, 2H), 2.15 (2.05) (s, 3H), 1.77 (1.75) (d, 3H, <i>J</i> = 8 Hz). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 400 (M + H). Anal. (C<sub>21</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>2</sub>S·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>)-2-[1-(4-Fluorophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one [(<i>S</i>)-<b>33a</b>, (<i>R</i>)-<b>33a</b>]</h3><div class="NLM_p last">According to the general procedure described for <b>33d</b>, <b>33a</b> was synthesized from 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (330 mg, 1.3 mmol), LDA (3.5 mL of a 1.5 M solution in THF/cyclohexane, 5.3 mmol), and acetone (0.29 mL, 3.9 mmol). After purification of the crude reaction mixture (silica gel, 0−50% EtOAc in hexanes), a colorless film was obtained as the mixture of diastereomers (300 mg, 73%). The isomers were separated using a Berger Multigram II supercritical fluid chromatography system. The column was Chiralpak ASH (21 mm × 250 mm, 5 μm) using CO<sub>2</sub>(l) with 25% methanol as the eluant with a flow rate of 60 mL/min. The column temperature was 40 °C, and the outlet pressure was 100 bar.</div></div><div id="sec3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one [(<i>S</i>)-<b>33a</b>]</h3><div class="NLM_p last">Yield: 57 mg, white solid (14%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.35−7.30 (m, 2H), 7.14−7.08 (m, 2 H), 4.59 (q, 1H, <i>J</i> = 8 Hz), 1.81 (s, 3H), 1.75 (d, 3H, <i>J</i> = 8 Hz), 1.31 (s, 3 H), 1.26 (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 311 (M + H). Anal. (C<sub>15</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub>S) C, H, N.</div></div><div id="sec3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>R</i>)-2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one [(<i>R</i>)-<b>33a</b>]</h3><div class="NLM_p last">Yield: 50 mg, white solid (12%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.35−7.30 (m, 2H), 7.14−7.09 (m, 2H), 4.62 (q, 1H, <i>J</i> = 8 Hz), 1.76 (d, 3H, <i>J</i> = 7 Hz), 1.72 (s, 3H), 1.46 (s, 3H), 1.43 (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 311 (M + H). Anal. (C<sub>15</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub>S) C, H, N.</div></div><div id="sec3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-(1-hydroxycyclobutyl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33b</b>)</h3><div class="NLM_p last">According to the procedure described <b>33d</b>, this compound was prepared from 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (0.20, 0.79 mmol), LDA (1.6 mL of a 2 M solution in THF, 0.32 mmol), and cyclobutanone (0.33 g, 4.8 mmol). After purification (silica gel, 2−5% methanol/CH<sub>2</sub>Cl<sub>2</sub>), the title compound was isolated as a white solid (65 mg, 25%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.67−7.47 (m, 2H), 7.11−6.97 (m, 2H), 6.01−5.96 (tautomer 3.95−3.79) (br s, 1H), 5.53−5.42 (tautomer 4.66−4.52) (m, 1H), 2.45−1.39 (m, 13H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 323.2 (M + H). HPLC purity at 215 and 254 nm: 99 and 100% in systems B and C.</div></div><div id="sec3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-(1-hydroxycyclopentyl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33c</b>)</h3><div class="NLM_p last">According to the general procedure described for <b>33d</b>, this compound was synthesized from 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one (<b>16</b>) (0.25 g, 1.0 mmol), LDA (2.5 mL of a 2 M solution in THF, 2.5 mL, 5 mmol), and cyclopentanone (0.27 mL, 3.0 mmol). After purification of the crude product (silica gel, 4:1 hexanes/ethyl acetate to 1:1 hexanes/ethyl acetate), the title compound was isolated as a white solid (230 mg, 67%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.31 (7.30) (d, 2H, <i>J</i> = 8 Hz); 7.11 (app t, 2H, <i>J</i> = 8 Hz), 4.69 (q, 1H, <i>J</i> = 8 Hz), 1.93−1.58 (m, 14H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 337 (M + H). Anal. (C<sub>17</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>2</sub>S) C, H, N.</div></div><div id="sec3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-{(<i>S</i>)-1-[5-(2-Hydroxypropan-2-yl)-5-methyl-4-oxo-4,5-dihydrothiazol-2-ylamino]ethyl}benzonitrile (<b>33d</b>)</h3><div class="NLM_p last">To a round-bottomed flask equipped with magnetic stirring and nitrogen purge was added a solution of 4-[(<i>S</i>)-1-(5-methyl-4-oxo-4,5-dihydrothiazol-2-ylamino)ethyl]benzonitrile<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.21 g, 0.81 mmol) in THF (10 mL). After the reaction flask was cooled to −78 °C, LDA (1.8 mL of a 1.8 M solution in heptane/THF/ethylbenzene, 3.2 mmol) was added. The reaction mixture was stirred at −78 °C for 30 min, and then, acetone (0.24 g, 4.0 mmol) was added. After the mixture was stirred for 1.5 h at −78 °C, the reaction mixture was quenched with a saturated solution of NH<sub>4</sub>Cl. The reaction mixture was then extracted with EtOAc (3 × 100 mL), and the combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 0−3% MeOH-CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (116 mg, 45%) as a tan solid. <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.74 (d, 2H, <i>J</i> = 8 Hz), 7.48 (d, 2H, <i>J</i> = 8 Hz), 4.66 (4.65) (q, 1H, <i>J</i> = 8 Hz), 1.78 (d, 3H, <i>J</i> = 8 Hz), 1.71 (1.82) (s, 1H), 1.46 (1.34) (s, 3H), 1.42 (1.26) (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 318 (M + H). Anal. (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>S·0.6H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-[(<i>S</i>)-1-(4-Bromophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33e</b>)</h3><div class="NLM_p last">Compound <b>33e</b> was prepared according to the general procedure described <b>33d</b> using 2-[(<i>S</i>)-1-(4-bromophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.70 g, 2.2 mmol), LDA (5 mL of a 1.8 M solution in heptane/THF/ethylbenzene, 8.9 mmol), and acetone (0.65 g, 11 mmol). After purification of the crude product (silica gel, 0−3% CH<sub>3</sub>OH in CH<sub>2</sub>Cl<sub>2</sub>), the product was isolated as a white solid (700 mg, 84%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.57 (d, 2H, <i>J</i> = 8 Hz), 7.22 (d, 2H, <i>J</i> = 8 Hz), 4.615 (q, 1H, <i>J</i> = 8 Hz), 1.83 (1.73) (s, 3H), 1.75 (1.46) (d, 3H, <i>J</i> = 8 Hz), 1.37 (1.35) (s, 3H), 1.31 (1.27) (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 371, 373 (M + H). Anal. (C<sub>15</sub>H<sub>19</sub>BrN<sub>2</sub>O<sub>2</sub>S) C, H, N.</div></div><div id="sec3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-(2-Hydroxypropan-2-yl)-5-methyl-2-[(<i>S</i>)-1-<i>p</i>-tolylethylamino]thiazol-4(5<i>H</i>)-one (<b>33f</b>)</h3><div class="NLM_p last">Compound <b>33f</b> was prepared according to the general procedure described <b>33d</b> using 5-methyl-2-[(<i>S</i>)-1-<i>p</i>-tolylethylamino]thiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.60 g, 2.4 mmol), LDA (5.4 mL of a 1.8 M solution in heptane/THF/ethylbenzene, 9.7 mmol), and acetone (0.70 g, 12 mmol). After purification of the crude product (silica gel, 0−3% CH<sub>3</sub>OH in CH<sub>2</sub>Cl<sub>2</sub>), the product was isolated as a colorless thin film (670 mg, 90%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.21 (m, 4H), 4.615 (m, 1H), 2.38 (s, 3H), 1.82 (1.76) (s, 3H), 1.445 (1.75) (d, 3H, <i>J</i> = 8 Hz), 1.28 (1.35) (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 307 (M + H). Anal. (C<sub>16</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>S·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-[(<i>S</i>)-1-(4-Chlorophenyl)ethylamino]-5-(3-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33g</b>)</h3><div class="NLM_p last">According to the procedure described for <b>33d</b>, this compound was synthesized from 2-[(<i>S</i>)-1-(4-chlorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.30 g, 1.1 mmol), LDA (2.2 mL of a 2.0 M solution in THF, 4.4 mmol), and acetone (0.52 g, 8.9 mmol). After purification (silica gel, 30−70% ethyl acetate/hexane), the title compound was isolated as a white foam (0.17 g, 47%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.41−7.28 (m, 4H), 4.62−4.51 (m, 1H), 3.96−3.83 (br s, 1H), 2.61 (s, 1H), 1.83−1.58 (m, 5H), 1.37−1.14 (m, 7H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 327.1 (M + H). HPLC purity at 215 and 254 nm: 100 and 100% in system B; 99 and 97% in system C.</div></div><div id="sec3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-(2-Hydroxypropan-2-yl)-5-methyl-2-[(<i>S</i>)-1-phenylethylamino]thiazol-4(5<i>H</i>)-one (<b>33h</b>)</h3><div class="NLM_p last">Compound <b>33h</b> was prepared according to procedure described for <b>33d</b> using 5-methyl-2-[(<i>S</i>)-1-phenylethylamino]thiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.51 g, 2.2 mmol), LDA (4.8 mL of a 1.8 M solution in heptane/THF/ethylbenzene, 8.7 mmol), and acetone (0.63 g, 11 mmol). The crude material was purified by flash column chromatography (silica gel, 0−3% MeOH−CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound as a white solid (600 mg, 94%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz,): δ 7.45−7.37 (m, 3H), 7.34−7.31 (m, 2H) 4.645 (q, 1H, <i>J</i> = <i>7</i> Hz), 1.82 (1.71) (s, 3H), 1.775 (1.45) (d, 3H, <i>J</i> = 7 Hz), 1.27 (1.33) (s, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 293(M + H). Anal. (C<sub>15</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>S·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-[(<i>S</i>)-1-(3-Fluorophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33i</b>)</h3><div class="NLM_p last">A 100 mL round-bottomed flask was charged with 2-[(<i>S</i>)-1-(3-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.66 g, 2.6 mmol) and 10 mL of THF. After the mixture was cooled to −78 °C, LDA (6.5 mL of a 2 M solution in THF, 13 mmol) was added, and the solution was stirred for 1 h at −78 °C. After that time, acetone (1.7 mL, 24 mmol) was added, and the mixture was stirred at −78 °C for 2.5 h. The reaction was quenched with a saturated solution of NH<sub>4</sub>Cl. The mixture was extracted with EtOAc, dried with MgSO<sub>4</sub>, and concentrated to give an oil, which was purified by silica gel chromatography (30−70% ethyl acetate/hexanes) to give the title compound as a white foam (0.55 g, 68%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.35−6.94 (m, 4H), 4.63−4.53 (m, 1H), 2.64 (s, 1H), 1.85−1.58 (m, 6H), 1.36−1.13 (m, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 311.2 (M + H). HPLC purity at 215 and 254 nm: 98 and 98% in system B; 98 and 96% in system C.</div></div><div id="sec3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-[(<i>S</i>)-1-(2-Fluorophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33j</b>)</h3><div class="NLM_p last">According to the general procedure described for <b>33d</b>, this compound was synthesized from 2-[(<i>S</i>)-1-(2-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.75 g, 3.0 mmol), LDA (6.0 mL of a 2 M solution in THF, 12 mmol), and acetone (0.47 mL, 6.0 mmol). After purification of the crude product (silica gel, 4:1 hexanes/ethyl acetate), the title compound was isolated as a white solid (160 mg, 17%). <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.40−7.33 (m, 2H); 7.23 (t, 1H, <i>J</i> = 8 Hz), 7.13 (dd, 1H, <i>J</i> = 8 Hz, 12 Hz), 5.01 (m, 1H), 1.84 (1.73) (3H, s), 1.78 (d, 3H, <i>J</i> = 4 Hz), 1.48(1.38) (s, 3H), 1.48(1.34) (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 311 (M + H). Anal. (C<sub>15</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub>S) C, H, N.</div></div><div id="sec3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-[(<i>S</i>)-1-(2-Chlorophenyl)ethylamino]-5-(2-hydroxypropan-2-yl)-5-methylthiazol-4(5<i>H</i>)-one (<b>33k</b>)</h3><div class="NLM_p last">According to the procedure described <b>33d</b>, this compound was prepared from 2-[(<i>S</i>)-1-(2-chlorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (1.3 g, 4.8 mmol), LDA (9.7 mL of a 2 M solution in THF, 19 mmol), and acetone (2.2 g, 39 mmol). After purification (silica gel, 10−50% ethyl acetate/hexane), the title compound was isolated as a light yellow foam (1.2 g, 76%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.62−7.16 (m, 4H), 5.15−5.01 (m, 1H), 3.99 (tautomer 3.48) (s, 1H), 2.62 (s, 1H), 1.80−1.58 (m, 6H), 1.36−1.07 (m, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 327.1 (M + H). HPLC purity at 215 and 254 nm: 100 and 100% in system B; 98 and 97% in system C.</div></div><div id="sec3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>S</i>)-5-(2-Hydroxypropan-2-yl)-5-methyl-2-{1-[2-(trifluoromethyl)phenyl]ethylamino}thiazol-4(5<i>H</i>)-one (<b>33l</b>)</h3><div class="NLM_p last">According to the procedure described for <b>33d</b>, this compound was prepared from 5-methyl-2-[(<i>S</i>)-1-(2-(trifluoromethyl)phenyl]ethylamino)thiazol-4(5<i>H</i>)-one<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (0.50 g, 1.7 mmol), LDA·THF (4.4 mL of a 1.5 M solution in cyclohexane, 6.6 mmol), and acetone (0.49 mL, 6.6 mmol). After purification (silica gel, 0−4% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), the desired product was isolated as a white solid (530 mg, 89%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.81 (dd, 1H, <i>J</i> = 8.0, 16.5 Hz), 7.67 (d, 1H, <i>J</i> = 8.0 Hz), 7.60−7.53 (m, 1H), 7.40 (m, 1H), 5.04−5.00 (m, 1H), 3.91 (m, 1H), 1.81−1.64 (m, 6 H), 1.34−1.12 (m, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 361 (M + H). HPLC purity at 215 and 254 nm: 100 and 100% in system A; 98 and 100% in system D.</div></div><div id="sec3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-(2-hydroxypropyl)-5-methylthiazol-4(5<i>H</i>)-one (<b>34</b>)</h3><div class="NLM_p last">To a round-bottomed flask equipped with stirring was added 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methylthiazol-4(5<i>H</i>)-one <b>16</b> (0.34 g, 1.4 mmol) in THF (3 mL) under nitrogen at 0 °C. Lithium bis(trimethylsilyl)amide (5.4 mL of a 1 M solution in THF, 5.4 mmol) was added, and the reaction mixture was stirred at 0 °C for 1 h. A solution of 2-methyloxirane (0.38 mL, 5.4 mmol) and lithium perchlorate (0.29 g, 2.7 mmol) in THF (4 mL) was added, and the reaction mixture was stirred at 0 °C for 2 h and then warmed to ambient temperature overnight. The reaction mixture was quenched with a saturated solution of NH<sub>4</sub>Cl and extracted with EtOAc (3×). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column chromatography (silica gel, 0−7% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound <b>34</b> (310 mg, 71%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.45−7.30 (m, 2H), 7.03−6.98 (m, 2H), 4.59−4.51 (m, 1 H), 4.06−3.91 (m, 1H), 2.15−1.98 (m, 2 H), 1.82−1.48 (m, 6H), 1.27−1.14 (m, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 311 (M + H).</div></div><div id="sec3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-methyl-5-(2-oxopropyl)thiazol-4(5<i>H</i>)-one</h3><div class="NLM_p last">To a round-bottomed flask equipped with stirring was added 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-(2-hydroxypropyl)-5-methylthiazol-4(5<i>H</i>)-one (<b>34</b>) (0.28 g, 0.90 mmol) and Dess−Martin periodinane (0.54 g, 1.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL). After the mixture was stirred at ambient temperature overnight, Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (1.5 g) and a saturated solution of NaHCO<sub>3</sub> (5 mL) were added, and the mixture was stirred at ambient temperature for 30 min. The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 60 mL), and the combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column (silica gel, 0−3% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (230 mg, 83%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub> + 1 drop of TFA, 400 MHz): δ 7.35−7.29 (m, 2H), 7.14−7.05 (m, 2H), 4.58 (4.53) (q, 1H, <i>J</i> = 8 Hz), 3.31 (3.30) (d, 1H, <i>J</i> = 20 Hz), 3.05 (2.91) (d, 1H, <i>J</i> = 20 Hz), 2.25 (2.19) (s, 3H), 1.74, 1.725 (2d, 3H, <i>J</i> = 8 Hz), 1.72 (1.63) (s, 3H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 309 (M + H).</div></div><div id="sec3_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-[(<i>S</i>)-1-(4-Fluorophenyl)ethylamino]-5-(2-hydroxy-2-methylpropyl)-5-methylthiazol-4(5<i>H</i>)-one (<b>35</b>)</h3><div class="NLM_p last">In a round-bottomed flask equipped with stirring was added methylmagnesium bromide (0.42 mL of a 3 M solution in diethyl ether, 1.3 mmol) to a solution of 2-[(<i>S</i>)-1-(4-fluorophenyl)ethylamino]-5-methyl-5-(2-oxopropyl)thiazol-4(5<i>H</i>)-one (98 mg, 0.32 mmol) in THF at 0 °C under nitrogen. The resulting reaction mixture was stirred at 0 °C for 5 h, and then, additional methylmagnesium bromide (0.42 mL of a 3 M solution in diethyl ether, 1.3 mmol) was added. The reaction mixture was stirred at 0 °C for 1 h, and again, methylmagnesium bromide (0.42 mL of a 3 M solution in diethyl ether, 1.3 mmol) was added. After the reaction mixture was stirred to ambient temperature for 1 h, the mixture was quenched with a saturated solution of NH<sub>4</sub>Cl and extracted with EtOAc (3 × 60 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash column (silica gel, 0−3% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (63 mg, 61%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub> 400 MHz): δ 7.47−7.30 (m, 2 H), 7.07−6.95 (m, 2H), 4.62−4.60 (m, 1H), 2.28−2.11 (m, 2H, m), 1.77 (m, 3H), 1.70−1.63 (m, 3H), 1.33−1.12 (m, 6H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 325 (M + H). Anal. (C<sub>16</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>2</sub>S·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 11β-HSD1 SPA Assay</h3><div class="NLM_p last">Enzyme assays were performed using purified recombinant 11β-HSD1 that was expressed in <i>E. coli</i>. Assays were run in a total volume of 100 μL, including 40 μL of purified enzyme, 10 μL of compound dilutions, 10 μL of [<sup>3</sup>H]cortisone (100 nM final), 10 μL of NADPH (200 μM final), and 30 μL of assay buffer (50 mM Tris-HCl, 1 mM EDTA, pH 7.2). The assay was initiated by the addition of purified enzyme preparation. The final concentrations of enzyme varied for different species. For human, rat, and dog 11β-HSD1, the final concentration of enzyme was 20 nM. For mouse and monkey 11β-HSD1, the final concentration of enzyme was 5 and 10 nM, respectively. Assay plates were incubated on an orbital shaker for 1 h at room temperature. The reaction was stopped by the addition of 10 μL of buffer containing 100 μM 18 β-glycyrrhetinic acid (GE). At the same time, 10 μL of a 1:50 dilution of anticortisol and 100 μL of 15 mg mL<sup>−1</sup> antimouse SPA beads were added to the wells. Plates were incubated on an orbital shaker for another 30 min at room temperature. Radiometric quantitation was determined on a TopCount NXT instrument (Perkin-Elmer, Downers Grove, IL).</div></div><div id="sec3_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 11β-HSD2 SPA Assay</h3><div class="NLM_p last">Enzyme assays were performed using human 11β-HSD2 enzyme expressed in CHO cells. Assays were run in a total volume of 100 μL, including 40 μL of enzyme, 10 μL of compound dilutions, 10 μL of [<sup>3</sup>H]cortisol (3 nM final), 10 μL of NAD<sup>+</sup> (300 μM final), and 30 μL of assay buffer (0.1 M sodium phosphate buffer, pH 7.6). The assay was initiated by the addition of 40 μL of enzyme preparation. Assay plates were incubated on an orbital shaker for 1 h at room temperature. The reaction was stopped by the addition of 10 μL of buffer containing 100 μM 18 β-glycyrrhetinic acid (GE). At the same time, 10 μL of a 1:70 dilution of anticortisol and 100 μL of 10 mg mL<sup>−1</sup> antimouse SPA beads were added to the wells. Plates were incubated on an orbital shaker for another 30 min at room temperature. Radiometric quantitation was determined on a TopCount NXT instrument (Perkin-Elmer).</div></div><div id="sec3_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Measurement of 11β-HSD1 Activity in Whole Cells</h3><div class="NLM_p last">Cell-based activity was measured by monitoring the conversion of cortisone to cortisol in CHO cell lines stably overexpressing 11β-HSD1. Cells were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% dialyzed serum, penicillin/streptomycin/glutamine, nonessential amino acids, and sodium pyruvate. Assay plates were prepared 1 day prior to the addition of the compound. Cells were seeded at a density of 30000 cells per well in 100 mL of maintenance medium. The assay was initiated by removing the medium and rinsing cells twice with glucose buffer (50 mM HEPES containing 120 mM NaCl, 1.85 mM CaCl<sub>2</sub>, 1.3 mM MgSO<sub>4</sub>, and 4.8 mM KCl, pH 7.4), followed by the addition of 80 mL of glucose buffer containing 0.1% DMSO. The compound was added to achieve a final concentration of 0.1 nM to 10 μM. The plates were incubated for 60 min at 37 °C. Following the incubation, cortisone was added to each well to achieve a final concentration of 100 nM. The plates were then incubated at 37 °C. The incubation time for human 11β-HSD1 was 40 min; for mouse 11β-HSD1, 45 min; for dog 11β-HSD1, 1.5 h; and for rat and monkey 11β-HSD1, 2 h. Cortisol formed from cortisone was quantitated using a cortisol enzyme-linked immunosorbent assay kit.</div></div><div id="sec3_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> PXR Reporter Gene Assay</h3><div class="NLM_p last">This assay was conducted at Indigo Biosciences (State College, PA).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec3_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Human Hepatocyte Culture and Experimental Procedure</h3><div class="NLM_p last">Fresh human hepatocytes from two donors were purchased from CellzDirect. Donor 1 was a 60 year old Caucasian male (lot DJV) with no adverse medical history or history of substance or alcohol abuse, and donor 2 was a 40 year old Caucasian female (lot NPV) with a history of tobacco usage and substance usage (cocaine and marijuana). On day 1, fresh hepatocytes were received and suspended in plating medium (0.8 × 10<sup>6</sup> cells mL<sup>−1</sup>). Hepatocytes were counted and plated in collagen-coated 24 well plates (BD Biosciences, Bedford, MA) with 0.4 × 10<sup>6</sup> cells per well. The hepatocytes were placed in a 37 °C incubator (Steri-Cult CO<sub>2</sub> Incubator, model 3310, Thermo Electron Corp., Waltham, MA) under an atmosphere of 95% air/5% CO<sub>2</sub> and 90% relative humidity and allowed a 3−5 h attachment period. Following the attachment period, the plating medium and unattached cells were aspirated, sandwich medium was applied (0.5 mL per well), and the cells were incubated overnight. On day 2, the sandwich medium was aspirated, and culture medium (0.5 mL per well) was applied for an overnight acclimation period. On days 3 and 4, culture medium containing either DMSO (0.1%) or rifampin (0.05−5 μM) was applied on each day (0.5 mL per well). The test articles were prepared in DMSO stock solutions resulting in final incubation concentrations of 0.1% DMSO. Compound treatment was maintained for a total of 48 h. On day 5, hepatocytes were gently washed with Krebs−Henseleit buffer (KHB) (2 × 0.5 mL per well; ∼37 °C) and allowed to acclimate for an additional 10 min. Subsequently, CYP enzyme activities were determined by the addition of the marker substrate midazolam (10 μM; CYP3A4) dissolved in KHB (0.5 mL per well; ∼37 °C). Following a 10 min incubation time period, the supernatant was removed and stored at −80 °C until analyzed. Hepatocytes designated for mRNA analysis were washed once with PBS (0.5 mL per well) containing calcium and magnesium and aspirated. To each well was added 0.5 mL of 33% lysis mixture (Panomics, Inc., Fremont, CA) and then stored at −80 °C until assay.</div></div><div id="sec3_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> mRNA Analysis</h3><div class="NLM_p last">The CYP3A4 mRNA content was determined with branched DNA (bDNA) signal amplification technology using the Panomics Discover XL Kit (Panomics, Inc.) with assays performed according to the manufacturer’s instructions. bDNA probe sets, containing capture extender, label extender, and blocking probes for human CYP3A4 (catalog no. PA-10909) and GAPDH (catalog no. PA-10382) were also purchased from Panomics, Inc. Plate washing steps were performed on an Elx405 automated microplate washer (BIO-TEK, Winooski, VT), and luminescence was analyzed on a Luminoskan Ascent microplate luminometer (Thermo Labsystems, Helsinki, Finland). CYP mRNA levels were normalized to the mRNA levels of the housekeeping gene GAPDH.</div></div><div id="sec3_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Enzyme Activity</h3><div class="NLM_p last">Following the induction treatment period, cell cultures were assayed for the metabolism of the CYP3A4 marker substrate, midazolam. Analysis and quantification of 1′-OH-midazolam, the major midazolam metabolite in hepatocyte cultures, were performed by LC-MS/MS on a system comprising a reverse phase HPLC (Shimadzu, Kyoto, Japan) and a triple quadrupole mass spectrometer (Applied Biosystems API 5000, Foster City, CA) using Turbo Ionspray (Applied Biosystems) via multiple reaction monitoring. Samples (25 μL) were loaded on a C18 column (Phenomenex Onyx Monolithic C18, 100 mm × 3.0 mm, P/no. CHO-8158) eluted with a linear gradient of mobile phase A (H<sub>2</sub>O with 0.1% acetic acid and 5% methanol) to B (H<sub>2</sub>O with 0.1% acetic acid and 95% methanol). The flow rate was 1 mL/min. Metabolites were quantitated by a peak area ratio of metabolite to internal standard (prazosin).</div></div><div id="sec3_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> X-ray Structure Determination</h3><div class="NLM_p last">The X-ray cocrystal structure of (<i>S</i>)-<b>33a</b> with human 11β-HSD1 was collected using the procedure described in ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>.</div></div><div id="sec3_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> In Vivo Pharmacodynamics in Monkeys</h3><div class="NLM_p last">Male cynomolgus monkeys were assigned based on their body weight to treatment groups [0, 0.3, 1, 3, and 30 mg kg<sup>−1</sup> of compound (<i>S</i>)-<b>31a</b>] with at least four animals per group. The animals were dosed via the nasal−gastric route once with compound of target dosage in dosing vehicle (1% Tween 80, 47.5% Ora-Plus, and 51.5% water). At 2 h postdosing, plasma and tissue samples were collected, snap-frozen in liquid nitrogen, and stored either in dry ice or at −80 °C. Approximately 50 mg of mesenteric fat tissues was cut in triplicate into a 24 well plate on dry ice. The tissues were then incubated with 600 μL of warm Krebs Ringer Phosphate (KRP) buffer (0.9% NaCl, 1.15% KCl, 1.8% MgSO<sub>4</sub>, and 0.1 M Na<sub>2</sub>HPO<sub>4</sub> at pH 7.4) containing <sup>3</sup>H-cortisone (Amersham, GE Healthcare) at 37 °C on a shaker for 1 h. After the incubation, 150 μL of media was collected into a 96 well plate. To measure <sup>3</sup>H-cortisol by SPA, 40 μL of SPA PVT beads (Amersham, GE Healthcare) mix containing cortisol monoclonal antibody (5.4 μg mL<sup>−1</sup>) (East Coast Biologics, MA) was added to all wells. The plates were incubated at room temperature on a shaker for 15 min, followed by centrifugation at 2500 RPM for 5 min. After the supernatant was removed, 100 μL of PBS/0.1% BSA was added for further incubation at room temperature on a shaker, followed by another round of centrifugation. The beads were resuspended in 150 μL of PBS/0.1% BSA and transferred to a 96 well Opti-Plate white assay plates (PerkinElmer, Waltham, MA) to be read on a TopCount plate reader (PerkinElmer). The DPM readout from TopCount was converted to the absolute amount of cortisol produced, which was then normalized by the amount of fat tissue used and the assay incubation time. The unit of ex vivo activity was expressed as fmol cortisol produced per mg of fat tissue used per hour (fmol cortisol/mg tissue/h).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83"><a href="/doi/suppl/10.1021/jm801073z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Analytical data for final compounds and X-ray structure coordinates for (<i>S</i>)-<b>33a</b> and (<i>S</i>)-<b>33a</b> with human 11β-HSD1 (PDB ID: 3EY4). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801073z/suppl_file/jm801073z_si_001.pdf">jm801073z_si_001.pdf (1.08 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm801073z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Fotsch</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a0c3c6cfd4d3c3c8e0c1cdc7c5ce8ec3cfcd"><span class="__cf_email__" data-cfemail="85e6e3eaf1f6e6edc5e4e8e2e0ebabe6eae8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Bartberger</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Bercot</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rod Cupples</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maury Emery</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenne Fretland</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anil Guram</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clarence Hale</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nianhe Han</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean Hickman</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randall W. Hungate</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Hayashi</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renee Komorowski</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingyian Liu</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Matsumoto</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. St. Jean</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Ursu</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murielle Véniant</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guifen Xu</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiuping Ye</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chester Yuan</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiandong Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiping Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Tu</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minghan Wang</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Kyung Gahm and Wes Barnhart for their assistance in separating the enantiomers of <b>33a</b>.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roglic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, H.</span><span> </span><span class="NLM_article-title">Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.2337%2Fdiacare.27.5.1047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15111519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1047-53&author=S.+Wildauthor=G.+Roglicauthor=A.+Greenauthor=R.+Sicreeauthor=H.+King&title=Global+prevalence+of+diabetes%3A+Estimates+for+the+year+2000+and+projections+for+2030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span></div><div class="casAuthors">Wild Sarah; Roglic Gojka; Green Anders; Sicree Richard; King Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-53</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.  RESEARCH DESIGN AND METHODS:  Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030.  Urban and rural populations were considered separately for developing countries.  RESULTS:  The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030.  The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.  The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men.  The urban population in developing countries is projected to double between 2000 and 2030.  The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.  CONCLUSIONS:  These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant.  Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS1_5FBm4QLEbxh97K6Vt6fW6udTcc2ebxAzYUVfhvtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D&md5=93096de002d513e4fdd49028be51d85d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.27.5.1047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.27.5.1047%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DS.%26aulast%3DRoglic%26aufirst%3DG.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DSicree%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DH.%26atitle%3DGlobal%2520prevalence%2520of%2520diabetes%253A%2520Estimates%2520for%2520the%2520year%25202000%2520and%2520projections%2520for%25202030%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D1047%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wang, M.</span><span> </span><span class="NLM_article-title">Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=319-323&author=M.+Wang&title=Inhibitors+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+for+the+treatment+of+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26atitle%3DInhibitors%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520for%2520the%2520treatment%2520of%2520metabolic%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D319%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wamil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2Fj.drudis.2007.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=17631244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=504-520&author=M.+Wamilauthor=J.+R.+Seckl&title=Inhibition+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+as+a+promising+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 11ss-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target</span></div><div class="casAuthors">Wamil, Malgorzata; Seckl, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13&14</span>),
    <span class="NLM_cas:pages">504-520</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronically elevated glucocorticoid levels cause obesity, diabetes, heart disease, mood disorders and memory impairments. 11ss-hydroxysteroid dehydrogenase type 1 (11ss-HSD1) catalyzes intracellular regeneration of active glucocorticoids (cortisol, corticosterone) from inert 11-keto forms in liver, adipose and brain, amplifying local action.  Obese humans and rodents show increased 11ss-HSD1 in adipose tissue.  Transgenic mice overexpressing 11ss-HSD1 selectively in adipose tissue faithfully recapitulate metabolic syndrome.  Conversely, 11ss-HSD1 knockout mice have a 'cardioprotective' phenotype, whose effects are also seen with 11ss-HSD1 inhibitors in rodents.  However, any major metabolic effects of 11ss-HSD1 inhibition in humans are, as yet, unreported. 11ss-HSD1 null mice also resist cognitive decline with aging, and this is seen in humans with a prototypic inhibitor.  Thus 11ss-HSD1 inhibition is an emerging pleiotropic therapeutic target.  The metabolic syndrome phenotypically resembles Cushing's, but plasma cortisol levels are normal.  Intracellular cortisol regeneration by 11ss-hydroxysteroid dehydrogenase type 1 in adipose tissue might explain this paradox, but is this a realistic therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOq2ZUL9_T57Vg90H21EOLACvtfcHk0lh6t5_t-yG46w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWlur0%253D&md5=34495eb846727e937849c38942bb3d8b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DWamil%26aufirst%3DM.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520as%2520a%2520promising%2520therapeutic%2520target%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D504%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Boyle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">11β-Hydroxysteroid dehydrogenase type 1 inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=127-140&author=C.+D.+Boyleauthor=T.+J.+Kowalskiauthor=L.+Zhang&title=11%CE%B2-Hydroxysteroid+dehydrogenase+type+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DKowalski%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D11%25CE%25B2-Hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span> </span><span class="NLM_article-title">11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1517%2F13543776.15.3.289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVerur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=289-303&author=C.+Fotschauthor=B.+C.+Askewauthor=J.+J.+Chen&title=11%CE%B2-Hydroxysteroid+dehydrogenase-1+as+a+therapeutic+target+for+metabolic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">11β-hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases</span></div><div class="casAuthors">Fotsch, Christopher; Askew, Ben C.; Chen, Jian Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  11β-Hydroxysteroid dehydrogenase-1 (11βHSD1) is a therapeutic target for Type 2 diabetes that has stimulated the interest of many pharmaceutical companies.  Mounting evidence obtained from both preclin. and clin. studies support the contention that inhibiting 11βHSD1 will have a therapeutic benefit by lowering glucose output and increasing insulin sensitivity.  In just over 2 years, 21 applications contg. 11βHSD1 inhibitors were published.  In this review, the target rationale and patent applications from Merck, Novo Nordisk, AstraZeneca, Sterix, Biovitrum, Janssen and Novartis will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHaQVmEFdy4bVg90H21EOLACvtfcHk0lh6t5_t-yG46w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVerur4%253D&md5=1c923df050c201a6b634ffcb88bb6d10</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543776.15.3.289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.15.3.289%26sid%3Dliteratum%253Aachs%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DAskew%26aufirst%3DB.%2BC.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3D11%25CE%25B2-Hydroxysteroid%2520dehydrogenase-1%2520as%2520a%2520therapeutic%2520target%2520for%2520metabolic%2520diseases%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D2005%26volume%3D15%26spage%3D289%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hanson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reshef, L.</span><span> </span><span class="NLM_article-title">Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1146%2Fannurev.biochem.66.1.581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=9242918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADyaK2sXktFOmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1997&pages=581-611&author=R.+W.+Hansonauthor=L.+Reshef&title=Regulation+of+phosphoenolpyruvate+carboxykinase+%28GTP%29+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression</span></div><div class="casAuthors">Hanson, Richard W.; Reshef, Lea</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">581-611</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 145 refs.  Phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) (PEPCK) is a key enzyme in the synthesis of glucose in the liver and kidney and of glyceride-glycerol in white adipose tissue and the small intestine.  The gene for the cytosolic form of PEPCK (PECPCK-C) is acutely regulated by a variety of dietary and hormonal signals, which result in alteration of synthesis of the enzyme.  Major factors that increase PEPCK-C gene expression include cAMP, glucocorticoids, and thyroid hormone, whereas insulin inhibits this process.  PEPCK-C is absent in fetal liver but appears at birth, concomitant with the capacity for gluconeogenesis.  Regulatory elements that control transcription of the PEPCK-C gene in liver, kidney, and adipose tissue have been delineated, and many of the transcription factors that bind to these elements have been identified.  Transgenic mice have been esp. useful in elucidating the physiol. roles of specific sequence elements in the PEPCK-C gene promoter and in demonstrating the key role played at these sites by the isoforms of CAAT/enhancer binding protein in patterning of PEPCK-C gene expression during the perinatal period.  The PEPCK-C gene provides a model for the metabolic control of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2wZa9oROWUrVg90H21EOLACvtfcHk0lh6t5_t-yG46w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFOmsbg%253D&md5=bde4eb97aeeb86fdb18cd680d43fbf5a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.66.1.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.66.1.581%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DR.%2BW.%26aulast%3DReshef%26aufirst%3DL.%26atitle%3DRegulation%2520of%2520phosphoenolpyruvate%2520carboxykinase%2520%2528GTP%2529%2520gene%2520expression%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1997%26volume%3D66%26spage%3D581%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bujalska, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, P. M.</span><span> </span><span class="NLM_article-title">Differentiation of adipose stromal cells: The roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">3188</span><span class="NLM_x">–</span> <span class="NLM_lpage">3196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1999&pages=3188-3196&author=I.+J.+Bujalskaauthor=S.+Kumarauthor=M.+Hewisonauthor=P.+M.+Stewart&title=Differentiation+of+adipose+stromal+cells%3A+The+roles+of+glucocorticoids+and+11%CE%B2-hydroxysteroid+dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBujalska%26aufirst%3DI.%2BJ.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DHewison%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DP.%2BM.%26atitle%3DDifferentiation%2520of%2520adipose%2520stromal%2520cells%253A%2520The%2520roles%2520of%2520glucocorticoids%2520and%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%26jtitle%3DEndocrinology%26date%3D1999%26volume%3D140%26spage%3D3188%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Masuzaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span> </span><span class="NLM_article-title">A transgenic model of visceral obesity and the metabolic syndrome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=2166-2170&author=H.+Masuzakiauthor=J.+Patersonauthor=H.+Shinyamaauthor=N.+M.+Mortonauthor=J.+J.+Mullinsauthor=J.+R.+Secklauthor=J.+S.+Flier&title=A+transgenic+model+of+visceral+obesity+and+the+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasuzaki%26aufirst%3DH.%26aulast%3DPaterson%26aufirst%3DJ.%26aulast%3DShinyama%26aufirst%3DH.%26aulast%3DMorton%26aufirst%3DN.%2BM.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26atitle%3DA%2520transgenic%2520model%2520of%2520visceral%2520obesity%2520and%2520the%2520metabolic%2520syndrome%26jtitle%3DScience%26date%3D2001%26volume%3D294%26spage%3D2166%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kotelevtsev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmoll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span> </span><span class="NLM_article-title">11beta-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">14924</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=14924-9&author=Y.+Kotelevtsevauthor=M.+C.+Holmesauthor=A.+Burchellauthor=P.+M.+Houstonauthor=D.+Schmollauthor=P.+Jamiesonauthor=R.+Bestauthor=R.+Brownauthor=C.+R.+Edwardsauthor=J.+R.+Secklauthor=J.+J.+Mullins&title=11beta-Hydroxysteroid+dehydrogenase+type+1+knockout+mice+show+attenuated+glucocorticoid-inducible+responses+and+resist+hyperglycemia+on+obesity+or+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotelevtsev%26aufirst%3DY.%26aulast%3DHolmes%26aufirst%3DM.%2BC.%26aulast%3DBurchell%26aufirst%3DA.%26aulast%3DHouston%26aufirst%3DP.%2BM.%26aulast%3DSchmoll%26aufirst%3DD.%26aulast%3DJamieson%26aufirst%3DP.%26aulast%3DBest%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DC.%2BR.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26atitle%3D11beta-Hydroxysteroid%2520dehydrogenase%2520type%25201%2520knockout%2520mice%2520show%2520attenuated%2520glucocorticoid-inducible%2520responses%2520and%2520resist%2520hyperglycemia%2520on%2520obesity%2520or%2520stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D14924%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Morton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuzaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fievet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span> </span><span class="NLM_article-title">Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=931-938&author=N.+M.+Mortonauthor=J.+M.+Patersonauthor=H.+Masuzakiauthor=M.+C.+Holmesauthor=B.+Staelsauthor=C.+Fievetauthor=B.+R.+Walkerauthor=J.+S.+Flierauthor=J.+J.+Mullinsauthor=J.+R.+Seckl&title=Novel+adipose+tissue-mediated+resistance+to+diet-induced+visceral+obesity+in+11%CE%B2-hydroxysteroid+dehydrogenase+type+1-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DN.%2BM.%26aulast%3DPaterson%26aufirst%3DJ.%2BM.%26aulast%3DMasuzaki%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DM.%2BC.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DFievet%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DB.%2BR.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26atitle%3DNovel%2520adipose%2520tissue-mediated%2520resistance%2520to%2520diet-induced%2520visceral%2520obesity%2520in%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201-deficient%2520mice%26jtitle%3DDiabetes%26date%3D2004%26volume%3D53%26spage%3D931%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Morton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fievet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tailleux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span> </span><span class="NLM_article-title">Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">41293</span><span class="NLM_x">–</span> <span class="NLM_lpage">41300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=41293-41300&author=N.+M.+Mortonauthor=M.+C.+Holmesauthor=C.+Fievetauthor=B.+Staelsauthor=A.+Tailleuxauthor=J.+J.+Mullinsauthor=J.+R.+Seckl&title=Improved+lipid+and+lipoprotein+profile%2C+hepatic+insulin+sensitivity%2C+and+glucose+tolerance+in+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+null+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DN.%2BM.%26aulast%3DHolmes%26aufirst%3DM.%2BC.%26aulast%3DFievet%26aufirst%3DC.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DTailleux%26aufirst%3DA.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26atitle%3DImproved%2520lipid%2520and%2520lipoprotein%2520profile%252C%2520hepatic%2520insulin%2520sensitivity%252C%2520and%2520glucose%2520tolerance%2520in%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520null%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D41293%26epage%3D41300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Alberts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engblom, L. O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edling, N. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingström, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsgren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashkzari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björkstrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L. B.</span><span> </span><span class="NLM_article-title">Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">4755</span><span class="NLM_x">–</span> <span class="NLM_lpage">4762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=4755-4762&author=P.+Albertsauthor=C.+Nilssonauthor=G.+Selenauthor=L.+O.+M.+Engblomauthor=N.+H.+M.+Edlingauthor=S.+Norlingauthor=G.+Klingstr%C3%B6mauthor=C.+Larssonauthor=M.+Forsgrenauthor=M.+Ashkzariauthor=C.+E.+Nilssonauthor=M.+Fiedlerauthor=E.+Bergqvistauthor=B.+Oehmanauthor=E.+Bj%C3%B6rkstrandauthor=L.+B.+Abrahms%C3%A9n&title=Selective+inhibition+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+improves+hepatic+insulin+sensitivity+in+hyperglycemic+mice+strains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberts%26aufirst%3DP.%26aulast%3DNilsson%26aufirst%3DC.%26aulast%3DSelen%26aufirst%3DG.%26aulast%3DEngblom%26aufirst%3DL.%2BO.%2BM.%26aulast%3DEdling%26aufirst%3DN.%2BH.%2BM.%26aulast%3DNorling%26aufirst%3DS.%26aulast%3DKlingstr%25C3%25B6m%26aufirst%3DG.%26aulast%3DLarsson%26aufirst%3DC.%26aulast%3DForsgren%26aufirst%3DM.%26aulast%3DAshkzari%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DC.%2BE.%26aulast%3DFiedler%26aufirst%3DM.%26aulast%3DBergqvist%26aufirst%3DE.%26aulast%3DOehman%26aufirst%3DB.%26aulast%3DBj%25C3%25B6rkstrand%26aufirst%3DE.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%2BB.%26atitle%3DSelective%2520inhibition%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520improves%2520hepatic%2520insulin%2520sensitivity%2520in%2520hyperglycemic%2520mice%2520strains%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D4755%26epage%3D4762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hermanowski-Vosatka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noonan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strack, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieringer, R.</span><span> </span><span class="NLM_article-title">11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=517-527&author=A.+Hermanowski-Vosatkaauthor=J.+M.+Balkovecauthor=K.+Chengauthor=H.+Y.+Chenauthor=M.+Hernandezauthor=G.+C.+Kooauthor=C.+B.+Le+Grandauthor=Z.+Liauthor=J.+M.+Metzgerauthor=S.+S.+Mundtauthor=H.+Noonanauthor=C.+N.+Nunesauthor=S.+H.+Olsonauthor=B.+Pikounisauthor=N.+Renauthor=N.+Robertsonauthor=J.+M.+Schaefferauthor=K.+Shahauthor=M.+S.+Springerauthor=A.+M.+Strackauthor=M.+Strowskiauthor=K.+Wuauthor=T.+Wuauthor=J.+Xiaoauthor=B.+B.+Zhangauthor=S.+D.+Wrightauthor=R.+Thieringer&title=11%CE%B2-HSD1+inhibition+ameliorates+metabolic+syndrome+and+prevents+progression+of+atherosclerosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHermanowski-Vosatka%26aufirst%3DA.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DHernandez%26aufirst%3DM.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DLe%2BGrand%26aufirst%3DC.%2BB.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMetzger%26aufirst%3DJ.%2BM.%26aulast%3DMundt%26aufirst%3DS.%2BS.%26aulast%3DNoonan%26aufirst%3DH.%26aulast%3DNunes%26aufirst%3DC.%2BN.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DPikounis%26aufirst%3DB.%26aulast%3DRen%26aufirst%3DN.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DSchaeffer%26aufirst%3DJ.%2BM.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DStrack%26aufirst%3DA.%2BM.%26aulast%3DStrowski%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DThieringer%26aufirst%3DR.%26atitle%3D11%25CE%25B2-HSD1%2520inhibition%2520ameliorates%2520metabolic%2520syndrome%2520and%2520prevents%2520progression%2520of%2520atherosclerosis%2520in%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D202%26spage%3D517%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprak, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeGrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieringer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermanowski-Vosatka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zokian, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waddell, S. T.</span><span> </span><span class="NLM_article-title">Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta -HSD1: Novel therapeutic agents for the treatment of metabolic syndrome</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5266</span><span class="NLM_x">–</span> <span class="NLM_lpage">5269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5266-5269&author=X.+Guauthor=J.+Dragovicauthor=G.+C.+Kooauthor=S.+L.+Koprakauthor=C.+LeGrandauthor=S.+S.+Mundtauthor=K.+Shahauthor=M.+S.+Springerauthor=E.+Y.+Tanauthor=R.+Thieringerauthor=A.+Hermanowski-Vosatkaauthor=H.+J.+Zokianauthor=J.+M.+Balkovecauthor=S.+T.+Waddell&title=Discovery+of+4-heteroarylbicyclo%5B2.2.2%5Doctyltriazoles+as+potent+and+selective+inhibitors+of+11beta+-HSD1%3A+Novel+therapeutic+agents+for+the+treatment+of+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26aulast%3DDragovic%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DKoprak%26aufirst%3DS.%2BL.%26aulast%3DLeGrand%26aufirst%3DC.%26aulast%3DMundt%26aufirst%3DS.%2BS.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DTan%26aufirst%3DE.%2BY.%26aulast%3DThieringer%26aufirst%3DR.%26aulast%3DHermanowski-Vosatka%26aufirst%3DA.%26aulast%3DZokian%26aufirst%3DH.%2BJ.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DWaddell%26aufirst%3DS.%2BT.%26atitle%3DDiscovery%2520of%25204-heteroarylbicyclo%255B2.2.2%255Doctyltriazoles%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%252011beta%2520-HSD1%253A%2520Novel%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520metabolic%2520syndrome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5266%26epage%3D5269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rohde, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pliushchev, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monzon, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chovan, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullally, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolarik, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imade, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, D. W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frevert, E. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. T.</span><span> </span><span class="NLM_article-title">Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0609364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=149-164&author=J.+J.+Rohdeauthor=M.+A.+Pliushchevauthor=B.+K.+Sorensenauthor=D.+Wodkaauthor=Q.+Shuaiauthor=J.+Wangauthor=S.+Fungauthor=K.+M.+Monzonauthor=W.+J.+Chiouauthor=L.+Panauthor=X.+Dengauthor=L.+E.+Chovanauthor=A.+Ramaiyaauthor=M.+Mullallyauthor=R.+F.+Henryauthor=D.+F.+Stolarikauthor=H.+M.+Imadeauthor=K.+C.+Marshauthor=D.+W.+A.+Benoauthor=T.+A.+Feyauthor=B.+A.+Drozauthor=M.+E.+Bruneauthor=H.+S.+Campauthor=H.+L.+Shamauthor=E.+U.+Frevertauthor=P.+B.+Jacobsonauthor=J.+T.+Link&title=Discovery+and+metabolic+stabilization+of+potent+and+selective+2-amino-N-%28adamant-2-yl%29+acetamide+11beta-hydroxysteroid+dehydrogenase+type+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm0609364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0609364%26sid%3Dliteratum%253Aachs%26aulast%3DRohde%26aufirst%3DJ.%2BJ.%26aulast%3DPliushchev%26aufirst%3DM.%2BA.%26aulast%3DSorensen%26aufirst%3DB.%2BK.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DShuai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DMonzon%26aufirst%3DK.%2BM.%26aulast%3DChiou%26aufirst%3DW.%2BJ.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChovan%26aufirst%3DL.%2BE.%26aulast%3DRamaiya%26aufirst%3DA.%26aulast%3DMullally%26aufirst%3DM.%26aulast%3DHenry%26aufirst%3DR.%2BF.%26aulast%3DStolarik%26aufirst%3DD.%2BF.%26aulast%3DImade%26aufirst%3DH.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBeno%26aufirst%3DD.%2BW.%2BA.%26aulast%3DFey%26aufirst%3DT.%2BA.%26aulast%3DDroz%26aufirst%3DB.%2BA.%26aulast%3DBrune%26aufirst%3DM.%2BE.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DFrevert%26aufirst%3DE.%2BU.%26aulast%3DJacobson%26aufirst%3DP.%2BB.%26aulast%3DLink%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520and%2520metabolic%2520stabilization%2520of%2520potent%2520and%2520selective%25202-amino-N-%2528adamant-2-yl%2529%2520acetamide%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D149%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukkola, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcopulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilci, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, R. E.</span><span> </span><span class="NLM_article-title">Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6696</span><span class="NLM_x">–</span> <span class="NLM_lpage">6712</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058228q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6696-6712&author=G.+M.+Coppolaauthor=P.+J.+Kukkolaauthor=J.+L.+Stantonauthor=A.+D.+Neubertauthor=N.+Marcopulosauthor=N.+A.+Bilciauthor=H.+Wangauthor=H.+C.+Tomaselliauthor=J.+Tanauthor=T.+D.+Aicherauthor=D.+C.+Knorrauthor=A.+Y.+Jengauthor=B.+Dardikauthor=R.+E.+Chatelain&title=Perhydroquinolylbenzamides+as+novel+inhibitors+of+11beta-hydroxysteroid+dehydrogenase+type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm058228q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058228q%26sid%3Dliteratum%253Aachs%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DKukkola%26aufirst%3DP.%2BJ.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DNeubert%26aufirst%3DA.%2BD.%26aulast%3DMarcopulos%26aufirst%3DN.%26aulast%3DBilci%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTomaselli%26aufirst%3DH.%2BC.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26aulast%3DDardik%26aufirst%3DB.%26aulast%3DChatelain%26aufirst%3DR.%2BE.%26atitle%3DPerhydroquinolylbenzamides%2520as%2520novel%2520inhibitors%2520of%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6696%26epage%3D6712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Xiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massefski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of sulfonamidooxazoles and beta-keto sulfones: Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2865-2869&author=J.+Xiangauthor=M.+Ipekauthor=V.+Suriauthor=W.+Massefskiauthor=N.+Panauthor=Y.+Geauthor=M.+Tamauthor=Y.+Xingauthor=J.+F.+Tobinauthor=X.+Xuauthor=S.+Tam&title=Synthesis+and+biological+evaluation+of+sulfonamidooxazoles+and+beta-keto+sulfones%3A+Selective+inhibitors+of+11beta-hydroxysteroid+dehydrogenase+type+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DSuri%26aufirst%3DV.%26aulast%3DMassefski%26aufirst%3DW.%26aulast%3DPan%26aufirst%3DN.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DTobin%26aufirst%3DJ.%2BF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520sulfonamidooxazoles%2520and%2520beta-keto%2520sulfones%253A%2520Selective%2520inhibitors%2520of%252011beta-hydroxysteroid%2520dehydrogenase%2520type%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2865%26epage%3D2869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Linders, J. T. M.; Willemsens, G. H. M.; Bellens, D.; Buyck, C.; De Backker, P.; Ethirajulu, K.; Gilissen, R. A. H. J.; Hrupka, B.; Jaroskova, L.; Van Lommen, G.; Meulemans, A.; Smans, K.; van Dorsselaer, P.; Van der Veken, L.; Berwaer, M.</span>Substituted Adamantanamides As Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1; Abstracts of Papers, 231st ACS National Meeting, Atlanta, GA, United States, March 26−30,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>MEDI-002.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+T.+M.+Linders&author=G.+H.+M.+Willemsens&author=D.+Bellens&author=C.+Buyck&author=P.+De+Backker&author=K.+Ethirajulu&author=R.+A.+H.+J.+Gilissen&author=B.+Hrupka&author=L.+Jaroskova&author=G.+Van+Lommen&author=A.+Meulemans&author=K.+Smans&author=P.+van+Dorsselaer&author=L.+Van+der+Veken&author=M.+Berwaer&title=Substituted+Adamantanamides+As+Novel+Inhibitors+of+11%CE%B2-Hydroxysteroid+Dehydrogenase+Type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLinders%26aufirst%3DJ.%2BT.%2BM.%26jtitle%3DSubstituted%2520Adamantanamides%2520As%2520Novel%2520Inhibitors%2520of%252011%25CE%25B2-Hydroxysteroid%2520Dehydrogenase%2520Type%25201%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rask, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingstone, D. E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. R.</span><span> </span><span class="NLM_article-title">Tissue-specific dysregulation of cortisol metabolism in human obesity</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1210%2Fjc.86.3.1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11238541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFWnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=1418-1421&author=E.+Raskauthor=T.+Olssonauthor=S.+Soderbergauthor=R.+Andrewauthor=D.+E.+W.+Livingstoneauthor=O.+Johnsonauthor=B.+R.+Walker&title=Tissue-specific+dysregulation+of+cortisol+metabolism+in+human+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-specific dysregulation of cortisol metabolism in human obesity</span></div><div class="casAuthors">Rask, Eva; Olsson, Tommy; Soderberg, Stefan; Andrew, Ruth; Livingstone, Dawn E. W.; Johnson, Owe; Walker, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1418-1421</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Cortisol has been implicated as a pathophysiol. mediator in idiopathic obesity, but circulating cortisol concns. are not consistently elevated.  The tissue-specific responses to cortisol may be influenced as much by local preceptor metab. as by circulating concns.  For example, in liver and adipose tissue cortisol is regenerated from inactive cortisone by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).  In obese Zucker rats 11β-HSD1 activity is reduced in liver but enhanced in adipose tissue.  This study addressed whether the same tissue-specific disruption of cortisol metab. occurs in human obesity.  34 Men were recruited from the MONICA population study in Northern Sweden to represent a wide range of body compn. and insulin sensitivity.  Plasma cortisol was measured at 0830h and 1230h, after overnight low-dose dexamethasone suppression, after i.v. corticotropin releasing hormone (CRH), and after oral cortisone administration.  Urinary cortisol metabolites were measured in a 24 h sample.  A s.c. fat biopsy was obtained from 16 participants to measure cortisol metab. in vitro.  Higher body mass index was assocd. with increased total cortisol metabolite excretion (r=0.47, p<0.01), but lower plasma cortisol at 1230 h and after dexamethasone, and no difference in response to CRH.  Obese men excreted a greater proportion of glucocorticoid as metabolites of cortisone rather than cortisol (r=0.43, p<0.02), and converted less cortisone to cortisol after oral administration (r=-0.49, p<0.01), suggesting impaired hepatic 11β-HSD1 activity.  By contrast, in vitro 11β-HSD1 activity in s.c. adipose tissue was markedly enhanced in obese men (r=0.66, p<0.01).  We conclude that in obesity, reactivation of cortisone to cortisol by 11β-HSD1 in liver is impaired, so that plasma cortisol levels tend to fall, and there may be a compensatory increase in cortisol secretion mediated by a normally functioning hypothalamic-pituitary-adrenal axis.  However, changes in 11β-HSD1 are tissue-specific: strikingly enhanced reactivation of cortisone to cortisol in s.c. adipose tissue may exacerbate obesity; and it may be beneficial to inhibit this enzyme in adipose tissue in obese patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMb3o2tQzRyrVg90H21EOLACvtfcHk0lip0wUew5FA0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFWnurk%253D&md5=dc5fe2f65e250984509bd997ad2e8674</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.3.1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.3.1418%26sid%3Dliteratum%253Aachs%26aulast%3DRask%26aufirst%3DE.%26aulast%3DOlsson%26aufirst%3DT.%26aulast%3DSoderberg%26aufirst%3DS.%26aulast%3DAndrew%26aufirst%3DR.%26aulast%3DLivingstone%26aufirst%3DD.%2BE.%2BW.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DWalker%26aufirst%3DB.%2BR.%26atitle%3DTissue-specific%2520dysregulation%2520of%2520cortisol%2520metabolism%2520in%2520human%2520obesity%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D1418%26epage%3D1421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kannisto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietilaeinen, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenborg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaprio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamsten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yki-Jaervinen, H.</span><span> </span><span class="NLM_article-title">Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: Studies in young adult monozygotic twins</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">4414</span><span class="NLM_x">–</span> <span class="NLM_lpage">4421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1210%2Fjc.2004-0153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15356040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslWht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=4414-4421&author=K.+Kannistoauthor=K.+H.+Pietilaeinenauthor=E.+Ehrenborgauthor=A.+Rissanenauthor=J.+Kaprioauthor=A.+Hamstenauthor=H.+Yki-Jaervinen&title=Overexpression+of+11%CE%B2-hydroxysteroid+dehydrogenase-1+in+adipose+tissue+is+associated+with+acquired+obesity+and+features+of+insulin+resistance%3A+Studies+in+young+adult+monozygotic+twins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: Studies in young adult monozygotic twins</span></div><div class="casAuthors">Kannisto, Katja; Pietilaeinen, Kirsi H.; Ehrenborg, Ewa; Rissanen, Aila; Kaprio, Jaakko; Hamsten, Anders; Yki-Jaervinen, Hannele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4414-4421</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD-1) catalyzes the interconversion of inactive cortisone to active cortisol.  Overexpression of 11β-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)α overexpression, central obesity, and insulin resistance.  It is controversial whether 11β-HSD-1 or GRα expression are increased in human adipose tissue in obesity.  The authors studied effects of acquired obesity on 11β-HSD-1 gene (real-time PCR) and protein (Western blotting) expression in s.c. adipose tissue in 17 monozygotic twin pairs aged 24-27 yr with a mean intrapair difference in body mass index (BMI) of 3.8 kg/m2 (range 0.4-10.1 kg/m2).  Intrapair correlations were calcd. to study effects of acquired obesity on 11β-HSD-1 expression.  Western blot anal. of adipose tissue homogenates identified approx. 50- and approx. 68-kDa proteins specific for 11β-HSD-1.  Both structural forms correlated pos. with 11β-HSD-1 mRNA concns.  Intrapair differences in 11β-HSD-1 mRNA, and the 50- and 68-kDa proteins in s.c. adipose tissue correlated pos. with those in BMI (kilograms per square meter) (r = 0.78 for 11β-HSD-1 mRNA, P = 0.0002; r = 0.87 for the 11β-HSD-1 50-kDa protein, P = 0.0003; and r = 0.62 for the 11β-HSD-1 68-kDa protein, P = 0.033), total body fat (percent) (r = 0.65, P = 0.005; r = 0.83, P = 0.001; and r = 0.69, P = 0.013, resp.) and s.c. fat (cubed centimeters) (r = 0.66, P = 0.004; r = 0.94, P = 0.0001; and r = 0.71, P = 0.009, resp.).  Furthermore, 11β-HSD-1 mRNA and 50-kDa protein expression, but not 68-kDa protein expression, correlated pos. with intrapair differences in intraabdominal fat mass (cubed centimeters) (r = 0.62, P = 0.008; r = 0.69, P = 0.013; r = 0.48, P = 0.112) and serum fasting insulin concn. (milliunits per L) (r = 0.76, P = 0.0004; r = 0.60, P = 0.037; and r = 0.43, P = 0.160, resp.).  Intrapair differences in GRα expression were significantly inversely correlated with those in BMI and total and s.c. fat mass.  In conclusion, expression of 11β-HSD-1 in s.c. adipose tissue is increased in human acquired obesity and is closely related to accumulation of s.c. and intraabdominal fat and features of insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruTvr6BBAoT7Vg90H21EOLACvtfcHk0lip0wUew5FA0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslWht74%253D&md5=faf0beaeba494bf1e99728a78026139a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1210%2Fjc.2004-0153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2004-0153%26sid%3Dliteratum%253Aachs%26aulast%3DKannisto%26aufirst%3DK.%26aulast%3DPietilaeinen%26aufirst%3DK.%2BH.%26aulast%3DEhrenborg%26aufirst%3DE.%26aulast%3DRissanen%26aufirst%3DA.%26aulast%3DKaprio%26aufirst%3DJ.%26aulast%3DHamsten%26aufirst%3DA.%26aulast%3DYki-Jaervinen%26aufirst%3DH.%26atitle%3DOverexpression%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase-1%2520in%2520adipose%2520tissue%2520is%2520associated%2520with%2520acquired%2520obesity%2520and%2520features%2520of%2520insulin%2520resistance%253A%2520Studies%2520in%2520young%2520adult%2520monozygotic%2520twins%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2004%26volume%3D89%26spage%3D4414%26epage%3D4421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bercot, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komorowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Véniant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">2-(<i>S</i>)-Phenethylaminothiazolones as potent, orally efficacious inhibitors of 11β-hydroxysteroid dehydrogenase type 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061214f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=429-432&author=D.+J.+St.+Jeanauthor=C.+Yuanauthor=E.+A.+Bercotauthor=R.+Cupplesauthor=M.+Chenauthor=J.+Fretlandauthor=C.+Haleauthor=R.+W.+Hungateauthor=R.+Komorowskiauthor=M.+V%C3%A9niantauthor=M.+Wangauthor=X.+Zhangauthor=C.+Fotsch&title=2-%28S%29-Phenethylaminothiazolones+as+potent%2C+orally+efficacious+inhibitors+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm061214f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061214f%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DBercot%26aufirst%3DE.%2BA.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DFretland%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DKomorowski%26aufirst%3DR.%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3D2-%2528S%2529-Phenethylaminothiazolones%2520as%2520potent%252C%2520orally%2520efficacious%2520inhibitors%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D429%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedenborg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6056</span><span class="NLM_x">–</span> <span class="NLM_lpage">6061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6056-6061&author=C.+Yuanauthor=D.+J.+St.+Jeanauthor=Q.+Liuauthor=L.+Caiauthor=A.+Liauthor=N.+Hanauthor=G.+Monizauthor=B.+Askewauthor=R.+W.+Hungateauthor=L.+Johanssonauthor=L.+Tedenborgauthor=D.+Pyringauthor=M.+Williamsauthor=C.+Haleauthor=M.+Chenauthor=R.+Cupplesauthor=J.+Zhangauthor=S.+Jordanauthor=M.+D.+Bartbergerauthor=Y.+Sunauthor=M.+Emeryauthor=M.+Wangauthor=C.+Fotsch&title=The+discovery+of+2-anilinothiazolones+as+11%CE%B2-HSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DN.%26aulast%3DMoniz%26aufirst%3DG.%26aulast%3DAskew%26aufirst%3DB.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DJohansson%26aufirst%3DL.%26aulast%3DTedenborg%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DEmery%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%25202-anilinothiazolones%2520as%252011%25CE%25B2-HSD1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6056%26epage%3D6061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Véniant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span> </span><span class="NLM_article-title">Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1111%2Fj.1747-0285.2007.00603.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=18069989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvF2lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=36-44&author=C.+Haleauthor=M.+V%C3%A9niantauthor=Z.+Wangauthor=M.+Chenauthor=J.+McCormickauthor=R.+Cupplesauthor=D.+Hickmanauthor=X.+Minauthor=A.+Sudomauthor=H.+Xuauthor=G.+Matsumotoauthor=C.+Fotschauthor=D.+J.+St.+Jeanauthor=M.+Wang&title=Structural+characterization+and+pharmacodynamic+effects+of+an+orally+active+11beta-hydroxysteroid+dehydrogenase+type+1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization and pharmacodynamic effects of an orally active 11β-hydroxysteroid dehydrogenase type 1 inhibitor</span></div><div class="casAuthors">Hale, Clarence; Veniant, Murielle; Wang, Zhulun; Chen, Michelle; McCormick, Jocelyn; Cupples, Rod; Hickman, Dean; Min, Xiaoshan; Sudom, Athena; Xu, Haoda; Matsumoto, Guy; Fotsch, Christopher; St. Jean, David J., Jr.; Wang, Minghan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">11β-Hydroxysteroid dehydrogenase type 1 regulates glucocorticoid action and inhibition of this enzyme is a viable therapeutic strategy for the treatment of type 2 diabetes and the metabolic syndrome.  Here, the authors report a potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor with a binding mode elucidated from the cocrystal structure with the human 11β-hydroxysteroid dehydrogenase type 1.  The inhibitor is bound to the steroid-binding pocket making contacts with the catalytic center and the solvent channel.  The inhibitor binding is facilitated by two direct hydrogen bond interactions involving Tyrosine-183 of the catalytic motif Tyr-X-X-X-Lys and Alanine-172.  In addn., the inhibitor makes many hydrophobic interactions with both the enzyme and the cofactor NADP (reduced).  In lean C57BL/6 mice, the compd. inhibited both the in vivo and ex vivo 11β-hydroxysteroid dehydrogenase type 1 activities in a dose-dependent manner.  The inhibitory effects correlate with the plasma compd. concns., suggesting that there is a clear pharmacokinetic and pharmacodynamic relationship.  Moreover, at the same doses used in the pharmacokinetic/pharmacodynamic studies, the inhibitor did not cause the activation of the hypothalamic-pituitary-adrenal axis in an acute mouse model, suggesting that this compd. exhibits biol. effects with minimal risk of activating the hypothalamic-pituitary-adrenal axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraRZglcwGWX7Vg90H21EOLACvtfcHk0lgQzXZkXpJ3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvF2lsLs%253D&md5=5b65b29897b0548a751f794ae145094b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00603.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00603.x%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DC.%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMcCormick%26aufirst%3DJ.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DSudom%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DStructural%2520characterization%2520and%2520pharmacodynamic%2520effects%2520of%2520an%2520orally%2520active%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitor%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D71%26spage%3D36%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Véniant, M.; Hale, C.; Komorowski, R.; Chen, M. M.; St. Jean, D. J.; Fotsch, C.; Wang, M.</span><span> </span><span class="NLM_article-title">Time of the day for 11β-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice</span>.  <span class="citation_source-journal">Diabetes, Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span>, in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&author=M.+V%C3%A9niant&author=C.+Hale&author=R.+Komorowski&author=M.+M.+Chen&author=D.+J.+St.+Jean&author=C.+Fotsch&author=M.+Wang&title=Time+of+the+day+for+11%CE%B2-HSD1+inhibition+plays+a+role+in+improving+glucose+homeostasis+in+DIO+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26atitle%3DTime%2520of%2520the%2520day%2520for%252011%25CE%25B2-HSD1%2520inhibition%2520plays%2520a%2520role%2520in%2520improving%2520glucose%2520homeostasis%2520in%2520DIO%2520mice%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2008%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radominska-Pandya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemaitis, M. A.</span><span> </span><span class="NLM_article-title">Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=442-449&author=W.+Xieauthor=H.+Uppalauthor=S.+P.+S.+Sainiauthor=Y.+Muauthor=J.+M.+Littleauthor=A.+Radominska-Pandyaauthor=M.+A.+Zemaitis&title=Orphan+nuclear+receptor-mediated+xenobiotic+regulation+in+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26aulast%3DUppal%26aufirst%3DH.%26aulast%3DSaini%26aufirst%3DS.%2BP.%2BS.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DLittle%26aufirst%3DJ.%2BM.%26aulast%3DRadominska-Pandya%26aufirst%3DA.%26aulast%3DZemaitis%26aufirst%3DM.%2BA.%26atitle%3DOrphan%2520nuclear%2520receptor-mediated%2520xenobiotic%2520regulation%2520in%2520drug%2520metabolism%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D442%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span> </span><span class="NLM_article-title">Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=124-138&author=Y.+D.+Gaoauthor=S.+H.+Olsonauthor=J.+M.+Balkovecauthor=Y.+Zhuauthor=I.+Royoauthor=J.+Yabutauthor=R.+Eversauthor=E.+Y.+Tanauthor=W.+Tangauthor=D.+P.+Hartleyauthor=R.+T.+Mosley&title=Attenuating+pregnane+X+receptor+%28PXR%29+activation%3A+a+molecular+modelling+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DRoyo%26aufirst%3DI.%26aulast%3DYabut%26aufirst%3DJ.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DE.%2BY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26atitle%3DAttenuating%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520activation%253A%2520a%2520molecular%2520modelling%2520approach%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26spage%3D124%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Watkins, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisely, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redinbo, M. R.</span><span> </span><span class="NLM_article-title">The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">2329</span><span class="NLM_x">–</span> <span class="NLM_lpage">2333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1126%2Fscience.1060762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11408620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2001&pages=2329-2333&author=R.+E.+Watkinsauthor=G.+B.+Wiselyauthor=L.+B.+Mooreauthor=J.+L.+Collinsauthor=M.+H.+Lambertauthor=S.+P.+Williamsauthor=T.+M.+Willsonauthor=S.+A.+Kliewerauthor=M.+R.+Redinbo&title=The+human+nuclear+xenobiotic+receptor+PXR%3A+Structural+determinants+of+directed+promiscuity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity</span></div><div class="casAuthors">Watkins, Ryan E.; Wisely, G. Bruce; Moore, Linda B.; Collins, Jon L.; Lambert, Millard H.; Williams, Shawn P.; Willson, Timothy M.; Kliewer, Steven A.; Redinbo, Matthew R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5525</span>),
    <span class="NLM_cas:pages">2329-2333</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The human nuclear pregnane X receptor (hPXR) activates cytochrome P 450-3A expression in response to a wide variety of xenobiotics and plays a crit. role in mediating dangerous drug-drug interactions.  The authors present the crystal structures of the ligand-binding domain of hPXR both alone and in complex with the cholesterol-lowering drug SR12813 at resolns. of 2.5 and 2.75 angstroms, resp.  The hydrophobic ligand-binding cavity of hPXR contains a small no. of polar residues, permitting SR12813 to bind-in three distinct orientations.  The position and nature of these polar residues were found to be crit. for establishing the precise pharmacol. activation profile of PXR.  The findings provide important insights into how hPXR detects xenobiotics and may prove useful in predicting and avoiding drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGros5DlMM1w9rVg90H21EOLACvtfcHk0liOpjJ5aKB2uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSht7c%253D&md5=f78d0d3e742427fc771a3c958b07be5a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1060762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1060762%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DR.%2BE.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DRedinbo%26aufirst%3DM.%2BR.%26atitle%3DThe%2520human%2520nuclear%2520xenobiotic%2520receptor%2520PXR%253A%2520Structural%2520determinants%2520of%2520directed%2520promiscuity%26jtitle%3DScience%26date%3D2001%26volume%3D292%26spage%3D2329%26epage%3D2333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span> </span><span class="NLM_article-title">A pharmacophore for human pregnane X receptor ligands</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=96-99&author=S.+Ekinsauthor=J.+A.+Erickson&title=A+pharmacophore+for+human+pregnane+X+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26atitle%3DA%2520pharmacophore%2520for%2520human%2520pregnane%2520X%2520receptor%2520ligands%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Henriksson, M.; Homan, E.; Johansson, L.; Vallgårda, J.; Williams, M.; Bercot, E. A.; Fotsch, C. H.; Li, A.; Cai, G.; Hungate, R. W.; Yuan, C. C.; Tegley, C.; St. Jean, D. J.,  Jr.; Han, N.; Huang, Q.; Liu, Q.; Bartberger, M. D.; Moniz, G. A.; Frizzle, M. J.; Marshall, T. L.</span> Preparation of 2-aminothiazolin-4-ones as inhibitors of 11β-hydroxy steroid dehydrogenase type 1. WO2007061661, 20070531, 2007.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Henriksson%2C+M.%3B+Homan%2C+E.%3B+Johansson%2C+L.%3B+Vallg%C3%A5rda%2C+J.%3B+Williams%2C+M.%3B+Bercot%2C+E.+A.%3B+Fotsch%2C+C.+H.%3B+Li%2C+A.%3B+Cai%2C+G.%3B+Hungate%2C+R.+W.%3B+Yuan%2C+C.+C.%3B+Tegley%2C+C.%3B+St.+Jean%2C+D.+J.%2C+Jr.%3B+Han%2C+N.%3B+Huang%2C+Q.%3B+Liu%2C+Q.%3B+Bartberger%2C+M.+D.%3B+Moniz%2C+G.+A.%3B+Frizzle%2C+M.+J.%3B+Marshall%2C+T.+L.+Preparation+of+2-aminothiazolin-4-ones+as+inhibitors+of+11%CE%B2-hydroxy+steroid+dehydrogenase+type+1.+WO2007061661%2C+20070531%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksson%26aufirst%3DM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">In the following reference, the authors noted that there are some compounds that bind PXR but do not activate the receptor:</p></div><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubaquie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanchunas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickinson, K.</span><span> </span><span class="NLM_article-title">Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1177%2F1087057104264902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15452340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosF2nu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=533-540&author=Z.+Zhuauthor=S.+Kimauthor=T.+Chenauthor=J.-H.+Linauthor=A.+Bellauthor=J.+Brysonauthor=Y.+Dubaquieauthor=N.+Yanauthor=J.+Yanchunasauthor=D.+Xieauthor=R.+Stoffelauthor=M.+Sinzauthor=K.+Dickinson&title=Correlation+of+high-throughput+pregnane+X+receptor+%28PXR%29+transactivation+and+binding+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays</span></div><div class="casAuthors">Zhu, Zhengrong; Kim, Sean; Chen, Taosheng; Lin, Jun-Hsiang; Bell, Aneka; Bryson, James; Dubaquie, Yves; Yan, Ning; Yanchunas, Joseph; Xie, Dianlin; Stoffel, Robert; Sinz, Michael; Dickinson, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-540</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Pregnane X receptor (PXR) transactivation and binding assays have been developed into high-throughput assays, which are robust and reproducible (Z' > 0.5).  For most compds., there was a good correlation between the results of the transactivation and binding assays.  EC50 values of compds. in the transactivation assay correlated reasonably well with their IC50 values in the binding assay.  However, there were discrepancies with some compds. showing high binding affinity in the binding assay translated into low transactivation.  The most likely cause for these discrepancies was an agonist dependent relation between binding affinity and transactivation response.  In general, compds. that bound to human PXR and transactivated PXR tended to be large hydrophobic mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpARKEiyaVugLVg90H21EOLACvtfcHk0ljG9Bj8H1xj-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosF2nu7g%253D&md5=b7b02b49016156d7dc847de32d5cc3e8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1087057104264902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104264902%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DJ.-H.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DBryson%26aufirst%3DJ.%26aulast%3DDubaquie%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DN.%26aulast%3DYanchunas%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DStoffel%26aufirst%3DR.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DDickinson%26aufirst%3DK.%26atitle%3DCorrelation%2520of%2520high-throughput%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520transactivation%2520and%2520binding%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D533%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">The stereochemistry of this compound was confirmed by the single-crystal X-ray structure. See the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+stereochemistry+of+this+compound+was+confirmed+by+the+single-crystal+X-ray+structure.+See+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Johansson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komorowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orihuela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Véniant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">2-Amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: Enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2933</span><span class="NLM_x">–</span> <span class="NLM_lpage">2943</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701551j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2933-2943&author=L.+Johanssonauthor=C.+Fotschauthor=M.+D.+Bartbergerauthor=V.+M.+Castroauthor=M.+Chenauthor=M.+Emeryauthor=S.+Gustafssonauthor=C.+Haleauthor=D.+Hickmanauthor=E.+Homanauthor=S.+R.+Jordanauthor=R.+Komorowskiauthor=A.+Liauthor=K.+McRaeauthor=G.+Monizauthor=G.+Matsumotoauthor=C.+Orihuelaauthor=G.+Palmauthor=M.+V%C3%A9niantauthor=M.+Wangauthor=M.+Williamsauthor=J.+Zhang&title=2-Amino-1%2C3-thiazol-4%285H%29-ones+as+potent+and+selective+11beta-hydroxysteroid+dehydrogenase+type+1+inhibitors%3A+Enzyme-ligand+co-crystal+structure+and+demonstration+of+pharmacodynamic+effects+in+C57Bl%2F6+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm701551j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701551j%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DL.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCastro%26aufirst%3DV.%2BM.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DEmery%26aufirst%3DM.%26aulast%3DGustafsson%26aufirst%3DS.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHoman%26aufirst%3DE.%26aulast%3DJordan%26aufirst%3DS.%2BR.%26aulast%3DKomorowski%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DMcRae%26aufirst%3DK.%26aulast%3DMoniz%26aufirst%3DG.%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DOrihuela%26aufirst%3DC.%26aulast%3DPalm%26aufirst%3DG.%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3D2-Amino-1%252C3-thiazol-4%25285H%2529-ones%2520as%2520potent%2520and%2520selective%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitors%253A%2520Enzyme-ligand%2520co-crystal%2520structure%2520and%2520demonstration%2520of%2520pharmacodynamic%2520effects%2520in%2520C57Bl%252F6%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2933%26epage%3D2943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sinnokrot, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrill, C. D.</span><span> </span><span class="NLM_article-title">Substituent effects in π−π interactions: Sandwich and T-shaped configurations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">7690</span><span class="NLM_x">–</span> <span class="NLM_lpage">7697</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja049434a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=7690-7697&author=M.+O.+Sinnokrotauthor=C.+D.+Sherrill&title=Substituent+effects+in+%CF%80%E2%88%92%CF%80+interactions%3A+Sandwich+and+T-shaped+configurations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja049434a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja049434a%26sid%3Dliteratum%253Aachs%26aulast%3DSinnokrot%26aufirst%3DM.%2BO.%26aulast%3DSherrill%26aufirst%3DC.%2BD.%26atitle%3DSubstituent%2520effects%2520in%2520%25CF%2580%25E2%2588%2592%25CF%2580%2520interactions%253A%2520Sandwich%2520and%2520T-shaped%2520configurations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D7690%26epage%3D7697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">LeCluyse, E. L.</span><span> </span><span class="NLM_article-title">Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2FS0928-0987%2801%2900135-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11408150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkt1yisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=343-368&author=E.+L.+LeCluyse&title=Human+hepatocyte+culture+systems+for+the+in+vitro+evaluation+of+cytochrome+P450+expression+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation</span></div><div class="casAuthors">LeCluyse, E. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-368</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 103 refs.  Primary cultures of human hepatocytes have been used extensively by both academic and industrial labs. for evaluating the hepatic disposition of drugs and other xenobiotics.  Their primary utility has been for assessing the induction potential of new chem. entities (NCEs) and they continue to serve as the gold std.  Primary considerations for conducting in vitro drug testing utilizing cultures of human hepatocytes, such as the effects of culture and study conditions, are discussed.  The maintenance of normal cellular physiol. and intercellular contacts in vitro is of particular importance for optimal phenotypic gene expression and response to drugs and other xenobiotics.  Significant advances in our understanding of cytochrome P 450 (CYP450) enzyme regulation have been made with the recent identification of the nuclear receptors mediating the induction of CYP2B and CYP3A enzymes.  In particular, the activation of pregnane X receptor (PXR) by prototypical inducers of CYP3A has been found to correlate well with the species-specific modulation of CYP3A by various drugs and other xenobiotics.  Concomitant with the discovery of PXR has been the identification of compds. that may act synergistically or antagonistically on multiple receptors (e.g., co-repressors and/or co-activators of the receptor) introducing novel mechanisms of drug-drug interactions.  Differential expression of the individual isoforms of the major CYP450 enzymes over time in culture suggest that this model system is not reflective of in vivo profiles and, therefore, may be limited in its application for drug metab. studies.  Overall, primary cultures of human hepatocytes can serve as a sensitive and selective model for predicting the regulation of CYP450 modulation by drugs and other xenobiotics.  Considerations and recommendations for standardizing testing conditions and choosing relevant endpoint(s) are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoySxZj9XLhfrVg90H21EOLACvtfcHk0ljG9Bj8H1xj-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkt1yisLY%253D&md5=9376441e1ae9f11fa5cb349713844fe4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2801%2900135-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252801%252900135-X%26sid%3Dliteratum%253Aachs%26aulast%3DLeCluyse%26aufirst%3DE.%2BL.%26atitle%3DHuman%2520hepatocyte%2520culture%2520systems%2520for%2520the%2520in%2520vitro%2520evaluation%2520of%2520cytochrome%2520P450%2520expression%2520and%2520regulation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D13%26spage%3D343%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. P.</span><span> </span><span class="NLM_article-title">Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2FS0009-2797%2801%2900162-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11336975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFCrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=271-281&author=C.+Luauthor=A.+P.+Li&title=Species+comparison+in+P450+induction%3A+effects+of+dexamethasone%2C+omeprazole%2C+and+rifampin+on+P450+isoforms+1A+and+3A+in+primary+cultured+hepatocytes+from+man%2C+Sprague-Dawley+rat%2C+minipig%2C+and+beagle+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog</span></div><div class="casAuthors">Lu, C.; Li, A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Induction of P 450 isoforms 1A (CYP1A) and 3A (CYP3A) by model inducers dexamethasone, omeprazole and rifampin was evaluated in primary cultured hepatocytes from man and lab. animals.  Inducer-specific species-differences were obsd.  Results with human hepatocytes from six human donors consistently show that both rifampin and dexamethasone were inducers of CYP3A activity (measured as testosterone 6β-hydroxylase activity), with rifampin being more potent.  Conversely, in rat hepatocytes, dexamethasone was a potent CYP3A inducer while rifampin was not an inducer.  Rifampin but not dexamethasone induced CYP3A in minipig and beagle dog hepatocytes.  Omeprazole was a potent inducer of CYP1A activity (measured as ethoxyresorufin-O-deethylase activity) in human, beagle dog and minipig hepatocytes, and not an inducer in rat hepatocytes.  The species-differences obsd. suggest that human hepatocytes represent the most appropriate preclin. exptl. system for the evaluation of P 450 induction in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRuU3adtVrObVg90H21EOLACvtfcHk0ljk7PgCTzVWug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFCrtb4%253D&md5=3a3021ca72fc55394876d39788480fcd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2801%2900162-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252801%252900162-4%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DA.%2BP.%26atitle%3DSpecies%2520comparison%2520in%2520P450%2520induction%253A%2520effects%2520of%2520dexamethasone%252C%2520omeprazole%252C%2520and%2520rifampin%2520on%2520P450%2520isoforms%25201A%2520and%25203A%2520in%2520primary%2520cultured%2520hepatocytes%2520from%2520man%252C%2520Sprague-Dawley%2520rat%252C%2520minipig%252C%2520and%2520beagle%2520dog%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2001%26volume%3D134%26spage%3D271%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Li, A. P.</span><span> </span><span class="NLM_article-title">Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions</span> <span class="citation_source-journal">Adv. Pharmacol. (San Diego)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2FS1054-3589%2808%2960203-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=9342174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1aksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1997&pages=103-130&author=A.+P.+Li&title=Primary+hepatocyte+cultures+as+an+in+vitro+experimental+model+for+the+evaluation+of+pharmacokinetic+drug-drug+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions</span></div><div class="casAuthors">Li, Albert P.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">Drug-Drug Interactions: Scientific and Regulatory Perspectives</span>),
    <span class="NLM_cas:pages">103-130</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review with over 70 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHUwBsyCmUqbVg90H21EOLACvtfcHk0ljk7PgCTzVWug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1aksL8%253D&md5=e2370c559cb996618e45ea66428b766a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1054-3589%2808%2960203-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1054-3589%252808%252960203-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%2BP.%26atitle%3DPrimary%2520hepatocyte%2520cultures%2520as%2520an%2520in%2520vitro%2520experimental%2520model%2520for%2520the%2520evaluation%2520of%2520pharmacokinetic%2520drug-drug%2520interactions%26jtitle%3DAdv.%2520Pharmacol.%2520%2528San%2520Diego%2529%26date%3D1997%26volume%3D43%26spage%3D103%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><div class="note"><p class="first last">This thiazolone was prepared using the alternative method described for the synthesis of compound <b>16</b>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=This+thiazolone+was+prepared+using+the+alternative+method+described+for+the+synthesis+of+compound+16."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><div class="note"><p class="first last">The nuclear receptor luciferase reporter gene assay was conducted with human PXR fused with a firefly luciferase promoter transfected into HEK cells. For a detailed protocol employing a similar system, see</p></div><span class="NLM_contrib-group">Bility, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butala, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanden Heuvel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. M.</span><span> </span><span class="NLM_article-title">Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1093%2Ftoxsci%2Fkfh253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15310864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2004&pages=170-182&author=M.+T.+Bilityauthor=J.+T.+Thompsonauthor=R.+H.+McKeeauthor=R.+M.+Davidauthor=J.+H.+Butalaauthor=J.+P.+Vanden+Heuvelauthor=J.+M.+Peters&title=Activation+of+mouse+and+human+peroxisome+proliferator-activated+receptors+%28PPARs%29+by+phthalate+monoesters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters</span></div><div class="casAuthors">Bility, Moses T.; Thompson, Jerry T.; McKee, Richard H.; David, Raymond M.; Butala, John H.; Vanden Heuvel, John P.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-182</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Administration of phthalates is known to cause toxicity and liver cancer in rodents through the activation of peroxisome proliferator-activated receptors (PPARs), and the monoesters appear to be the active metabolites that function as ligands of PPARs.  There is evidence that PPARs exhibit significant species differences in response to ligand activation.  In this study, the activation of mouse and human PPARα, PPARβ, and PPARγ by a broad class of phthalate monoesters was investigated using a trans-activation assay, functional anal. of PPARα target gene expression, and a PPARγ-mediated differentiation assay.  These studies demonstrated a range in the ability of various phthalate monoesters to activate PPARα, with the mouse PPARα generally being activated at lower concns. and exhibiting a greater response than human PPARα.  Similarly, a range in the trans-activation of mouse PPARβ by phthalate monoesters was also obsd., but this effect was not found with human PPARβ.  A no. of phthalate monoesters activated both mouse and human PPARγ, with similar sensitivity being exhibited by both receptors.  These studies show that the potency and efficacy of phthalate monoesters for the activation of PPARα and PPARγ increase with increasing side-chain length.  These studies also show that mouse PPARα and PPARβ are generally activated at lower concns. of phthalate monoesters than human PPARα and PPARβ, and that both mouse and human PPARγ exhibit similar sensitivity to phthalate monoesters.  Lastly, there is a good relationship between the relative ability of phthalate monoesters to trans-activate PPARα and PPARγ, and the relative induction of PPARα target gene mRNA and PPARγ-mediated adipocyte differentiation, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi9tBxttCJLLVg90H21EOLACvtfcHk0ljk7PgCTzVWug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLY%253D&md5=ca1345a28f90ac6d022aad298a65445b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfh253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfh253%26sid%3Dliteratum%253Aachs%26aulast%3DBility%26aufirst%3DM.%2BT.%26aulast%3DThompson%26aufirst%3DJ.%2BT.%26aulast%3DMcKee%26aufirst%3DR.%2BH.%26aulast%3DDavid%26aufirst%3DR.%2BM.%26aulast%3DButala%26aufirst%3DJ.%2BH.%26aulast%3DVanden%2BHeuvel%26aufirst%3DJ.%2BP.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520mouse%2520and%2520human%2520peroxisome%2520proliferator-activated%2520receptors%2520%2528PPARs%2529%2520by%2520phthalate%2520monoesters%26jtitle%3DToxicol.%2520Sci.%26date%3D2004%26volume%3D82%26spage%3D170%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Adrian Hall, Hugues Chanteux, Karelle Ménochet, Marie Ledecq, <span class="NLM_string-name hlFld-ContribAuthor">Monika-Sarah E. D. Schulze</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6413-6522. <a href="https://doi.org/10.1021/acs.jmedchem.0c02245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02245%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252BOut%252BPXR%252BActivity%252Bon%252BDrug%252BDiscovery%252BProjects%25253A%252BA%252BReview%252Bof%252BStructure-Based%252BMethods%25252C%252BEmpirical%252Band%252BComputational%252BApproaches%26aulast%3DHall%26aufirst%3DAdrian%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27122020%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6413%26epage%3D6522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiangtao  Li</span>, <span class="hlFld-ContribAuthor ">Shuai  Qiu</span>, <span class="hlFld-ContribAuthor ">Xinyi  Ye</span>, <span class="hlFld-ContribAuthor ">Bo  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongjun  Liu</span>, and <span class="hlFld-ContribAuthor ">Zhiyong  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Dipeptide-Based Chiral Tertiary Amine-Catalyzed Asymmetric Conjugate Addition Reactions of 5H-Thiazol/Oxazol-4-Ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (23)
                                     , 11916-11923. <a href="https://doi.org/10.1021/acs.joc.6b02384" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02384%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDipeptide-Based%252BChiral%252BTertiary%252BAmine-Catalyzed%252BAsymmetric%252BConjugate%252BAddition%252BReactions%252Bof%252B5H-Thiazol%25252FOxazol-4-Ones%26aulast%3DLi%26aufirst%3DJiangtao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30092016%26date%3D15112016%26date%3D02122016%26date%3D08112016%26volume%3D81%26issue%3D23%26spage%3D11916%26epage%3D11923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Frederick W.  Goldberg</span>, and <span class="hlFld-ContribAuthor ">Andrew V.  Turnbull</span>  . </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4466-4486. <a href="https://doi.org/10.1021/jm4014746" title="DOI URL">https://doi.org/10.1021/jm4014746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014746%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252Bof%252BInhibitors%252Bof%252B11%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%252B1%252B%25252811%2525CE%2525B2-HSD1%252529%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D23092013%26date%3D13122013%26date%3D12062014%26date%3D02122013%26volume%3D57%26issue%3D11%26spage%3D4466%26epage%3D4486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick W.  Goldberg</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Dossetter</span>, <span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Graeme R.  Robb</span>, <span class="hlFld-ContribAuthor ">Scott  Boyd</span>, <span class="hlFld-ContribAuthor ">Sam D.  Groombridge</span>, <span class="hlFld-ContribAuthor ">Paul D.  Kemmitt</span>, <span class="hlFld-ContribAuthor ">Tove  Sjögren</span>, <span class="hlFld-ContribAuthor ">Pablo Morentin  Gutierrez</span>, <span class="hlFld-ContribAuthor ">Joanne  deSchoolmeester</span>, <span class="hlFld-ContribAuthor ">John G.  Swales</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Turnbull</span>, and <span class="hlFld-ContribAuthor ">Martin J.  Wild</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Brain Penetrant 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors and in Vivo Testing in Diet-Induced Obese Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 970-986. <a href="https://doi.org/10.1021/jm4016729" title="DOI URL">https://doi.org/10.1021/jm4016729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4016729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4016729%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BBrain%252BPenetrant%252B11%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%252BI%252BInhibitors%252Band%252Bin%252BVivo%252BTesting%252Bin%252BDiet-Induced%252BObese%252BMice%26aulast%3DGoldberg%26aufirst%3DFrederick%2BW.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D28102013%26date%3D27012014%26date%3D13022014%26date%3D14012014%26volume%3D57%26issue%3D3%26spage%3D970%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Xing  Song</span>, <span class="hlFld-ContribAuthor ">Da-Ming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the catalytic asymmetric reactions of thiazolone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (31)
                                     , 6018-6041. <a href="https://doi.org/10.1039/D0OB01261K" title="DOI URL">https://doi.org/10.1039/D0OB01261K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01261K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01261K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bcatalytic%252Basymmetric%252Breactions%252Bof%252Bthiazolone%252Bderivatives%26aulast%3DSong%26aufirst%3DYong-Xing%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D31%26spage%3D6018%26epage%3D6041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong‐Xing  Song</span>, <span class="hlFld-ContribAuthor ">Da‐Ming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Squaramide‐Catalysed Asymmetric Michael/Hemiketalization/Retro‐Aldol Reaction of Unsaturated Thiazolones with α‐Nitroketones: Synthesis of Chiral 4‐Acyloxythiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (21)
                                     , 5042-5049. <a href="https://doi.org/10.1002/adsc.201900901" title="DOI URL">https://doi.org/10.1002/adsc.201900901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900901%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DBifunctional%252BSquaramide%2525E2%252580%252590Catalysed%252BAsymmetric%252BMichael%25252FHemiketalization%25252FRetro%2525E2%252580%252590Aldol%252BReaction%252Bof%252BUnsaturated%252BThiazolones%252Bwith%252B%2525CE%2525B1%2525E2%252580%252590Nitroketones%25253A%252BSynthesis%252Bof%252BChiral%252B4%2525E2%252580%252590Acyloxythiazole%252BDerivatives%26aulast%3DSong%26aufirst%3DYong%25E2%2580%2590Xing%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D21%26spage%3D5042%26epage%3D5049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongjie  Guo</span>, <span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Xueying  Liu</span>, <span class="hlFld-ContribAuthor ">Shengyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic asymmetric synthesis of highly functionalized spiro-thiazolone–cyclopropane-oxindoles bearing two vicinal spiro quaternary centers. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (9)
                                     , 1442-1447. <a href="https://doi.org/10.1039/C9QO00145J" title="DOI URL">https://doi.org/10.1039/C9QO00145J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00145J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00145J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DOrganocatalytic%252Basymmetric%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252Bspiro-thiazolone%2525E2%252580%252593cyclopropane-oxindoles%252Bbearing%252Btwo%252Bvicinal%252Bspiro%252Bquaternary%252Bcenters%26aulast%3DWang%26aufirst%3DShengzheng%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D9%26spage%3D1442%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie E.  Moscovitz</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Lin</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Johnson</span>, <span class="hlFld-ContribAuthor ">Meihua  Tu</span>, <span class="hlFld-ContribAuthor ">Theunis C.  Goosen</span>, <span class="hlFld-ContribAuthor ">Yan  Weng</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2018,</strong> <em>48 </em>
                                    (7)
                                     , 647-655. <a href="https://doi.org/10.1080/00498254.2017.1353163" title="DOI URL">https://doi.org/10.1080/00498254.2017.1353163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00498254.2017.1353163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00498254.2017.1353163%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DInduction%252Bof%252Bhuman%252Bcytochrome%252BP450%252B3A4%252Bby%252Bthe%252Birreversible%252Bmyeloperoxidase%252Binactivator%252BPF-06282999%252Bis%252Bmediated%252Bby%252Bthe%252Bpregnane%252BX%252Breceptor%26aulast%3DMoscovitz%26aufirst%3DJamie%2BE.%26date%3D2018%26date%3D2017%26volume%3D48%26issue%3D7%26spage%3D647%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. R.  Murumkar</span>, <span class="hlFld-ContribAuthor ">A. C.  Shinde</span>, <span class="hlFld-ContribAuthor ">M. K.  Sharma</span>, <span class="hlFld-ContribAuthor ">H.  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">P. B.  Miniyar</span>, <span class="hlFld-ContribAuthor ">M. R.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a credible 3D-QSAR CoMSIA model and docking studies for a series of triazoles and tetrazoles containing 11β-HSD1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2016,</strong> <em>27 </em>
                                    (4)
                                     , 265-292. <a href="https://doi.org/10.1080/1062936X.2016.1167774" title="DOI URL">https://doi.org/10.1080/1062936X.2016.1167774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2016.1167774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2016.1167774%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DDevelopment%252Bof%252Ba%252Bcredible%252B3D-QSAR%252BCoMSIA%252Bmodel%252Band%252Bdocking%252Bstudies%252Bfor%252Ba%252Bseries%252Bof%252Btriazoles%252Band%252Btetrazoles%252Bcontaining%252B11%2525CE%2525B2-HSD1%252Binhibitors%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26date%3D2016%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D265%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmine  Giorgio</span>, <span class="hlFld-ContribAuthor ">Simonetta  Russo</span>, <span class="hlFld-ContribAuthor ">Matteo  Incerti</span>, <span class="hlFld-ContribAuthor ">Antonella  Bugatti</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Barocelli</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Daniele  Pala</span>, <span class="hlFld-ContribAuthor ">Iftiin  Hassan-Mohamed</span>, <span class="hlFld-ContribAuthor ">Antimo  Gioiello</span>, <span class="hlFld-ContribAuthor ">Marco  Rusnati</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Tognolini</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2016,</strong> <em>99 </em>, 18-30. <a href="https://doi.org/10.1016/j.bcp.2015.10.006" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DBiochemical%252Bcharacterization%252Bof%252BEphA2%252Bantagonists%252Bwith%252Bimproved%252Bphysico-chemical%252Bproperties%252Bby%252Bcell-based%252Bassays%252Band%252Bsurface%252Bplasmon%252Bresonance%252Banalysis%26aulast%3DGiorgio%26aufirst%3DCarmine%26date%3D2016%26volume%3D99%26spage%3D18%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2013,</strong> <em>45 </em>
                                    (1)
                                     , 3-14. <a href="https://doi.org/10.3109/03602532.2012.743560" title="DOI URL">https://doi.org/10.3109/03602532.2012.743560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/03602532.2012.743560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F03602532.2012.743560%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DEvaluation%252Bof%252Bpregnane%252BX%252Breceptor%252B%252528PXR%252529-mediated%252BCYP3A4%252Bdrug-drug%252Binteractions%252Bin%252Bdrug%252Bdevelopment%26aulast%3DSinz%26aufirst%3DMichael%2BW.%26date%3D2013%26date%3D2013%26volume%3D45%26issue%3D1%26spage%3D3%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>. </span><span class="cited-content_cbyCitation_article-title">Avoiding PXR and CAR Activation and CYP3A4 Enzyme Induction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 159-190. <a href="https://doi.org/10.1007/7355_2013_24" title="DOI URL">https://doi.org/10.1007/7355_2013_24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_24%26sid%3Dliteratum%253Aachs%26atitle%3DAvoiding%252BPXR%252Band%252BCAR%252BActivation%252Band%252BCYP3A4%252BEnzyme%252BInduction%26aulast%3DSinz%26aufirst%3DMichael%2BW.%26date%3D2013%26date%3D2013%26spage%3D159%26epage%3D190%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hans  Matter</span>, <span class="hlFld-ContribAuthor ">Lennart T.  Anger</span>, <span class="hlFld-ContribAuthor ">Clemens  Giegerich</span>, <span class="hlFld-ContribAuthor ">Stefan  Güssregen</span>, <span class="hlFld-ContribAuthor ">Gerhard  Hessler</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Baringhaus</span>. </span><span class="cited-content_cbyCitation_article-title">Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (18)
                                     , 5352-5365. <a href="https://doi.org/10.1016/j.bmc.2012.04.020" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.04.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.04.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bin%252Bsilico%252Bfilters%252Bto%252Bpredict%252Bactivation%252Bof%252Bthe%252Bpregnane%252BX%252Breceptor%252B%252528PXR%252529%252Bby%252Bstructurally%252Bdiverse%252Bdrug-like%252Bmolecules%26aulast%3DMatter%26aufirst%3DHans%26date%3D2012%26volume%3D20%26issue%3D18%26spage%3D5352%26epage%3D5365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Hamann</span>, <span class="hlFld-ContribAuthor ">Ligaya  Simpkins</span>, <span class="hlFld-ContribAuthor ">Rajasree  Golla</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Li</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Seethala</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">David A.  Gordon</span>, <span class="hlFld-ContribAuthor ">James J.  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (14)
                                     , 4146-4149. <a href="https://doi.org/10.1016/j.bmcl.2011.05.101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DGeneration%252Bof%252B3%25252C8-substituted%252B1%25252C2%25252C4-triazolopyridines%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252B11%2525CE%2525B2-hydroxysteroid%252Bdehydrogenase%252Btype%252B1%252B%25252811%2525CE%2525B2-HSD-1%252529%26aulast%3DWang%26aufirst%3DHaixia%26date%3D2011%26volume%3D21%26issue%3D14%26spage%3D4146%26epage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clarence  Hale</span>, <span class="hlFld-ContribAuthor ">David J.  St. Jean</span>. </span><span class="cited-content_cbyCitation_article-title">11β-Hydroxysteroid Dehydrogenase Type 1 as a Therapeutic Target for Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 423-458. <a href="https://doi.org/10.1002/9780470910016.ch16" title="DOI URL">https://doi.org/10.1002/9780470910016.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470910016.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470910016.ch16%26sid%3Dliteratum%253Aachs%26atitle%3D11%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%252B1%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252BType%252B2%252BDiabetes%26aulast%3DHale%26aufirst%3DClarence%26date%3D2011%26date%3D2011%26spage%3D423%26epage%3D458%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DMetabolic%252BSyndrome%26aulast%3DWang%26aufirst%3DMinghan%26date%3D2011%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark P  Thomas</span>, <span class="hlFld-ContribAuthor ">Barry VL  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (3)
                                     , 367-390. <a href="https://doi.org/10.4155/fmc.10.282" title="DOI URL">https://doi.org/10.4155/fmc.10.282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.10.282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.10.282%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructures%252Bof%252B11%2525CE%2525B2-hydroxysteroid%252Bdehydrogenase%252Btype%252B1%252Band%252Btheir%252Buse%252Bin%252Bdrug%252Bdiscovery%26aulast%3DThomas%26aufirst%3DMark%2BP%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D367%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangdong  Su</span>, <span class="hlFld-ContribAuthor ">Fabienne  Pradaux-Caggiano</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Michelle W. Y.  Szeto</span>, <span class="hlFld-ContribAuthor ">Heather A.  Halem</span>, <span class="hlFld-ContribAuthor ">Michael D.  Culler</span>, <span class="hlFld-ContribAuthor ">Nigel  Vicker</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Adamantyl Ethanone Derivatives as Potent 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (7)
                                     , 1026-1044. <a href="https://doi.org/10.1002/cmdc.201000081" title="DOI URL">https://doi.org/10.1002/cmdc.201000081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201000081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201000081%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252BAdamantyl%252BEthanone%252BDerivatives%252Bas%252BPotent%252B11%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%2525E2%252580%2525851%252B%25252811%2525CE%2525B2-HSD1%252529%252BInhibitors%26aulast%3DSu%26aufirst%3DXiangdong%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D7%26spage%3D1026%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Mark D.  Wittman</span>, <span class="hlFld-ContribAuthor ">Mark G.  Saulnier</span>, <span class="hlFld-ContribAuthor ">Upender  Velaparthi</span>, <span class="hlFld-ContribAuthor ">Xiaopeng  Sang</span>, <span class="hlFld-ContribAuthor ">David B.  Frennesson</span>, <span class="hlFld-ContribAuthor ">Charles  Struzynski</span>, <span class="hlFld-ContribAuthor ">Steven P.  Seitz</span>, <span class="hlFld-ContribAuthor ">Liqi  He</span>, <span class="hlFld-ContribAuthor ">Joan M.  Carboni</span>, <span class="hlFld-ContribAuthor ">Aixin  Li</span>, <span class="hlFld-ContribAuthor ">Ann F.  Greer</span>, <span class="hlFld-ContribAuthor ">Marco  Gottardis</span>, <span class="hlFld-ContribAuthor ">Ricardo M.  Attar</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Lorell N.  Discenza</span>, <span class="hlFld-ContribAuthor ">Francis Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Michael  Sinz</span>, <span class="hlFld-ContribAuthor ">Sean  Kim</span>, <span class="hlFld-ContribAuthor ">Dolatrai  Vyas</span>. </span><span class="cited-content_cbyCitation_article-title">SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 1744-1748. <a href="https://doi.org/10.1016/j.bmcl.2010.01.087" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.087%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Bof%252BPXR%252Btransactivation%252Bin%252Bbenzimidazole-based%252BIGF-1R%252Bkinase%252Binhibitors%26aulast%3DZimmermann%26aufirst%3DKurt%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhenrong  Xu</span>, <span class="hlFld-ContribAuthor ">Salvacion T.  Cacatian</span>, <span class="hlFld-ContribAuthor ">Robert D.  Simpson</span>, <span class="hlFld-ContribAuthor ">Yuan-Jie  Ye</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>, <span class="hlFld-ContribAuthor ">Brian M.  McKeever</span>, <span class="hlFld-ContribAuthor ">Peter  Lindblom</span>, <span class="hlFld-ContribAuthor ">Joan  Guo</span>, <span class="hlFld-ContribAuthor ">Paula M.  Krosky</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Kruk</span>, <span class="hlFld-ContribAuthor ">Jennifer  Berbaum</span>, <span class="hlFld-ContribAuthor ">Richard K.  Harrison</span>, <span class="hlFld-ContribAuthor ">Judith J.  Johnson</span>, <span class="hlFld-ContribAuthor ">Yuri  Bukhtiyarov</span>, <span class="hlFld-ContribAuthor ">Reshma  Panemangalore</span>, <span class="hlFld-ContribAuthor ">Boyd B.  Scott</span>, <span class="hlFld-ContribAuthor ">Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Bruno</span>, <span class="hlFld-ContribAuthor ">Linghang  Zhuang</span>, <span class="hlFld-ContribAuthor ">Gerard M.  McGeehan</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">David A.  Claremon</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors identified by computer-aided drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (3)
                                     , 881-886. <a href="https://doi.org/10.1016/j.bmcl.2009.12.082" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.12.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.12.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.12.082%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpirocyclic%252Bureas%25253A%252BOrally%252Bbioavailable%252B11%2525CE%2525B2-HSD1%252Binhibitors%252Bidentified%252Bby%252Bcomputer-aided%252Bdrug%252Bdesign%26aulast%3DTice%26aufirst%3DColin%2BM.%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D881%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig D  Boyle</span>, <span class="hlFld-ContribAuthor ">Timothy J  Kowalski</span>. </span><span class="cited-content_cbyCitation_article-title">11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2009,</strong> <em>19 </em>
                                    (6)
                                     , 801-825. <a href="https://doi.org/10.1517/13543770902967658" title="DOI URL">https://doi.org/10.1517/13543770902967658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543770902967658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543770902967658%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D11%2525CE%2525B2-hydroxysteroid%252Bdehydrogenase%252Btype%252B1%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatents%26aulast%3DBoyle%26aufirst%3DCraig%2BD%26date%3D2009%26date%3D2009%26volume%3D19%26issue%3D6%26spage%3D801%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Interconversion of Cortisone, <b>1a</b> (Dehydrocorticosterone, <b>1b</b>), to Cortisol, <b>2a</b> (Corticosterone, <b>2b</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Examples of 11β-HSD1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Chart a</span>Ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>.</p><p><span class="fn-label">Chart b</span>Ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</p><p><span class="fn-label">Chart c</span>Ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p><p><span class="fn-label">Chart d</span>Ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p><p class="last"><span class="fn-label">Chart e</span>Ref <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Strategy To Address the Issue of PXR Activation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PXR activity with a 20 μM concentration of <b>3</b> (100% of control is equivalent to the activity achieved with 12.5 μM rifampin).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0006.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Benzoyl isothiocyanate, CH<sub>2</sub>Cl<sub>2</sub>. (b) K<sub>2</sub>CO<sub>3</sub>, THF/methanol/H<sub>2</sub>O, 98% for two steps. (c) NBS, AIBN, CCl<sub>4</sub>, 80 °C (X = F, R = H, 86%; X = Br, R = Et, 96%). (d) X = F, NaOAc, ethanol, reflux, 48%; X = Br, NEt(<i>i</i>-Pr)<sub>2</sub>, ethanol, reflux, 71%. (e) LDA, CH<sub>3</sub>I, THF, −78 °C, (X = F, 68%, X = Br, 97%). (f) CO, PPh<sub>3</sub>, Pd(OAc)<sub>2</sub>, KOAc, methanol, DMF, 100 °C, 99%. (g) LiOH, H<sub>2</sub>O, THF, methanol, reflux, 62%. (h) LiAlH<sub>4</sub>, THF, 0 °C, 70%. (i) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 100%. (j) HNR<sub>1</sub>R<sub>2</sub>, THF, 0 °C, 8−79%. (k) Morpholine, HOBT, dicyclohexanecarbodiimide, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 91%. (l) SOCl<sub>2</sub>, dioxane, room temperature, 100%. (m) Bu<sub>4</sub>NCN, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 63%. (n) KOH, <i>t</i>-BuOH, 100 °C, 17%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0007.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Methyl 2-bromopropanoate, Et<sub>3</sub>N, ethanol, 100 °C, microwave, 88%. (b) Compound <b>16</b>, LDA, THF, −78 to 0 °C, 87%. (c) KOH, <i>t</i>-BuOH, 85−100 °C, 66−86%. (d) Compound <b>16</b>, LiHMDS, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, toluene, 95 °C, 26−37%. (e) <i>t</i>-BuOK, 18-crown-6, CH<sub>3</sub>I, THF, −78 °C to room temperature, 99%. (f) CH<sub>3</sub>MgBr, THF, 0 °C to room temperature, 74%. (g) TMSCl, NEt(<i>i</i>-Pr)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temperature, 84%. (h) K<sub>2</sub>CO<sub>3</sub>, methanol, room temperature, 93%. (i) Imidazole, iodine, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 82%. (j) Bu<sub>4</sub>NCN, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 65%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0008.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-Bromopropanoic acid, NaOAc, ethanol, reflux, 88−100%. (b) LDA, THF, −78 °C. (c) R<sub>1</sub>R<sub>2</sub>C═O, THF, −78−0 °C, 17−100%. (d) Lithium bis(trimethylsilyl)amide, THF, 0 °C. (e) 2-Methyloxirane, LiClO<sub>4</sub>, THF, 0 °C to room temperature, 71%. (f) Dess−Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 83%. (g) CH<sub>3</sub>MgBr, THF, 0 °C, 61%.</p></p></figure><figure data-id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0002.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray structure of human 11β-HSD1−(<i>S</i>)-<b>33a</b> complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/medium/jm-2008-01073z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0003.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of 11β-HSD1 activity with (<i>S</i>)-<b>33a</b> (dosed PO) in the mesenteric fat of cynomolgus monkeys. *<i>p</i> = 0.0048, **<i>p</i> = 0.0007, and <i>n</i> ≥ 4. Statistical analyses were carried out using a two-tailed Student’s t-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-24/jm801073z/production/images/large/jm-2008-01073z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801073z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roglic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, H.</span><span> </span><span class="NLM_article-title">Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.2337%2Fdiacare.27.5.1047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15111519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1047-53&author=S.+Wildauthor=G.+Roglicauthor=A.+Greenauthor=R.+Sicreeauthor=H.+King&title=Global+prevalence+of+diabetes%3A+Estimates+for+the+year+2000+and+projections+for+2030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span></div><div class="casAuthors">Wild Sarah; Roglic Gojka; Green Anders; Sicree Richard; King Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-53</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.  RESEARCH DESIGN AND METHODS:  Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030.  Urban and rural populations were considered separately for developing countries.  RESULTS:  The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030.  The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.  The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men.  The urban population in developing countries is projected to double between 2000 and 2030.  The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.  CONCLUSIONS:  These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant.  Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS1_5FBm4QLEbxh97K6Vt6fW6udTcc2eZWfrURP7G-lLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D&md5=93096de002d513e4fdd49028be51d85d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.27.5.1047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.27.5.1047%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DS.%26aulast%3DRoglic%26aufirst%3DG.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DSicree%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DH.%26atitle%3DGlobal%2520prevalence%2520of%2520diabetes%253A%2520Estimates%2520for%2520the%2520year%25202000%2520and%2520projections%2520for%25202030%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D1047%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wang, M.</span><span> </span><span class="NLM_article-title">Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=319-323&author=M.+Wang&title=Inhibitors+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+for+the+treatment+of+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26atitle%3DInhibitors%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520for%2520the%2520treatment%2520of%2520metabolic%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D319%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wamil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2Fj.drudis.2007.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=17631244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=504-520&author=M.+Wamilauthor=J.+R.+Seckl&title=Inhibition+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+as+a+promising+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 11ss-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target</span></div><div class="casAuthors">Wamil, Malgorzata; Seckl, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13&14</span>),
    <span class="NLM_cas:pages">504-520</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronically elevated glucocorticoid levels cause obesity, diabetes, heart disease, mood disorders and memory impairments. 11ss-hydroxysteroid dehydrogenase type 1 (11ss-HSD1) catalyzes intracellular regeneration of active glucocorticoids (cortisol, corticosterone) from inert 11-keto forms in liver, adipose and brain, amplifying local action.  Obese humans and rodents show increased 11ss-HSD1 in adipose tissue.  Transgenic mice overexpressing 11ss-HSD1 selectively in adipose tissue faithfully recapitulate metabolic syndrome.  Conversely, 11ss-HSD1 knockout mice have a 'cardioprotective' phenotype, whose effects are also seen with 11ss-HSD1 inhibitors in rodents.  However, any major metabolic effects of 11ss-HSD1 inhibition in humans are, as yet, unreported. 11ss-HSD1 null mice also resist cognitive decline with aging, and this is seen in humans with a prototypic inhibitor.  Thus 11ss-HSD1 inhibition is an emerging pleiotropic therapeutic target.  The metabolic syndrome phenotypically resembles Cushing's, but plasma cortisol levels are normal.  Intracellular cortisol regeneration by 11ss-hydroxysteroid dehydrogenase type 1 in adipose tissue might explain this paradox, but is this a realistic therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOq2ZUL9_T57Vg90H21EOLACvtfcHk0lg20VInRkiiDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWlur0%253D&md5=34495eb846727e937849c38942bb3d8b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DWamil%26aufirst%3DM.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520as%2520a%2520promising%2520therapeutic%2520target%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D504%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Boyle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">11β-Hydroxysteroid dehydrogenase type 1 inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=127-140&author=C.+D.+Boyleauthor=T.+J.+Kowalskiauthor=L.+Zhang&title=11%CE%B2-Hydroxysteroid+dehydrogenase+type+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DKowalski%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D11%25CE%25B2-Hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span> </span><span class="NLM_article-title">11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1517%2F13543776.15.3.289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVerur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=289-303&author=C.+Fotschauthor=B.+C.+Askewauthor=J.+J.+Chen&title=11%CE%B2-Hydroxysteroid+dehydrogenase-1+as+a+therapeutic+target+for+metabolic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">11β-hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases</span></div><div class="casAuthors">Fotsch, Christopher; Askew, Ben C.; Chen, Jian Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">289-303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  11β-Hydroxysteroid dehydrogenase-1 (11βHSD1) is a therapeutic target for Type 2 diabetes that has stimulated the interest of many pharmaceutical companies.  Mounting evidence obtained from both preclin. and clin. studies support the contention that inhibiting 11βHSD1 will have a therapeutic benefit by lowering glucose output and increasing insulin sensitivity.  In just over 2 years, 21 applications contg. 11βHSD1 inhibitors were published.  In this review, the target rationale and patent applications from Merck, Novo Nordisk, AstraZeneca, Sterix, Biovitrum, Janssen and Novartis will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHaQVmEFdy4bVg90H21EOLACvtfcHk0ljTYCCNGF02Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVerur4%253D&md5=1c923df050c201a6b634ffcb88bb6d10</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543776.15.3.289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.15.3.289%26sid%3Dliteratum%253Aachs%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DAskew%26aufirst%3DB.%2BC.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3D11%25CE%25B2-Hydroxysteroid%2520dehydrogenase-1%2520as%2520a%2520therapeutic%2520target%2520for%2520metabolic%2520diseases%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D2005%26volume%3D15%26spage%3D289%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hanson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reshef, L.</span><span> </span><span class="NLM_article-title">Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1146%2Fannurev.biochem.66.1.581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=9242918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADyaK2sXktFOmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1997&pages=581-611&author=R.+W.+Hansonauthor=L.+Reshef&title=Regulation+of+phosphoenolpyruvate+carboxykinase+%28GTP%29+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression</span></div><div class="casAuthors">Hanson, Richard W.; Reshef, Lea</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">581-611</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 145 refs.  Phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) (PEPCK) is a key enzyme in the synthesis of glucose in the liver and kidney and of glyceride-glycerol in white adipose tissue and the small intestine.  The gene for the cytosolic form of PEPCK (PECPCK-C) is acutely regulated by a variety of dietary and hormonal signals, which result in alteration of synthesis of the enzyme.  Major factors that increase PEPCK-C gene expression include cAMP, glucocorticoids, and thyroid hormone, whereas insulin inhibits this process.  PEPCK-C is absent in fetal liver but appears at birth, concomitant with the capacity for gluconeogenesis.  Regulatory elements that control transcription of the PEPCK-C gene in liver, kidney, and adipose tissue have been delineated, and many of the transcription factors that bind to these elements have been identified.  Transgenic mice have been esp. useful in elucidating the physiol. roles of specific sequence elements in the PEPCK-C gene promoter and in demonstrating the key role played at these sites by the isoforms of CAAT/enhancer binding protein in patterning of PEPCK-C gene expression during the perinatal period.  The PEPCK-C gene provides a model for the metabolic control of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2wZa9oROWUrVg90H21EOLACvtfcHk0ljTYCCNGF02Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFOmsbg%253D&md5=bde4eb97aeeb86fdb18cd680d43fbf5a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.66.1.581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.66.1.581%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DR.%2BW.%26aulast%3DReshef%26aufirst%3DL.%26atitle%3DRegulation%2520of%2520phosphoenolpyruvate%2520carboxykinase%2520%2528GTP%2529%2520gene%2520expression%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1997%26volume%3D66%26spage%3D581%26epage%3D611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bujalska, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, P. M.</span><span> </span><span class="NLM_article-title">Differentiation of adipose stromal cells: The roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">3188</span><span class="NLM_x">–</span> <span class="NLM_lpage">3196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1999&pages=3188-3196&author=I.+J.+Bujalskaauthor=S.+Kumarauthor=M.+Hewisonauthor=P.+M.+Stewart&title=Differentiation+of+adipose+stromal+cells%3A+The+roles+of+glucocorticoids+and+11%CE%B2-hydroxysteroid+dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBujalska%26aufirst%3DI.%2BJ.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DHewison%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DP.%2BM.%26atitle%3DDifferentiation%2520of%2520adipose%2520stromal%2520cells%253A%2520The%2520roles%2520of%2520glucocorticoids%2520and%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%26jtitle%3DEndocrinology%26date%3D1999%26volume%3D140%26spage%3D3188%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Masuzaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span> </span><span class="NLM_article-title">A transgenic model of visceral obesity and the metabolic syndrome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">2166</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=2166-2170&author=H.+Masuzakiauthor=J.+Patersonauthor=H.+Shinyamaauthor=N.+M.+Mortonauthor=J.+J.+Mullinsauthor=J.+R.+Secklauthor=J.+S.+Flier&title=A+transgenic+model+of+visceral+obesity+and+the+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasuzaki%26aufirst%3DH.%26aulast%3DPaterson%26aufirst%3DJ.%26aulast%3DShinyama%26aufirst%3DH.%26aulast%3DMorton%26aufirst%3DN.%2BM.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26atitle%3DA%2520transgenic%2520model%2520of%2520visceral%2520obesity%2520and%2520the%2520metabolic%2520syndrome%26jtitle%3DScience%26date%3D2001%26volume%3D294%26spage%3D2166%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kotelevtsev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmoll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span> </span><span class="NLM_article-title">11beta-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">14924</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=14924-9&author=Y.+Kotelevtsevauthor=M.+C.+Holmesauthor=A.+Burchellauthor=P.+M.+Houstonauthor=D.+Schmollauthor=P.+Jamiesonauthor=R.+Bestauthor=R.+Brownauthor=C.+R.+Edwardsauthor=J.+R.+Secklauthor=J.+J.+Mullins&title=11beta-Hydroxysteroid+dehydrogenase+type+1+knockout+mice+show+attenuated+glucocorticoid-inducible+responses+and+resist+hyperglycemia+on+obesity+or+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotelevtsev%26aufirst%3DY.%26aulast%3DHolmes%26aufirst%3DM.%2BC.%26aulast%3DBurchell%26aufirst%3DA.%26aulast%3DHouston%26aufirst%3DP.%2BM.%26aulast%3DSchmoll%26aufirst%3DD.%26aulast%3DJamieson%26aufirst%3DP.%26aulast%3DBest%26aufirst%3DR.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DEdwards%26aufirst%3DC.%2BR.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26atitle%3D11beta-Hydroxysteroid%2520dehydrogenase%2520type%25201%2520knockout%2520mice%2520show%2520attenuated%2520glucocorticoid-inducible%2520responses%2520and%2520resist%2520hyperglycemia%2520on%2520obesity%2520or%2520stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D14924%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Morton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuzaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fievet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span> </span><span class="NLM_article-title">Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=931-938&author=N.+M.+Mortonauthor=J.+M.+Patersonauthor=H.+Masuzakiauthor=M.+C.+Holmesauthor=B.+Staelsauthor=C.+Fievetauthor=B.+R.+Walkerauthor=J.+S.+Flierauthor=J.+J.+Mullinsauthor=J.+R.+Seckl&title=Novel+adipose+tissue-mediated+resistance+to+diet-induced+visceral+obesity+in+11%CE%B2-hydroxysteroid+dehydrogenase+type+1-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DN.%2BM.%26aulast%3DPaterson%26aufirst%3DJ.%2BM.%26aulast%3DMasuzaki%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DM.%2BC.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DFievet%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DB.%2BR.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26atitle%3DNovel%2520adipose%2520tissue-mediated%2520resistance%2520to%2520diet-induced%2520visceral%2520obesity%2520in%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201-deficient%2520mice%26jtitle%3DDiabetes%26date%3D2004%26volume%3D53%26spage%3D931%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Morton, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fievet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tailleux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seckl, J. R.</span><span> </span><span class="NLM_article-title">Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">41293</span><span class="NLM_x">–</span> <span class="NLM_lpage">41300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=41293-41300&author=N.+M.+Mortonauthor=M.+C.+Holmesauthor=C.+Fievetauthor=B.+Staelsauthor=A.+Tailleuxauthor=J.+J.+Mullinsauthor=J.+R.+Seckl&title=Improved+lipid+and+lipoprotein+profile%2C+hepatic+insulin+sensitivity%2C+and+glucose+tolerance+in+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+null+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DN.%2BM.%26aulast%3DHolmes%26aufirst%3DM.%2BC.%26aulast%3DFievet%26aufirst%3DC.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DTailleux%26aufirst%3DA.%26aulast%3DMullins%26aufirst%3DJ.%2BJ.%26aulast%3DSeckl%26aufirst%3DJ.%2BR.%26atitle%3DImproved%2520lipid%2520and%2520lipoprotein%2520profile%252C%2520hepatic%2520insulin%2520sensitivity%252C%2520and%2520glucose%2520tolerance%2520in%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520null%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D41293%26epage%3D41300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Alberts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engblom, L. O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edling, N. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingström, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsgren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashkzari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björkstrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L. B.</span><span> </span><span class="NLM_article-title">Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">4755</span><span class="NLM_x">–</span> <span class="NLM_lpage">4762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=4755-4762&author=P.+Albertsauthor=C.+Nilssonauthor=G.+Selenauthor=L.+O.+M.+Engblomauthor=N.+H.+M.+Edlingauthor=S.+Norlingauthor=G.+Klingstr%C3%B6mauthor=C.+Larssonauthor=M.+Forsgrenauthor=M.+Ashkzariauthor=C.+E.+Nilssonauthor=M.+Fiedlerauthor=E.+Bergqvistauthor=B.+Oehmanauthor=E.+Bj%C3%B6rkstrandauthor=L.+B.+Abrahms%C3%A9n&title=Selective+inhibition+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+improves+hepatic+insulin+sensitivity+in+hyperglycemic+mice+strains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberts%26aufirst%3DP.%26aulast%3DNilsson%26aufirst%3DC.%26aulast%3DSelen%26aufirst%3DG.%26aulast%3DEngblom%26aufirst%3DL.%2BO.%2BM.%26aulast%3DEdling%26aufirst%3DN.%2BH.%2BM.%26aulast%3DNorling%26aufirst%3DS.%26aulast%3DKlingstr%25C3%25B6m%26aufirst%3DG.%26aulast%3DLarsson%26aufirst%3DC.%26aulast%3DForsgren%26aufirst%3DM.%26aulast%3DAshkzari%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DC.%2BE.%26aulast%3DFiedler%26aufirst%3DM.%26aulast%3DBergqvist%26aufirst%3DE.%26aulast%3DOehman%26aufirst%3DB.%26aulast%3DBj%25C3%25B6rkstrand%26aufirst%3DE.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%2BB.%26atitle%3DSelective%2520inhibition%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520improves%2520hepatic%2520insulin%2520sensitivity%2520in%2520hyperglycemic%2520mice%2520strains%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D4755%26epage%3D4762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hermanowski-Vosatka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noonan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strack, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieringer, R.</span><span> </span><span class="NLM_article-title">11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=517-527&author=A.+Hermanowski-Vosatkaauthor=J.+M.+Balkovecauthor=K.+Chengauthor=H.+Y.+Chenauthor=M.+Hernandezauthor=G.+C.+Kooauthor=C.+B.+Le+Grandauthor=Z.+Liauthor=J.+M.+Metzgerauthor=S.+S.+Mundtauthor=H.+Noonanauthor=C.+N.+Nunesauthor=S.+H.+Olsonauthor=B.+Pikounisauthor=N.+Renauthor=N.+Robertsonauthor=J.+M.+Schaefferauthor=K.+Shahauthor=M.+S.+Springerauthor=A.+M.+Strackauthor=M.+Strowskiauthor=K.+Wuauthor=T.+Wuauthor=J.+Xiaoauthor=B.+B.+Zhangauthor=S.+D.+Wrightauthor=R.+Thieringer&title=11%CE%B2-HSD1+inhibition+ameliorates+metabolic+syndrome+and+prevents+progression+of+atherosclerosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHermanowski-Vosatka%26aufirst%3DA.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DCheng%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DHernandez%26aufirst%3DM.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DLe%2BGrand%26aufirst%3DC.%2BB.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMetzger%26aufirst%3DJ.%2BM.%26aulast%3DMundt%26aufirst%3DS.%2BS.%26aulast%3DNoonan%26aufirst%3DH.%26aulast%3DNunes%26aufirst%3DC.%2BN.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DPikounis%26aufirst%3DB.%26aulast%3DRen%26aufirst%3DN.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DSchaeffer%26aufirst%3DJ.%2BM.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DStrack%26aufirst%3DA.%2BM.%26aulast%3DStrowski%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DThieringer%26aufirst%3DR.%26atitle%3D11%25CE%25B2-HSD1%2520inhibition%2520ameliorates%2520metabolic%2520syndrome%2520and%2520prevents%2520progression%2520of%2520atherosclerosis%2520in%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D202%26spage%3D517%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprak, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeGrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieringer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermanowski-Vosatka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zokian, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waddell, S. T.</span><span> </span><span class="NLM_article-title">Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta -HSD1: Novel therapeutic agents for the treatment of metabolic syndrome</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5266</span><span class="NLM_x">–</span> <span class="NLM_lpage">5269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5266-5269&author=X.+Guauthor=J.+Dragovicauthor=G.+C.+Kooauthor=S.+L.+Koprakauthor=C.+LeGrandauthor=S.+S.+Mundtauthor=K.+Shahauthor=M.+S.+Springerauthor=E.+Y.+Tanauthor=R.+Thieringerauthor=A.+Hermanowski-Vosatkaauthor=H.+J.+Zokianauthor=J.+M.+Balkovecauthor=S.+T.+Waddell&title=Discovery+of+4-heteroarylbicyclo%5B2.2.2%5Doctyltriazoles+as+potent+and+selective+inhibitors+of+11beta+-HSD1%3A+Novel+therapeutic+agents+for+the+treatment+of+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26aulast%3DDragovic%26aufirst%3DJ.%26aulast%3DKoo%26aufirst%3DG.%2BC.%26aulast%3DKoprak%26aufirst%3DS.%2BL.%26aulast%3DLeGrand%26aufirst%3DC.%26aulast%3DMundt%26aufirst%3DS.%2BS.%26aulast%3DShah%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DM.%2BS.%26aulast%3DTan%26aufirst%3DE.%2BY.%26aulast%3DThieringer%26aufirst%3DR.%26aulast%3DHermanowski-Vosatka%26aufirst%3DA.%26aulast%3DZokian%26aufirst%3DH.%2BJ.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DWaddell%26aufirst%3DS.%2BT.%26atitle%3DDiscovery%2520of%25204-heteroarylbicyclo%255B2.2.2%255Doctyltriazoles%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%252011beta%2520-HSD1%253A%2520Novel%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520metabolic%2520syndrome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5266%26epage%3D5269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rohde, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pliushchev, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monzon, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chovan, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullally, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolarik, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imade, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, D. W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fey, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frevert, E. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J. T.</span><span> </span><span class="NLM_article-title">Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0609364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=149-164&author=J.+J.+Rohdeauthor=M.+A.+Pliushchevauthor=B.+K.+Sorensenauthor=D.+Wodkaauthor=Q.+Shuaiauthor=J.+Wangauthor=S.+Fungauthor=K.+M.+Monzonauthor=W.+J.+Chiouauthor=L.+Panauthor=X.+Dengauthor=L.+E.+Chovanauthor=A.+Ramaiyaauthor=M.+Mullallyauthor=R.+F.+Henryauthor=D.+F.+Stolarikauthor=H.+M.+Imadeauthor=K.+C.+Marshauthor=D.+W.+A.+Benoauthor=T.+A.+Feyauthor=B.+A.+Drozauthor=M.+E.+Bruneauthor=H.+S.+Campauthor=H.+L.+Shamauthor=E.+U.+Frevertauthor=P.+B.+Jacobsonauthor=J.+T.+Link&title=Discovery+and+metabolic+stabilization+of+potent+and+selective+2-amino-N-%28adamant-2-yl%29+acetamide+11beta-hydroxysteroid+dehydrogenase+type+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm0609364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0609364%26sid%3Dliteratum%253Aachs%26aulast%3DRohde%26aufirst%3DJ.%2BJ.%26aulast%3DPliushchev%26aufirst%3DM.%2BA.%26aulast%3DSorensen%26aufirst%3DB.%2BK.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DShuai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DMonzon%26aufirst%3DK.%2BM.%26aulast%3DChiou%26aufirst%3DW.%2BJ.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChovan%26aufirst%3DL.%2BE.%26aulast%3DRamaiya%26aufirst%3DA.%26aulast%3DMullally%26aufirst%3DM.%26aulast%3DHenry%26aufirst%3DR.%2BF.%26aulast%3DStolarik%26aufirst%3DD.%2BF.%26aulast%3DImade%26aufirst%3DH.%2BM.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBeno%26aufirst%3DD.%2BW.%2BA.%26aulast%3DFey%26aufirst%3DT.%2BA.%26aulast%3DDroz%26aufirst%3DB.%2BA.%26aulast%3DBrune%26aufirst%3DM.%2BE.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DFrevert%26aufirst%3DE.%2BU.%26aulast%3DJacobson%26aufirst%3DP.%2BB.%26aulast%3DLink%26aufirst%3DJ.%2BT.%26atitle%3DDiscovery%2520and%2520metabolic%2520stabilization%2520of%2520potent%2520and%2520selective%25202-amino-N-%2528adamant-2-yl%2529%2520acetamide%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D149%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukkola, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcopulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilci, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, R. E.</span><span> </span><span class="NLM_article-title">Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6696</span><span class="NLM_x">–</span> <span class="NLM_lpage">6712</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058228q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6696-6712&author=G.+M.+Coppolaauthor=P.+J.+Kukkolaauthor=J.+L.+Stantonauthor=A.+D.+Neubertauthor=N.+Marcopulosauthor=N.+A.+Bilciauthor=H.+Wangauthor=H.+C.+Tomaselliauthor=J.+Tanauthor=T.+D.+Aicherauthor=D.+C.+Knorrauthor=A.+Y.+Jengauthor=B.+Dardikauthor=R.+E.+Chatelain&title=Perhydroquinolylbenzamides+as+novel+inhibitors+of+11beta-hydroxysteroid+dehydrogenase+type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm058228q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058228q%26sid%3Dliteratum%253Aachs%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DKukkola%26aufirst%3DP.%2BJ.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DNeubert%26aufirst%3DA.%2BD.%26aulast%3DMarcopulos%26aufirst%3DN.%26aulast%3DBilci%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DTomaselli%26aufirst%3DH.%2BC.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26aulast%3DDardik%26aufirst%3DB.%26aulast%3DChatelain%26aufirst%3DR.%2BE.%26atitle%3DPerhydroquinolylbenzamides%2520as%2520novel%2520inhibitors%2520of%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6696%26epage%3D6712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Xiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massefski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of sulfonamidooxazoles and beta-keto sulfones: Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2865-2869&author=J.+Xiangauthor=M.+Ipekauthor=V.+Suriauthor=W.+Massefskiauthor=N.+Panauthor=Y.+Geauthor=M.+Tamauthor=Y.+Xingauthor=J.+F.+Tobinauthor=X.+Xuauthor=S.+Tam&title=Synthesis+and+biological+evaluation+of+sulfonamidooxazoles+and+beta-keto+sulfones%3A+Selective+inhibitors+of+11beta-hydroxysteroid+dehydrogenase+type+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DSuri%26aufirst%3DV.%26aulast%3DMassefski%26aufirst%3DW.%26aulast%3DPan%26aufirst%3DN.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DTobin%26aufirst%3DJ.%2BF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTam%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520sulfonamidooxazoles%2520and%2520beta-keto%2520sulfones%253A%2520Selective%2520inhibitors%2520of%252011beta-hydroxysteroid%2520dehydrogenase%2520type%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2865%26epage%3D2869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Linders, J. T. M.; Willemsens, G. H. M.; Bellens, D.; Buyck, C.; De Backker, P.; Ethirajulu, K.; Gilissen, R. A. H. J.; Hrupka, B.; Jaroskova, L.; Van Lommen, G.; Meulemans, A.; Smans, K.; van Dorsselaer, P.; Van der Veken, L.; Berwaer, M.</span>Substituted Adamantanamides As Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1; Abstracts of Papers, 231st ACS National Meeting, Atlanta, GA, United States, March 26−30,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>MEDI-002.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+T.+M.+Linders&author=G.+H.+M.+Willemsens&author=D.+Bellens&author=C.+Buyck&author=P.+De+Backker&author=K.+Ethirajulu&author=R.+A.+H.+J.+Gilissen&author=B.+Hrupka&author=L.+Jaroskova&author=G.+Van+Lommen&author=A.+Meulemans&author=K.+Smans&author=P.+van+Dorsselaer&author=L.+Van+der+Veken&author=M.+Berwaer&title=Substituted+Adamantanamides+As+Novel+Inhibitors+of+11%CE%B2-Hydroxysteroid+Dehydrogenase+Type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLinders%26aufirst%3DJ.%2BT.%2BM.%26jtitle%3DSubstituted%2520Adamantanamides%2520As%2520Novel%2520Inhibitors%2520of%252011%25CE%25B2-Hydroxysteroid%2520Dehydrogenase%2520Type%25201%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rask, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soderberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingstone, D. E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. R.</span><span> </span><span class="NLM_article-title">Tissue-specific dysregulation of cortisol metabolism in human obesity</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1418</span><span class="NLM_x">–</span> <span class="NLM_lpage">1421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1210%2Fjc.86.3.1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11238541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFWnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=1418-1421&author=E.+Raskauthor=T.+Olssonauthor=S.+Soderbergauthor=R.+Andrewauthor=D.+E.+W.+Livingstoneauthor=O.+Johnsonauthor=B.+R.+Walker&title=Tissue-specific+dysregulation+of+cortisol+metabolism+in+human+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-specific dysregulation of cortisol metabolism in human obesity</span></div><div class="casAuthors">Rask, Eva; Olsson, Tommy; Soderberg, Stefan; Andrew, Ruth; Livingstone, Dawn E. W.; Johnson, Owe; Walker, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1418-1421</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Cortisol has been implicated as a pathophysiol. mediator in idiopathic obesity, but circulating cortisol concns. are not consistently elevated.  The tissue-specific responses to cortisol may be influenced as much by local preceptor metab. as by circulating concns.  For example, in liver and adipose tissue cortisol is regenerated from inactive cortisone by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).  In obese Zucker rats 11β-HSD1 activity is reduced in liver but enhanced in adipose tissue.  This study addressed whether the same tissue-specific disruption of cortisol metab. occurs in human obesity.  34 Men were recruited from the MONICA population study in Northern Sweden to represent a wide range of body compn. and insulin sensitivity.  Plasma cortisol was measured at 0830h and 1230h, after overnight low-dose dexamethasone suppression, after i.v. corticotropin releasing hormone (CRH), and after oral cortisone administration.  Urinary cortisol metabolites were measured in a 24 h sample.  A s.c. fat biopsy was obtained from 16 participants to measure cortisol metab. in vitro.  Higher body mass index was assocd. with increased total cortisol metabolite excretion (r=0.47, p<0.01), but lower plasma cortisol at 1230 h and after dexamethasone, and no difference in response to CRH.  Obese men excreted a greater proportion of glucocorticoid as metabolites of cortisone rather than cortisol (r=0.43, p<0.02), and converted less cortisone to cortisol after oral administration (r=-0.49, p<0.01), suggesting impaired hepatic 11β-HSD1 activity.  By contrast, in vitro 11β-HSD1 activity in s.c. adipose tissue was markedly enhanced in obese men (r=0.66, p<0.01).  We conclude that in obesity, reactivation of cortisone to cortisol by 11β-HSD1 in liver is impaired, so that plasma cortisol levels tend to fall, and there may be a compensatory increase in cortisol secretion mediated by a normally functioning hypothalamic-pituitary-adrenal axis.  However, changes in 11β-HSD1 are tissue-specific: strikingly enhanced reactivation of cortisone to cortisol in s.c. adipose tissue may exacerbate obesity; and it may be beneficial to inhibit this enzyme in adipose tissue in obese patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMb3o2tQzRyrVg90H21EOLACvtfcHk0lhB9D1-C2TjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFWnurk%253D&md5=dc5fe2f65e250984509bd997ad2e8674</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.3.1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.3.1418%26sid%3Dliteratum%253Aachs%26aulast%3DRask%26aufirst%3DE.%26aulast%3DOlsson%26aufirst%3DT.%26aulast%3DSoderberg%26aufirst%3DS.%26aulast%3DAndrew%26aufirst%3DR.%26aulast%3DLivingstone%26aufirst%3DD.%2BE.%2BW.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DWalker%26aufirst%3DB.%2BR.%26atitle%3DTissue-specific%2520dysregulation%2520of%2520cortisol%2520metabolism%2520in%2520human%2520obesity%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D1418%26epage%3D1421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kannisto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietilaeinen, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenborg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaprio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamsten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yki-Jaervinen, H.</span><span> </span><span class="NLM_article-title">Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: Studies in young adult monozygotic twins</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">4414</span><span class="NLM_x">–</span> <span class="NLM_lpage">4421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1210%2Fjc.2004-0153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15356040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslWht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2004&pages=4414-4421&author=K.+Kannistoauthor=K.+H.+Pietilaeinenauthor=E.+Ehrenborgauthor=A.+Rissanenauthor=J.+Kaprioauthor=A.+Hamstenauthor=H.+Yki-Jaervinen&title=Overexpression+of+11%CE%B2-hydroxysteroid+dehydrogenase-1+in+adipose+tissue+is+associated+with+acquired+obesity+and+features+of+insulin+resistance%3A+Studies+in+young+adult+monozygotic+twins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: Studies in young adult monozygotic twins</span></div><div class="casAuthors">Kannisto, Katja; Pietilaeinen, Kirsi H.; Ehrenborg, Ewa; Rissanen, Aila; Kaprio, Jaakko; Hamsten, Anders; Yki-Jaervinen, Hannele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4414-4421</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD-1) catalyzes the interconversion of inactive cortisone to active cortisol.  Overexpression of 11β-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)α overexpression, central obesity, and insulin resistance.  It is controversial whether 11β-HSD-1 or GRα expression are increased in human adipose tissue in obesity.  The authors studied effects of acquired obesity on 11β-HSD-1 gene (real-time PCR) and protein (Western blotting) expression in s.c. adipose tissue in 17 monozygotic twin pairs aged 24-27 yr with a mean intrapair difference in body mass index (BMI) of 3.8 kg/m2 (range 0.4-10.1 kg/m2).  Intrapair correlations were calcd. to study effects of acquired obesity on 11β-HSD-1 expression.  Western blot anal. of adipose tissue homogenates identified approx. 50- and approx. 68-kDa proteins specific for 11β-HSD-1.  Both structural forms correlated pos. with 11β-HSD-1 mRNA concns.  Intrapair differences in 11β-HSD-1 mRNA, and the 50- and 68-kDa proteins in s.c. adipose tissue correlated pos. with those in BMI (kilograms per square meter) (r = 0.78 for 11β-HSD-1 mRNA, P = 0.0002; r = 0.87 for the 11β-HSD-1 50-kDa protein, P = 0.0003; and r = 0.62 for the 11β-HSD-1 68-kDa protein, P = 0.033), total body fat (percent) (r = 0.65, P = 0.005; r = 0.83, P = 0.001; and r = 0.69, P = 0.013, resp.) and s.c. fat (cubed centimeters) (r = 0.66, P = 0.004; r = 0.94, P = 0.0001; and r = 0.71, P = 0.009, resp.).  Furthermore, 11β-HSD-1 mRNA and 50-kDa protein expression, but not 68-kDa protein expression, correlated pos. with intrapair differences in intraabdominal fat mass (cubed centimeters) (r = 0.62, P = 0.008; r = 0.69, P = 0.013; r = 0.48, P = 0.112) and serum fasting insulin concn. (milliunits per L) (r = 0.76, P = 0.0004; r = 0.60, P = 0.037; and r = 0.43, P = 0.160, resp.).  Intrapair differences in GRα expression were significantly inversely correlated with those in BMI and total and s.c. fat mass.  In conclusion, expression of 11β-HSD-1 in s.c. adipose tissue is increased in human acquired obesity and is closely related to accumulation of s.c. and intraabdominal fat and features of insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruTvr6BBAoT7Vg90H21EOLACvtfcHk0lhB9D1-C2TjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslWht74%253D&md5=faf0beaeba494bf1e99728a78026139a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1210%2Fjc.2004-0153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2004-0153%26sid%3Dliteratum%253Aachs%26aulast%3DKannisto%26aufirst%3DK.%26aulast%3DPietilaeinen%26aufirst%3DK.%2BH.%26aulast%3DEhrenborg%26aufirst%3DE.%26aulast%3DRissanen%26aufirst%3DA.%26aulast%3DKaprio%26aufirst%3DJ.%26aulast%3DHamsten%26aufirst%3DA.%26aulast%3DYki-Jaervinen%26aufirst%3DH.%26atitle%3DOverexpression%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase-1%2520in%2520adipose%2520tissue%2520is%2520associated%2520with%2520acquired%2520obesity%2520and%2520features%2520of%2520insulin%2520resistance%253A%2520Studies%2520in%2520young%2520adult%2520monozygotic%2520twins%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2004%26volume%3D89%26spage%3D4414%26epage%3D4421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bercot, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komorowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Véniant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">2-(<i>S</i>)-Phenethylaminothiazolones as potent, orally efficacious inhibitors of 11β-hydroxysteroid dehydrogenase type 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061214f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=429-432&author=D.+J.+St.+Jeanauthor=C.+Yuanauthor=E.+A.+Bercotauthor=R.+Cupplesauthor=M.+Chenauthor=J.+Fretlandauthor=C.+Haleauthor=R.+W.+Hungateauthor=R.+Komorowskiauthor=M.+V%C3%A9niantauthor=M.+Wangauthor=X.+Zhangauthor=C.+Fotsch&title=2-%28S%29-Phenethylaminothiazolones+as+potent%2C+orally+efficacious+inhibitors+of+11%CE%B2-hydroxysteroid+dehydrogenase+type+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm061214f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061214f%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DBercot%26aufirst%3DE.%2BA.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DFretland%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DKomorowski%26aufirst%3DR.%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3D2-%2528S%2529-Phenethylaminothiazolones%2520as%2520potent%252C%2520orally%2520efficacious%2520inhibitors%2520of%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D429%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Yuan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedenborg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6056</span><span class="NLM_x">–</span> <span class="NLM_lpage">6061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6056-6061&author=C.+Yuanauthor=D.+J.+St.+Jeanauthor=Q.+Liuauthor=L.+Caiauthor=A.+Liauthor=N.+Hanauthor=G.+Monizauthor=B.+Askewauthor=R.+W.+Hungateauthor=L.+Johanssonauthor=L.+Tedenborgauthor=D.+Pyringauthor=M.+Williamsauthor=C.+Haleauthor=M.+Chenauthor=R.+Cupplesauthor=J.+Zhangauthor=S.+Jordanauthor=M.+D.+Bartbergerauthor=Y.+Sunauthor=M.+Emeryauthor=M.+Wangauthor=C.+Fotsch&title=The+discovery+of+2-anilinothiazolones+as+11%CE%B2-HSD1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DN.%26aulast%3DMoniz%26aufirst%3DG.%26aulast%3DAskew%26aufirst%3DB.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DJohansson%26aufirst%3DL.%26aulast%3DTedenborg%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DEmery%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%25202-anilinothiazolones%2520as%252011%25CE%25B2-HSD1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6056%26epage%3D6061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Véniant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span> </span><span class="NLM_article-title">Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1111%2Fj.1747-0285.2007.00603.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=18069989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvF2lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=36-44&author=C.+Haleauthor=M.+V%C3%A9niantauthor=Z.+Wangauthor=M.+Chenauthor=J.+McCormickauthor=R.+Cupplesauthor=D.+Hickmanauthor=X.+Minauthor=A.+Sudomauthor=H.+Xuauthor=G.+Matsumotoauthor=C.+Fotschauthor=D.+J.+St.+Jeanauthor=M.+Wang&title=Structural+characterization+and+pharmacodynamic+effects+of+an+orally+active+11beta-hydroxysteroid+dehydrogenase+type+1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization and pharmacodynamic effects of an orally active 11β-hydroxysteroid dehydrogenase type 1 inhibitor</span></div><div class="casAuthors">Hale, Clarence; Veniant, Murielle; Wang, Zhulun; Chen, Michelle; McCormick, Jocelyn; Cupples, Rod; Hickman, Dean; Min, Xiaoshan; Sudom, Athena; Xu, Haoda; Matsumoto, Guy; Fotsch, Christopher; St. Jean, David J., Jr.; Wang, Minghan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">11β-Hydroxysteroid dehydrogenase type 1 regulates glucocorticoid action and inhibition of this enzyme is a viable therapeutic strategy for the treatment of type 2 diabetes and the metabolic syndrome.  Here, the authors report a potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor with a binding mode elucidated from the cocrystal structure with the human 11β-hydroxysteroid dehydrogenase type 1.  The inhibitor is bound to the steroid-binding pocket making contacts with the catalytic center and the solvent channel.  The inhibitor binding is facilitated by two direct hydrogen bond interactions involving Tyrosine-183 of the catalytic motif Tyr-X-X-X-Lys and Alanine-172.  In addn., the inhibitor makes many hydrophobic interactions with both the enzyme and the cofactor NADP (reduced).  In lean C57BL/6 mice, the compd. inhibited both the in vivo and ex vivo 11β-hydroxysteroid dehydrogenase type 1 activities in a dose-dependent manner.  The inhibitory effects correlate with the plasma compd. concns., suggesting that there is a clear pharmacokinetic and pharmacodynamic relationship.  Moreover, at the same doses used in the pharmacokinetic/pharmacodynamic studies, the inhibitor did not cause the activation of the hypothalamic-pituitary-adrenal axis in an acute mouse model, suggesting that this compd. exhibits biol. effects with minimal risk of activating the hypothalamic-pituitary-adrenal axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraRZglcwGWX7Vg90H21EOLACvtfcHk0lh4exZtesKO5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvF2lsLs%253D&md5=5b65b29897b0548a751f794ae145094b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00603.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00603.x%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DC.%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMcCormick%26aufirst%3DJ.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DSudom%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26atitle%3DStructural%2520characterization%2520and%2520pharmacodynamic%2520effects%2520of%2520an%2520orally%2520active%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitor%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D71%26spage%3D36%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Véniant, M.; Hale, C.; Komorowski, R.; Chen, M. M.; St. Jean, D. J.; Fotsch, C.; Wang, M.</span><span> </span><span class="NLM_article-title">Time of the day for 11β-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice</span>.  <span class="citation_source-journal">Diabetes, Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span>, in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&author=M.+V%C3%A9niant&author=C.+Hale&author=R.+Komorowski&author=M.+M.+Chen&author=D.+J.+St.+Jean&author=C.+Fotsch&author=M.+Wang&title=Time+of+the+day+for+11%CE%B2-HSD1+inhibition+plays+a+role+in+improving+glucose+homeostasis+in+DIO+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26atitle%3DTime%2520of%2520the%2520day%2520for%252011%25CE%25B2-HSD1%2520inhibition%2520plays%2520a%2520role%2520in%2520improving%2520glucose%2520homeostasis%2520in%2520DIO%2520mice%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2008%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radominska-Pandya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemaitis, M. A.</span><span> </span><span class="NLM_article-title">Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=442-449&author=W.+Xieauthor=H.+Uppalauthor=S.+P.+S.+Sainiauthor=Y.+Muauthor=J.+M.+Littleauthor=A.+Radominska-Pandyaauthor=M.+A.+Zemaitis&title=Orphan+nuclear+receptor-mediated+xenobiotic+regulation+in+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26aulast%3DUppal%26aufirst%3DH.%26aulast%3DSaini%26aufirst%3DS.%2BP.%2BS.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DLittle%26aufirst%3DJ.%2BM.%26aulast%3DRadominska-Pandya%26aufirst%3DA.%26aulast%3DZemaitis%26aufirst%3DM.%2BA.%26atitle%3DOrphan%2520nuclear%2520receptor-mediated%2520xenobiotic%2520regulation%2520in%2520drug%2520metabolism%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D442%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkovec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span> </span><span class="NLM_article-title">Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=124-138&author=Y.+D.+Gaoauthor=S.+H.+Olsonauthor=J.+M.+Balkovecauthor=Y.+Zhuauthor=I.+Royoauthor=J.+Yabutauthor=R.+Eversauthor=E.+Y.+Tanauthor=W.+Tangauthor=D.+P.+Hartleyauthor=R.+T.+Mosley&title=Attenuating+pregnane+X+receptor+%28PXR%29+activation%3A+a+molecular+modelling+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DOlson%26aufirst%3DS.%2BH.%26aulast%3DBalkovec%26aufirst%3DJ.%2BM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DRoyo%26aufirst%3DI.%26aulast%3DYabut%26aufirst%3DJ.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DE.%2BY.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26atitle%3DAttenuating%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520activation%253A%2520a%2520molecular%2520modelling%2520approach%26jtitle%3DXenobiotica%26date%3D2007%26volume%3D37%26spage%3D124%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Watkins, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisely, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redinbo, M. R.</span><span> </span><span class="NLM_article-title">The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">2329</span><span class="NLM_x">–</span> <span class="NLM_lpage">2333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1126%2Fscience.1060762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11408620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2001&pages=2329-2333&author=R.+E.+Watkinsauthor=G.+B.+Wiselyauthor=L.+B.+Mooreauthor=J.+L.+Collinsauthor=M.+H.+Lambertauthor=S.+P.+Williamsauthor=T.+M.+Willsonauthor=S.+A.+Kliewerauthor=M.+R.+Redinbo&title=The+human+nuclear+xenobiotic+receptor+PXR%3A+Structural+determinants+of+directed+promiscuity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity</span></div><div class="casAuthors">Watkins, Ryan E.; Wisely, G. Bruce; Moore, Linda B.; Collins, Jon L.; Lambert, Millard H.; Williams, Shawn P.; Willson, Timothy M.; Kliewer, Steven A.; Redinbo, Matthew R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5525</span>),
    <span class="NLM_cas:pages">2329-2333</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The human nuclear pregnane X receptor (hPXR) activates cytochrome P 450-3A expression in response to a wide variety of xenobiotics and plays a crit. role in mediating dangerous drug-drug interactions.  The authors present the crystal structures of the ligand-binding domain of hPXR both alone and in complex with the cholesterol-lowering drug SR12813 at resolns. of 2.5 and 2.75 angstroms, resp.  The hydrophobic ligand-binding cavity of hPXR contains a small no. of polar residues, permitting SR12813 to bind-in three distinct orientations.  The position and nature of these polar residues were found to be crit. for establishing the precise pharmacol. activation profile of PXR.  The findings provide important insights into how hPXR detects xenobiotics and may prove useful in predicting and avoiding drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGros5DlMM1w9rVg90H21EOLACvtfcHk0lizkbGnFzZaIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSht7c%253D&md5=f78d0d3e742427fc771a3c958b07be5a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1060762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1060762%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DR.%2BE.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DRedinbo%26aufirst%3DM.%2BR.%26atitle%3DThe%2520human%2520nuclear%2520xenobiotic%2520receptor%2520PXR%253A%2520Structural%2520determinants%2520of%2520directed%2520promiscuity%26jtitle%3DScience%26date%3D2001%26volume%3D292%26spage%3D2329%26epage%3D2333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span> </span><span class="NLM_article-title">A pharmacophore for human pregnane X receptor ligands</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=96-99&author=S.+Ekinsauthor=J.+A.+Erickson&title=A+pharmacophore+for+human+pregnane+X+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26atitle%3DA%2520pharmacophore%2520for%2520human%2520pregnane%2520X%2520receptor%2520ligands%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Henriksson, M.; Homan, E.; Johansson, L.; Vallgårda, J.; Williams, M.; Bercot, E. A.; Fotsch, C. H.; Li, A.; Cai, G.; Hungate, R. W.; Yuan, C. C.; Tegley, C.; St. Jean, D. J.,  Jr.; Han, N.; Huang, Q.; Liu, Q.; Bartberger, M. D.; Moniz, G. A.; Frizzle, M. J.; Marshall, T. L.</span> Preparation of 2-aminothiazolin-4-ones as inhibitors of 11β-hydroxy steroid dehydrogenase type 1. WO2007061661, 20070531, 2007.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Henriksson%2C+M.%3B+Homan%2C+E.%3B+Johansson%2C+L.%3B+Vallg%C3%A5rda%2C+J.%3B+Williams%2C+M.%3B+Bercot%2C+E.+A.%3B+Fotsch%2C+C.+H.%3B+Li%2C+A.%3B+Cai%2C+G.%3B+Hungate%2C+R.+W.%3B+Yuan%2C+C.+C.%3B+Tegley%2C+C.%3B+St.+Jean%2C+D.+J.%2C+Jr.%3B+Han%2C+N.%3B+Huang%2C+Q.%3B+Liu%2C+Q.%3B+Bartberger%2C+M.+D.%3B+Moniz%2C+G.+A.%3B+Frizzle%2C+M.+J.%3B+Marshall%2C+T.+L.+Preparation+of+2-aminothiazolin-4-ones+as+inhibitors+of+11%CE%B2-hydroxy+steroid+dehydrogenase+type+1.+WO2007061661%2C+20070531%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksson%26aufirst%3DM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">In the following reference, the authors noted that there are some compounds that bind PXR but do not activate the receptor:</p></div><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubaquie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanchunas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickinson, K.</span><span> </span><span class="NLM_article-title">Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1177%2F1087057104264902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15452340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosF2nu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=533-540&author=Z.+Zhuauthor=S.+Kimauthor=T.+Chenauthor=J.-H.+Linauthor=A.+Bellauthor=J.+Brysonauthor=Y.+Dubaquieauthor=N.+Yanauthor=J.+Yanchunasauthor=D.+Xieauthor=R.+Stoffelauthor=M.+Sinzauthor=K.+Dickinson&title=Correlation+of+high-throughput+pregnane+X+receptor+%28PXR%29+transactivation+and+binding+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays</span></div><div class="casAuthors">Zhu, Zhengrong; Kim, Sean; Chen, Taosheng; Lin, Jun-Hsiang; Bell, Aneka; Bryson, James; Dubaquie, Yves; Yan, Ning; Yanchunas, Joseph; Xie, Dianlin; Stoffel, Robert; Sinz, Michael; Dickinson, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-540</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Pregnane X receptor (PXR) transactivation and binding assays have been developed into high-throughput assays, which are robust and reproducible (Z' > 0.5).  For most compds., there was a good correlation between the results of the transactivation and binding assays.  EC50 values of compds. in the transactivation assay correlated reasonably well with their IC50 values in the binding assay.  However, there were discrepancies with some compds. showing high binding affinity in the binding assay translated into low transactivation.  The most likely cause for these discrepancies was an agonist dependent relation between binding affinity and transactivation response.  In general, compds. that bound to human PXR and transactivated PXR tended to be large hydrophobic mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpARKEiyaVugLVg90H21EOLACvtfcHk0lh3BJgQw1z2tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosF2nu7g%253D&md5=b7b02b49016156d7dc847de32d5cc3e8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1177%2F1087057104264902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104264902%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DJ.-H.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DBryson%26aufirst%3DJ.%26aulast%3DDubaquie%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DN.%26aulast%3DYanchunas%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DStoffel%26aufirst%3DR.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DDickinson%26aufirst%3DK.%26atitle%3DCorrelation%2520of%2520high-throughput%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520transactivation%2520and%2520binding%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D533%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">The stereochemistry of this compound was confirmed by the single-crystal X-ray structure. See the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+stereochemistry+of+this+compound+was+confirmed+by+the+single-crystal+X-ray+structure.+See+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Johansson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komorowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moniz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orihuela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Véniant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">2-Amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: Enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2933</span><span class="NLM_x">–</span> <span class="NLM_lpage">2943</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701551j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2933-2943&author=L.+Johanssonauthor=C.+Fotschauthor=M.+D.+Bartbergerauthor=V.+M.+Castroauthor=M.+Chenauthor=M.+Emeryauthor=S.+Gustafssonauthor=C.+Haleauthor=D.+Hickmanauthor=E.+Homanauthor=S.+R.+Jordanauthor=R.+Komorowskiauthor=A.+Liauthor=K.+McRaeauthor=G.+Monizauthor=G.+Matsumotoauthor=C.+Orihuelaauthor=G.+Palmauthor=M.+V%C3%A9niantauthor=M.+Wangauthor=M.+Williamsauthor=J.+Zhang&title=2-Amino-1%2C3-thiazol-4%285H%29-ones+as+potent+and+selective+11beta-hydroxysteroid+dehydrogenase+type+1+inhibitors%3A+Enzyme-ligand+co-crystal+structure+and+demonstration+of+pharmacodynamic+effects+in+C57Bl%2F6+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm701551j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701551j%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DL.%26aulast%3DFotsch%26aufirst%3DC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DCastro%26aufirst%3DV.%2BM.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DEmery%26aufirst%3DM.%26aulast%3DGustafsson%26aufirst%3DS.%26aulast%3DHale%26aufirst%3DC.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHoman%26aufirst%3DE.%26aulast%3DJordan%26aufirst%3DS.%2BR.%26aulast%3DKomorowski%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DMcRae%26aufirst%3DK.%26aulast%3DMoniz%26aufirst%3DG.%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DOrihuela%26aufirst%3DC.%26aulast%3DPalm%26aufirst%3DG.%26aulast%3DV%25C3%25A9niant%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3D2-Amino-1%252C3-thiazol-4%25285H%2529-ones%2520as%2520potent%2520and%2520selective%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitors%253A%2520Enzyme-ligand%2520co-crystal%2520structure%2520and%2520demonstration%2520of%2520pharmacodynamic%2520effects%2520in%2520C57Bl%252F6%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2933%26epage%3D2943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sinnokrot, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrill, C. D.</span><span> </span><span class="NLM_article-title">Substituent effects in π−π interactions: Sandwich and T-shaped configurations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">7690</span><span class="NLM_x">–</span> <span class="NLM_lpage">7697</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja049434a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=7690-7697&author=M.+O.+Sinnokrotauthor=C.+D.+Sherrill&title=Substituent+effects+in+%CF%80%E2%88%92%CF%80+interactions%3A+Sandwich+and+T-shaped+configurations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja049434a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja049434a%26sid%3Dliteratum%253Aachs%26aulast%3DSinnokrot%26aufirst%3DM.%2BO.%26aulast%3DSherrill%26aufirst%3DC.%2BD.%26atitle%3DSubstituent%2520effects%2520in%2520%25CF%2580%25E2%2588%2592%25CF%2580%2520interactions%253A%2520Sandwich%2520and%2520T-shaped%2520configurations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D7690%26epage%3D7697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">LeCluyse, E. L.</span><span> </span><span class="NLM_article-title">Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2FS0928-0987%2801%2900135-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11408150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkt1yisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=343-368&author=E.+L.+LeCluyse&title=Human+hepatocyte+culture+systems+for+the+in+vitro+evaluation+of+cytochrome+P450+expression+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation</span></div><div class="casAuthors">LeCluyse, E. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-368</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 103 refs.  Primary cultures of human hepatocytes have been used extensively by both academic and industrial labs. for evaluating the hepatic disposition of drugs and other xenobiotics.  Their primary utility has been for assessing the induction potential of new chem. entities (NCEs) and they continue to serve as the gold std.  Primary considerations for conducting in vitro drug testing utilizing cultures of human hepatocytes, such as the effects of culture and study conditions, are discussed.  The maintenance of normal cellular physiol. and intercellular contacts in vitro is of particular importance for optimal phenotypic gene expression and response to drugs and other xenobiotics.  Significant advances in our understanding of cytochrome P 450 (CYP450) enzyme regulation have been made with the recent identification of the nuclear receptors mediating the induction of CYP2B and CYP3A enzymes.  In particular, the activation of pregnane X receptor (PXR) by prototypical inducers of CYP3A has been found to correlate well with the species-specific modulation of CYP3A by various drugs and other xenobiotics.  Concomitant with the discovery of PXR has been the identification of compds. that may act synergistically or antagonistically on multiple receptors (e.g., co-repressors and/or co-activators of the receptor) introducing novel mechanisms of drug-drug interactions.  Differential expression of the individual isoforms of the major CYP450 enzymes over time in culture suggest that this model system is not reflective of in vivo profiles and, therefore, may be limited in its application for drug metab. studies.  Overall, primary cultures of human hepatocytes can serve as a sensitive and selective model for predicting the regulation of CYP450 modulation by drugs and other xenobiotics.  Considerations and recommendations for standardizing testing conditions and choosing relevant endpoint(s) are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoySxZj9XLhfrVg90H21EOLACvtfcHk0lh3BJgQw1z2tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkt1yisLY%253D&md5=9376441e1ae9f11fa5cb349713844fe4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2801%2900135-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252801%252900135-X%26sid%3Dliteratum%253Aachs%26aulast%3DLeCluyse%26aufirst%3DE.%2BL.%26atitle%3DHuman%2520hepatocyte%2520culture%2520systems%2520for%2520the%2520in%2520vitro%2520evaluation%2520of%2520cytochrome%2520P450%2520expression%2520and%2520regulation%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D13%26spage%3D343%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. P.</span><span> </span><span class="NLM_article-title">Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2FS0009-2797%2801%2900162-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=11336975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFCrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=271-281&author=C.+Luauthor=A.+P.+Li&title=Species+comparison+in+P450+induction%3A+effects+of+dexamethasone%2C+omeprazole%2C+and+rifampin+on+P450+isoforms+1A+and+3A+in+primary+cultured+hepatocytes+from+man%2C+Sprague-Dawley+rat%2C+minipig%2C+and+beagle+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog</span></div><div class="casAuthors">Lu, C.; Li, A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Induction of P 450 isoforms 1A (CYP1A) and 3A (CYP3A) by model inducers dexamethasone, omeprazole and rifampin was evaluated in primary cultured hepatocytes from man and lab. animals.  Inducer-specific species-differences were obsd.  Results with human hepatocytes from six human donors consistently show that both rifampin and dexamethasone were inducers of CYP3A activity (measured as testosterone 6β-hydroxylase activity), with rifampin being more potent.  Conversely, in rat hepatocytes, dexamethasone was a potent CYP3A inducer while rifampin was not an inducer.  Rifampin but not dexamethasone induced CYP3A in minipig and beagle dog hepatocytes.  Omeprazole was a potent inducer of CYP1A activity (measured as ethoxyresorufin-O-deethylase activity) in human, beagle dog and minipig hepatocytes, and not an inducer in rat hepatocytes.  The species-differences obsd. suggest that human hepatocytes represent the most appropriate preclin. exptl. system for the evaluation of P 450 induction in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRuU3adtVrObVg90H21EOLACvtfcHk0lgD7QxZSZLgRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFCrtb4%253D&md5=3a3021ca72fc55394876d39788480fcd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2801%2900162-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252801%252900162-4%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DA.%2BP.%26atitle%3DSpecies%2520comparison%2520in%2520P450%2520induction%253A%2520effects%2520of%2520dexamethasone%252C%2520omeprazole%252C%2520and%2520rifampin%2520on%2520P450%2520isoforms%25201A%2520and%25203A%2520in%2520primary%2520cultured%2520hepatocytes%2520from%2520man%252C%2520Sprague-Dawley%2520rat%252C%2520minipig%252C%2520and%2520beagle%2520dog%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2001%26volume%3D134%26spage%3D271%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Li, A. P.</span><span> </span><span class="NLM_article-title">Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions</span> <span class="citation_source-journal">Adv. Pharmacol. (San Diego)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1016%2FS1054-3589%2808%2960203-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=9342174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1aksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1997&pages=103-130&author=A.+P.+Li&title=Primary+hepatocyte+cultures+as+an+in+vitro+experimental+model+for+the+evaluation+of+pharmacokinetic+drug-drug+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions</span></div><div class="casAuthors">Li, Albert P.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">Drug-Drug Interactions: Scientific and Regulatory Perspectives</span>),
    <span class="NLM_cas:pages">103-130</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review with over 70 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHUwBsyCmUqbVg90H21EOLACvtfcHk0lgD7QxZSZLgRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1aksL8%253D&md5=e2370c559cb996618e45ea66428b766a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1054-3589%2808%2960203-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1054-3589%252808%252960203-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%2BP.%26atitle%3DPrimary%2520hepatocyte%2520cultures%2520as%2520an%2520in%2520vitro%2520experimental%2520model%2520for%2520the%2520evaluation%2520of%2520pharmacokinetic%2520drug-drug%2520interactions%26jtitle%3DAdv.%2520Pharmacol.%2520%2528San%2520Diego%2529%26date%3D1997%26volume%3D43%26spage%3D103%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><div class="note"><p class="first last">This thiazolone was prepared using the alternative method described for the synthesis of compound <b>16</b>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=This+thiazolone+was+prepared+using+the+alternative+method+described+for+the+synthesis+of+compound+16."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><div class="note"><p class="first last">The nuclear receptor luciferase reporter gene assay was conducted with human PXR fused with a firefly luciferase promoter transfected into HEK cells. For a detailed protocol employing a similar system, see</p></div><span class="NLM_contrib-group">Bility, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butala, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanden Heuvel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. M.</span><span> </span><span class="NLM_article-title">Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm801073z&amp;key=10.1093%2Ftoxsci%2Fkfh253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm801073z&amp;key=15310864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm801073z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2004&pages=170-182&author=M.+T.+Bilityauthor=J.+T.+Thompsonauthor=R.+H.+McKeeauthor=R.+M.+Davidauthor=J.+H.+Butalaauthor=J.+P.+Vanden+Heuvelauthor=J.+M.+Peters&title=Activation+of+mouse+and+human+peroxisome+proliferator-activated+receptors+%28PPARs%29+by+phthalate+monoesters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters</span></div><div class="casAuthors">Bility, Moses T.; Thompson, Jerry T.; McKee, Richard H.; David, Raymond M.; Butala, John H.; Vanden Heuvel, John P.; Peters, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">170-182</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Administration of phthalates is known to cause toxicity and liver cancer in rodents through the activation of peroxisome proliferator-activated receptors (PPARs), and the monoesters appear to be the active metabolites that function as ligands of PPARs.  There is evidence that PPARs exhibit significant species differences in response to ligand activation.  In this study, the activation of mouse and human PPARα, PPARβ, and PPARγ by a broad class of phthalate monoesters was investigated using a trans-activation assay, functional anal. of PPARα target gene expression, and a PPARγ-mediated differentiation assay.  These studies demonstrated a range in the ability of various phthalate monoesters to activate PPARα, with the mouse PPARα generally being activated at lower concns. and exhibiting a greater response than human PPARα.  Similarly, a range in the trans-activation of mouse PPARβ by phthalate monoesters was also obsd., but this effect was not found with human PPARβ.  A no. of phthalate monoesters activated both mouse and human PPARγ, with similar sensitivity being exhibited by both receptors.  These studies show that the potency and efficacy of phthalate monoesters for the activation of PPARα and PPARγ increase with increasing side-chain length.  These studies also show that mouse PPARα and PPARβ are generally activated at lower concns. of phthalate monoesters than human PPARα and PPARβ, and that both mouse and human PPARγ exhibit similar sensitivity to phthalate monoesters.  Lastly, there is a good relationship between the relative ability of phthalate monoesters to trans-activate PPARα and PPARγ, and the relative induction of PPARα target gene mRNA and PPARγ-mediated adipocyte differentiation, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi9tBxttCJLLVg90H21EOLACvtfcHk0lgD7QxZSZLgRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLY%253D&md5=ca1345a28f90ac6d022aad298a65445b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfh253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfh253%26sid%3Dliteratum%253Aachs%26aulast%3DBility%26aufirst%3DM.%2BT.%26aulast%3DThompson%26aufirst%3DJ.%2BT.%26aulast%3DMcKee%26aufirst%3DR.%2BH.%26aulast%3DDavid%26aufirst%3DR.%2BM.%26aulast%3DButala%26aufirst%3DJ.%2BH.%26aulast%3DVanden%2BHeuvel%26aufirst%3DJ.%2BP.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520mouse%2520and%2520human%2520peroxisome%2520proliferator-activated%2520receptors%2520%2528PPARs%2529%2520by%2520phthalate%2520monoesters%26jtitle%3DToxicol.%2520Sci.%26date%3D2004%26volume%3D82%26spage%3D170%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i83"><a href="/doi/suppl/10.1021/jm801073z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62275"></div></div></div></div></div><hr /></hr><p class="last">Analytical data for final compounds and X-ray structure coordinates for (<i>S</i>)-<b>33a</b> and (<i>S</i>)-<b>33a</b> with human 11β-HSD1 (PDB ID: 3EY4). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801073z/suppl_file/jm801073z_si_001.pdf">jm801073z_si_001.pdf (1.08 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm801073z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-24%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm801073z%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm801073z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                441KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c8f52f4d3dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
